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Proper progression through mitosis ensures the maintenance of whole chromosomal 
stability in a eukaryotic cell. Hence, failures during this tightly regulated process can lead 
to the perpetual mis-segregation of whole chromosomes, which is referred to as 
chromosomal instability (CIN). This process results in the generation of aneuploidy and 
an increased genetic variability contributing to tumourigenesis and tumour progression. 
Although CIN is a major hallmark of human cancer, the underlying mechanisms leading 
to perpetual chromosome mis-segregation during mitosis are largely unknown. 
Interestingly, the tumour suppressor Brca1 and its positive regulator Chk2 were found to 
be crucial for the proper regulation of spindle microtubule plus end polymerization within 
mitotic spindles, which is pivotal for correct microtubule-kinetochore attachments and 
faithful chromosome segregation. Consequently, loss of the CHK2-BRCA1 axis leads to 
enhanced spindle microtubule plus end assembly and the induction of CIN. Despite the 
importance of these findings the underlying molecular mechanism remained elusive and 
the regulation of Brca1 during mitosis is still poorly understood. 
In this study we identified the centrosomal protein Cep72 as a novel Brca1-interacting 
protein. Importantly, Cep72 was found to be frequently upregulated in human colorectal 
cancer suggesting that CEP72 represents a putative oncogene. Overexpression of CEP72 
mirrors mitotic defects seen upon loss of BRCA1 or its positive regulator CHK2, indicating 
a possible function for Cep72 in negatively regulating Brca1 during mitosis. In detail, 
overexpression of CEP72 results in enhanced spindle microtubule plus end polymerization 
rates causing spindle assembly defects, lagging chromosomes and the induction of CIN. 
Intriguingly, these defects can be suppressed by concomitantly increasing the levels of 
the positive Brca1 regulator Chk2. Vice versa, reducing the Cep72 protein levels restores 
proper microtubule plus end polymerization and spindle assembly in cells with a partial 
loss of CHK2. Thus, my results suggest that the mitotic function of Brca1 is positively 
regulated by Chk2, and counteracted by Cep72. Furthermore, the balanced regulation of 
Brca1 by Chk2 and Cep72 seems to be crucial for proper microtubule dynamics and 









1.1 The eukaryotic cell cycle 
Proliferating eukaryotic cells pass through a series of stages, which are collectively known 
as the cell cycle. Characterized by cell growth and cell division, the eukaryotic cell cycle 
comprises four phases, mitosis, gap 1 (G1) phase, DNA-synthesis phase (S-phase) and 
G2 phase (Figure 1.1). Together, G1-, S- and G2-phase are referred to as interphase. 
After a cell emerged from a cell division it grows in size during G1 and prepares for 
chromosome duplication. In the absence of growth signals, the cell can exit from the cell 
cycle and enter a quiescent state called G0. However, depending on cell type, cell size, 
nutrient availability or mitogenic signalling, the cell can re-enter the cycle by passing the 
restriction point. In the following S-phase the DNA is replicated and the centrosome, 
which forms the major microtubule organizing centre in the cell, duplicates. 
Subsequently, in the second gap phase (G2), the cell prepares for cell division by 
synthesizing essential proteins. During mitosis, the replicated DNA is equally segregated 
onto two emerging daughter cells, which re-enter G1 phase and start a new cell cycle on 
their own (Morgan 2007; Alberts et al. 2007).  
1.2 Regulation of the cell cycle by reversible protein phosphorylation 
and ubiquitin-mediated protein proteolysis 
The cell cycle progression is controlled by cyclin-dependent kinases (Cdks), which 
phosphorylate and therefore control the activity, stability and localization of proteins that 
are responsible for individual cell cycle processes. While Cdks are present throughout the 
cell cycle, their activity is tightly regulated by the formation of complexes with their 
regulatory subunits, the cyclins. The cell cycle dependent expression and proteasomal 
degradation of cyclins causes the oscillating activation of Cdks (Figure 1.1). Whereas 
initially in G1 all cyclin-Cdk complexes are inactive to prevent an unscheduled entry into 
the cell cycle, Cdk4 and Cdk6 are activated by cyclin D when cells pass the restriction 
point upon mitogenic signalling. Cyclin A and E control Cdk2 activation and mediate the 
entry into S-phase. In G2-phase the levels of cyclin B constantly increase, which, 
together with cyclin A and C, triggers the enzymatic activity of Cdk1 and thereby the 
entry into mitosis. Moreover, in metaphase, the proteasomal destruction of cyclin B and 
securin, a protein that controls sister chromatid cohesion, enables the metaphase to 
anaphase transition and thus, the termination of mitosis (Morgan 2007). 





Figure 1.1 The cell cycle and its regulation. The cell cycle consists of four phases: G1 phase, 
S-phase and G2-phase, which are referred to as interphase and mitosis representing the stage of 
cell division. The cell cycle is regulated by CDKs which are activated by different cyclins oscillating 
in a cell cycle dependent manner. Parts of the graphic were modified from Morgan, 2007. 
 
Although cyclins are the major regulators of Cdks, their binding alone is not sufficient to 
achieve a full activation. For this, an activating phosphorylation mediated by a Cdk-
activating kinase (CAK) is required. Beyond, two inhibitory phosphorylations at Thr14 and 
Tyr15 play an important role for the regulation of Cdk activity. While they are catalysed 
by the kinases Wee1 and Myt1 in a localization dependent manner, their removal is 
carried out by phosphatases of the Cdc25 family. These antagonistically acting enzymes 
enable the switch-like activation of cyclin B/Cdk1 in late G2-phase, whereupon they are 
themselves regulated by their own substrate. Consequently, Cyclin B/Cdk1 mediated 
phosphorylation represses Wee1/Myt1 and promotes Cdc25 activity, hence, creating a 
positive feedback loop for cyclin B/Cdk1 activation and enabling the entry into mitosis. 
Moreover, Wee1 and Cdc25 are crucial for the cellular response upon DNA damage in S- 
and G2-phase. In addition to Cdk activity regulation by reversible phosphorylation, the 
degradation of regulatory proteins and cyclins by ubiquitin-mediated protein proteolysis 
is essential for irreversible cell cycle progression. In this connection, the E3-ubiquitin 




ligase Skp1/Cul1/F-box (SCF) and the anaphase- promoting complex/cyclosome (APC/C) 
are of utmost importance (Morgan 2007; Alberts et al. 2007). 
1.3 The ubiquitin pathway 
The vast majority of proteins involved in all cellular processes are regulated by post-
translational ubiquitination. While the best-known function of ubiquitination is to target 
proteins for degradation by the 26S proteasome, it also leads to activation and 
deactivation of proteins, modulates protein-protein-interactions and affects their cellular 
localization (Mukhopadhyay & Riezman 2009; Schnell & Hicke 2003; Metzger et al. 2012; 
Hershko & Ciechanover 1998). Ubiquitin is a 76 amino acid polypeptide of ~8.5 kDa, 
which is attached to substrates in a three step process. It starts with the ATP-dependent 
covalent binding of ubiquitin to the ubiquitin activating enzyme E1. The ubiquitin-
conjugating enzyme E2 binds to both proteins and catalyses the transfer of the activated 
ubiquitin from E1 to its own active site. Finally, the ubiquitin transfer to substrate 
proteins is mediated by the E3 ubiquitin ligase, which functions as the substrate 
recognition module (Metzger et al. 2012; Hershko & Ciechanover 1998; Komander 
2009). E3 ubiquitin ligases are subdivided into two main classes: really interesting gene 
(RING) finger E3s (as well as RING-related E3s) and homologous to the E6-AP carboxyl 
terminus (HECT) domain E3s. Whereas HECT domain E3 ubiquitin ligases transiently bind 
the activated ubiquitin prior to substrate ubiquitination, RING finger E3s catalyse the 
direct transfer of ubiquitin from the E2 activating enzyme to the substrate (Metzger et al. 
2012). Monoubiquitination of proteins can either serve as modulating posttranslational 
modification or form the priming site for the assembly of polyubiquitin chains. Ubiquitin 
itself contains seven lysine residues (Lys6, 11, 27, 29, 33, 48 and 63), which provide 
potential acceptor sites for the addition of further ubiquitin proteins. The best studied and 
most abundant polyubiquitination is linked to the Lys48 site chain, which targets the 
substrate protein for proteasomal degradation (Komander 2009). Essential for protein 
degradation at metaphase to anaphase transition, the RING finger E3 ligase APC/C rather 
mediates Lys11- than Lys48-linkages, thus demonstrating that also Lys11-linked 
polyubiquitination plays an important role in proteolysis (Komander 2009; Primorac & 
Musacchio 2013). In contrast, the formation of Lys63-linked ubiquitin moieties and the 
more unusual polyubiquitination with Lys6-linkage serve as post-translational 
modification essential to modulate interactions and protein functions involved in DNA 
damage response or in signalling and trafficking processes (Komander 2009). While the 
human genome encodes only two E1 and 37 E2 enzymes, E3 ubiquitin ligases represent a 
group of over 600 different proteins indicating that the substrate specific, spatial and 
temporal highly regulated ubiquitination is mainly coordinated by E3 enzymes (Metzger 
et al. 2012; Komander 2009). Another important role in ubiquitin-dependent protein 




regulation is taken by deubiquitinating enzymes (DUBs), which remove ubiquitin moieties 
from substrate proteins and thereby counteract the ubiquitin-assembly pathway (Reyes 
Turcu et al. 2009; Komander et al. 2009). 
1.4 The E3-ubiquitin ligases SCF and APC/C 
The E3-ubiquitin ligases SCF and APC/C are crucial for cell cycle progression. 
SCF is named after its subunits Skp1, Cul1 and an F-box protein. Beyond, the SCF-
complex includes the RING finger motif containing protein Roc1/Rbx1, which is 
responsible for E2 protein binding (Lee & Diehl 2014; Vodermaier 2004; Morgan 2007). 
The substrate specificity is mediated by F-box proteins that bind the particular targets, 
whereupon the SCF mediated ubiquitination is triggered by their phosphorylation 
(Vodermaier 2004; Morgan 2007). Since the phosphorylation is typically catalysed by 
cyclin-dependent kinases, ubiquitination and proteolytic degradation of many proteins is 
tightly linked to specific cell cycle phases (Morgan 2007). The SCF-complex has a central 
function at the G1/S-transition where it is crucial for the destruction of Cdk inhibitory 
proteins like p21 or p27 enabling cell cycle progression and the entry into S-phase 
(Bornstein et al. 2003; Carrano et al. 1999; Morgan 2007). Moreover SCF is involved in 
G2/M-transition by promoting the proteasomal degradation of the Cdk inhibitor Wee1. 
The anaphase promoting complex or cyclosome consists of 15 subunits (Apc1-11, Apc13, 
Apc15-16 and Cdc26) and belongs to the group of RING finger E3 ubiquitin ligases 
(Primorac & Musacchio 2013). In contrast to the SCF-complex, which is active throughout 
the cell cycle, the activity of the APC/C is restricted to mitosis and G1 phase where it is 
responsible for the metaphase-to-anaphase transition and the exit from mitosis (Morgan 
2007; Primorac & Musacchio 2013; Vodermaier 2004). For this, two substrates are of 
major importance. The APC/C triggers the separase-dependent release of sister 
chromatid cohesion by targeting the separase inhibitor securin for proteasomal 
degradation. Hence, APC/C activation at metaphase, which is tightly controlled by the 
spindle assembly checkpoint, enables sister chromatid separation and anaphase onset. 
Concomitantly, the APC/C mediates the destruction of cyclin B leading to Cdk1 
inactivation and the completion of mitosis. The protein ubiquitination by the APC/C is 
temporally controlled by binding of the activator subunits Cdc20 and Cdh1, which 
coordinate APC/C activation and mediate substrate binding (Morgan 2007; Primorac & 
Musacchio 2013; Vodermaier 2004). Upon satisfaction of the spindle assembly checkpoint 
at metaphase, Cdk1-dependent phosphorylation and binding of the co-activator Cdc20 
lead to the activation of the anaphase-promoting complex. While in the presence of 
active Cdk1, Cdh1 is phosphorylated and, hence, inactivated, cyclin B degradation and 
Cdk1 inhibition in anaphase allows the dephosphorylation of Cdh1. Thus, Cdh1 binds to  
 




APC/C in late mitosis and maintains its activity in G1. When the cell enters a new cell 
cycle the APC/C is phosphorylated and inhibited by G1/S-Cdks (Morgan 2007; Primorac & 
Musacchio 2013). The substrate recognition by Cdc20 and Cdh1 is mediated by motifs in 
the amino acid sequence of the target protein, whereas the destruction box (D-box) and 
KEN-box motifs are prevalent (Morgan 2007). 
1.5 DNA damage response 
Each eukaryotic cell is subject to endogenous or environmental DNA damaging conditions 
like reactive oxygen species, ultraviolet light, background radiation or environmental 
mutagens (Smith et al. 2010; Morgan 2007; Reinhardt & Yaffe 2009). In order to 
faithfully maintain the encoded information and thus, the genetic stability of a cell, there 
is a need for DNA damage repair. While many forms of DNA damage can be quickly 
corrected, defects including nucleotide damage, stalled replication forks and double 
strand breaks trigger a DNA damage response, which blocks the cell cycle progression 
until the damaged sites are repaired. Since DNA damage can occur at any time of the cell 
cycle, eukaryotic cells are featured with DNA damage checkpoints at G1-, S- and G2 
phase (Morgan 2007; Shaltiel et al. 2015). The DNA damage response is orchestrated by 
the key protein kinases ataxia telangialectasia mutated (ATM) and ATM/Rad3-related 
(ATR), which are activated upon double strand breaks (DSBs) and by single stranded 
DNA (ssDNA), respectively (Smith et al. 2010; Shaltiel et al. 2015; Morgan 2007). The 
particular response differs with respect to the cell cycle phase at which the DNA damage 
occurs. Upon double strand breaks ATM is activated and recruited to damaged sites by a 
sensory complex consisting of Mre11, Rad50 and Nbs1 (MRN-complex). ATM 
phosphorylates the histone variant H2AX leading to the recruitment of mediator proteins 
like breast cancer 1, early onset (Brca1), mediator of DNA damage checkpoint 1 (MDC1), 
or p53 binding protein 1 (53BP1), which in turn amplify the ATM signal and provide a 
platform for the assembly of the DNA damage response machinery (Shaltiel et al. 2015; 
Morgan 2007). In addition, ATM activates the checkpoint kinase 2 (Chk2), which 
subsequently transduces the DNA damage response signal. In G1 phase, ATM and Chk2 
promote the stabilization of p53 leading to the transcription and accumulation of the Cdk 
inhibiting protein p21 (CDKN1A). Moreover, ATM activates the p38 MAPK family, which 
further stabilizes the p21 encoding mRNA. The p21-dependent inhibition of Cdk4/6 and 
Cdk2 is complemented by ATM-, Chk2- and p38-dependent pathways, which 
concomitantly promote the degradation of cyclin D and the Cdk activating phosphatase 
Cdc25A, hence, preventing S-phase entry (Shaltiel et al. 2015; Reinhardt et al. 2007). 
While in G1 phase DNA double strand breaks can only be repaired by error-prone non 
homologous end joining (NHEJ), error-free correction by homologous recombination (HR) 
is enabled in the presence of active Cdk2 during S- and G2-phase (Shaltiel et al. 2015). 




Single-stranded DNA generated by HR associated DNA-strand resection or stalled 
replication forks triggers the additional activation of ATR and the checkpoint kinase 1 
(Chk1). Although the activation of the ATM-Chk2- and ATR-Chk1-pathway stabilizes p53 
during S-phase, the accumulation of p21 during DNA replication is prevented by the 
PCNA-associated CRL4Cdt2 ubiquitin ligase (Shaltiel et al. 2015). Thus, in contrast to G1, 
the intra-S-phase arrest depends on Chk1 mediated activation of the Cdk inhibitor Wee1 
and Chk1/2 dependent inhibition of Cdc25A (Shaltiel et al. 2015; Reinhardt & Yaffe 
2009). For the checkpoint response in G2-phase, the Wee1 induced inhibition of Cdks 
remains crucial and the p21-dependent Cdk inhibition is reinstated. Whereas the ATM-
Chk2-pathway still controls the establishment of the cell cycle arrest, ATR-Chk1 pathway 
signalling is essential for the maintenance of the G2 checkpoint. Moreover, ATM/ATR 
dependent p38 signalling might induce the destruction of Cdc25A and B, hence, 
contributing to checkpoint maintenance in G2 (Shaltiel et al. 2015; Reinhardt et al. 
2007). 
1.6 Mitosis 
Mitosis represents the key event during the eukaryotic cell cycle, in which the duplicated 
DNA is equally distributed onto two emerging daughter cells. Coming along with dramatic 
morphological changes, mitosis is subdivided into five phases: prophase, prometaphase, 
metaphase, anaphase and telophase (Figure 1.2). In prophase the centrosomes maturate 
by growing in size and increasing their microtubule nucleation potential (Lee & Rhee 
2011; Menella et al. 2014; Menella et al. 2012). Additionally, the chromosomes condense 
and the centrosomes are separated, thus starting the assembly of a bipolar spindle, 
which is fundamental for proper chromosome segregation (Tanenbaum & Medema 2010; 
Morgan 2007). Moreover, the nuclear envelope breaks down (Burke & Ellenberg 2002). 
In prometaphase the spindle further develops and kinetochore protein complexes 
assemble at centromeric regions of the chromosomes, hence, providing docking sites for 
microtubules (Cheeseman et al. 2006; Cheeseman & Desai 2008; Cheeseman 2014). 
Dynamic microtubules search and capture the kinetochores and align the chromosomes 
at the equatorial plane. By excessive microtubules de novo nucleation and amplification 
huge kinetochore fibres consisting of 20-40 microtubules attach to the kinetochore 
protein complex (Meunier & Vernos 2012; McEwen et al. 1997). A correct amphitelic 
attachment mediates tension between the kinetochores of sister chromatids, which is 
needed for satisfying the spindle assembly checkpoint (SAC). One unattached 
kinetochore, which is accompanied by an unsatisfied SAC is sufficient to block the E3 
ubiquitin ligase APC/C that is indispensable for anaphase onset by targeting cyclin B and 
securin (amongst others) for proteasomal degradation. Finally, when all chromosomes  






Figure 1.2 Subphases of mitosis. Mitosis is subdivided into the five phases prophase, 
prometaphase, metaphase, anaphase and telophase. In prophase centrosomes undergo a 
maturation process and start to separate. Moreover the chromosomes condense and the nuclear 
envelope breaks down. During Prometaphase the spindle further develops and chromosomes are 
aligned in equatorial plane by microtubule search and capture. When the chromosomes are 
perfectly aligned in metaphase, sister chromatids are separated and pulled to opposing poles in 
anaphase. In Telophase the spindle disassembles, the chromosomes decondense and the nuclear 
envelope is re-assembled. Moreover the cell divides by cytokinesis. 
 
are properly attached, the condensin protein complexes that link sister chromatids, are 
abruptly cleaved (Musacchio & Salmon 2007; Morgan 2007; Primorac & Musacchio 2013; 
Mehta et al. 2013) and the separated sister chromatids are pulled to opposing spindle 
poles by plus-end depolymerization of kinetochore fibres and motor-protein mediated 
poleward transport. Following this process, designated as anaphase A, the centrosomes 
are pushed farther apart from each other, thus completing sister chromatid segregation 
(anaphase B). In telophase the mitotic spindle disassembles and the chromosomes de-
condense. Moreover, the nuclear envelope re-assembles around chromosomes located at 
the spindle poles thereby forming two daughter nuclei and terminating mitosis (Morgan 
2007). Over the time period from early anaphase to the end of telophase cytokinesis 
takes place. The cell forms a contractile ring consisting of actin-myosin-filaments, which 
constricts the cell membrane and finally divides the cell (Akhshi et al. 2014). 




1.7 The spindle assembly checkpoint 
In order to achieve an equal distribution of sister chromatids onto daughter cells, the 
chromosomes have to be properly attached to the spindle apparatus. For this, 
centromere bound kinetochore complexes mediate the connection between chromatids 
and spindle microtubules (Cheeseman 2014; Foley & Kapoor 2013; Lara-Gonzalez et al. 
2012). In a proper amphitelic attachment, the sister kinetochores bind to microtubules 
emanating from opposing spindle poles. However, especially during the early phases of 
mitosis, inappropriate kinetochore-microtubule attachments including the attachment of 
only one kinetochore (monotelic), the attachment of both sister-kinetochores to one pole 
(synthelic) or the simultaneous attachment of one sister kinetochore to both poles can 
occur (Cheeseman 2014) (Figure 1.3). In order to prevent chromosome mis-segregation 
during anaphase, both, erroneous microtubule-kinetochore attachments have to be 
dissolved and mitotic progression must be delayed until all chromosomes are properly 
attached (Foley & Kapoor 2013). The Aurora B kinase plays an essential role in error 
correction (Primorac & Musacchio 2013; Cheeseman 2014; Foley & Kapoor 2013). 
Localized to the inner centromere Aurora B phosphorylates different outer kinetochore 
components like the Ndc80-, the Dam1- and the Skp1-complex leading to the elimination 
of inappropriate kinetochore-microtubule connections (Cheeseman 2014). Amphitelic 
attachments create tension causing intra- and inter-kinetochore stretching and the 
spatial separation of Aurora B and its substrates. Thus, phosphorylation is abolished, 
which allows the formation of stable microtubule-kinetochore attachments (Primorac & 
Musacchio 2013; Foley & Kapoor 2013; Cheeseman 2014). The transient inhibition of the  
 
 
Figure 1.3 Kinetochore-microtubule attachments. Amphitelic attachments are characterized 
by the linkage of microtubules  emanating from both spindle poles to one kinetochore each and 
represent the only form of attachment, which ensures proper chromosome segregation. While 
chromosomes with monotelic attachments are linked with only one kinetochore to one pole, the 
attachment of both kinetochores to microtubules emanating from the same pole are termed 
synthelic. One kinetochore linked to spindle microtubules emanating from opposing poles 
represents a merotelic attachment. 
 




metaphase-to-anaphase transition is caused by an active spindle assembly checkpoint 
(SAC). Unattached kinetochores catalyse the formation of mitotic checkpoint complexes 
consisting of Mad2, Bub3 and BubR1, which sequester and inhibit the APC/C activating 
protein Cdc20 (Primorac & Musacchio 2013; Foley & Kapoor 2013). Moreover, the mitotic 
checkpoint complex directly binds to the APC/C and thus, prevents its activation. When 
all chromosomes are properly attached, the spindle assembly checkpoint is satified and 
the APC/C is activated leading to securin and cyclin B degradation and metaphase-to-
anaphase transition (Primorac & Musacchio 2013; Foley & Kapoor 2013; Lara-Gonzalez et 
al. 2012).   
1.8 The dynamic instability of microtubules 
Microtubules represent the main structural component of the mitotic spindle and their 
intrinsic properties are essential for spindle assembly and function. They consist of α- and 
ß- tubulin heterodimers, which are linked in a head-to-tail fashion, thus forming 
protofilaments, which assemble laterally to build a hollow cylindrical structure of ~25 nm 
in diameter. Since all tubulin subunits within are oriented the same way, a microtubule 
exhibits a minus end exposing α-tubulin and a plus end, which is characterized by ß-
tubulin. Both ends differ with respect to their dynamic properties (Figure 1.4). While at 
the minus-end α- and ß- tubulin heterodimers mainly dissociate, the rate of tubulin 
association at the plus end is much higher. Tubulin subunits are GTPases, which in the 
cytoplasm mainly exist in the GTP-bound form. When they are incorporated in a growing 
microtubule they rapidly catalyse their hydrolysis, thus mediating a conformational 
change and influencing their binding capacities. Newly added α- and ß- tubulin 
heterodimers form a “GTP-cap” at the plus tip, which leads to a continuous growing of 
the microtubule. However, when the GTP hydrolysis exceeds the addition of new GTP-
bound tubulin, heterodimers start to dissociate from the plus tip and the polymer shrinks. 
Thus, microtubules abruptly switch between growing and shrinking states, a behaviour 
known as dynamic instability. Therefore, the transition from polymerization to 
depolymerization at the plus end is referred to as catastrophe, whereas the sudden 
change from shrinking to growing is termed rescue. Moreover, the addition of tubulin 
subunits at the plus tip and the concomitant dissociation of α- and ß- tubulin at the 
minus end leads to a process termed treadmilling, which describes the continuous 
migration of α- and ß- tubulin heterodimers from the plus end to the minus end (Helmke 
et al. 2013; Morgan 2007). The dynamic properties of microtubules are mainly 
modulated by microtubule associated proteins, which influence growth and shrinkage 
speed, as well as the frequency of catastrophe and rescue events (van der Vaart et al. 
2009; Helmke et al. 2013). 
 





Figure 1.4  Microtubules and their dynamic instability. Microtubules are assembled by α- and 
ß- tubulin heterodimers, which are incorporated at the plus end. The concomitant assembly at the 
plus tip and disassembly at the minus end without any net changes in length is termed 
treadmilling. Moreover microtubules exhibit dynamic instability. The increased incorporation of α- 
and ß- tubulin heterodimers at the plus-end causes microtubule polymerization and net growth, 
whereas the disassembly at the tip results in microtubule shrinkage. The transition between growth 
and shrinkage is referred to as catastrophe and rescue, respectively. γ-tubulin ring complexes (γ-
TuRCs), which consists of γ-tubulin and γ-tubulin complex proteins (GCPs), form the basis for 
microtubule nucleation. Their localization to centrosomes or the mitotic spindle is dependent on the 
γ-TuRC subunit GCP-WD/NEDD1. Graphic in part modified from Raynaud-Messina & Merdes, 2007. 
 
The nucleation of microtubules is based on pre-existing nucleation centres, of which the 
most important one is the γ-tubulin ring complex (γ-TuRC) (Figure 1.4). It consists of γ-
tubulin complex proteins (GCPs) forming a ring like structure, in which γ-tubulin provides 
the basis for α- and ß- tubulin heterodimer assembly. Importantly, the γ-TuRC associated 
protein GCP-WD/NEDD1, which potentially represents a γ-TuRC component itself, is 
responsible for targeting γ-TuRCs to centrosomes and spindle microtubules, thereby 
ensuring the assembly of the spindle during mitosis  (Raynaud-Messina & Merdes 2007; 
Lüders & Stearns 2007; Lüders et al. 2006; Haren et al. 2006).  
1.9 The assembly of the mitotic spindle 
The assembly of the mitotic spindle starts with the separation of the two centrosomes, a 
process for which the activity of motor proteins is of major importance. While most 
kinesins (except kinesin-14 familiy members) exhibit a plus-end directed motility along 
microtubules, dyneins move to their minus-ends. Centrosome separation is mainly  
 




mediated by the mitotic kinesin Eg5 (Tanenbaum & Medema 2010). Its tetrameric 
composition allows Eg5 to cross-link and slide apart antiparallel microtubules, thus 
pushing centrosomes to opposing sites (Kapitein et al. 2005). Additionally, the kinesin 
Kif15 was shown to generate similar outward forces during mitotic spindle formation, 
however, its role in centrosome separation is only minor (Tanenbaum et al. 2009). 
Beside its function in spindle positioning, also cortical dynein has been implicated in 
centrosome separation. Additionally, in cooperation with HSET (Mountain et al. 1999), it 
maintains permanent inward force for the maintenance of a functional spindle. 
Importantly, to ensure spindle pole integrity and tension generation for proper 
chromosome segregation, it is of major importance to keep the balance between outward 
and inward forces within an established spindle (van Heesbeen et al. 2014).  
Microtubules represent the fundamental structure of the mitotic spindle apparatus. Its 
highly dynamic behaviour is modulated by different microtubule associated proteins 
(MAPs), which influence polymerization, depolymerization and stability. While, amongst 
others, TACC3/ch-TOG, EB1 and HURP represent stabilizing MAPs (Cheeseman et al. 
2013; Booth et al. 2011; Wong & Fang 2006; Mimori-Kiyosue et al. 2005; Piehl et al. 
2004), members of the kinesin families 13, 14 and 8 (e.g. MCAK, Kif2A, Kif2B, Kif18A) as 
well as AAA ATPase family members were shown to destabilize microtubules (Helmke et 
al. 2013; Ganem & Compton 2004; Manning et al. 2007; Stumpff et al. 2012; van der 
Vaart et al. 2009). Within the mitotic spindle three different types of microtubules can be 
defined. Astral microtubules reach from the poles to the cell cortex and mediate the 
anchorage and proper positioning of the spindle (Kiyomitsu & Cheeseman 2013; 
Kiyomitsu & Cheeseman 2012). In contrast, interpolar microtubules range from the poles 
to the centre being essential for spindle bipolarity, chromosome congression and the 
assembly of the central spindle (Cai et al. 2009; Magidson et al. 2011; Meunier & Vernos 
2012). Moreover, k-fibres, consisting of 20-40 microtubules, link the centrosome with the 
kinetochore region of chromosomes and directly mediate chromosome congression and 
segregation (McEwen et al. 1997; Meunier & Vernos 2012; Helmke et al. 2013).  
In early stages of mitosis microtubules are mainly nucleated by the centrosome (Figure 
1.5). The Aurora A kinase recruits a complex containing TACC3 and ch-TOG to the 
centrosome and phosphorylates TACC3 at S558, thereby promoting microtubule 
nucleation activity and the localization of TACC3 (pS558) / ch-TOG complexes to the 
mitotic spindle (Barr & Gergely 2008; LeRoy et al. 2007; Thakur et al. 2013). The 
microtubule polymerase ch-TOG stabilizes pre-existing microtubules and mediates the 
incorporation of α/ß tubulin heterodimers (Brouhard et al. 2008; Widlund et al. 2011). 
Additionally, along microtubules, the TACC3 (pS558) / ch-TOG complexes interact with 
clathrin heavy chains and further stabilize microtubule fibres by intermediary cross  
 




Figure 1.5 Mechanisms of mitotic spindle assembly. For centrosome dependent assembly of 
the mitotic spindle the Aurora A kinase and its cofactor Bora activate the Polo-like kinase 1 (Plk1). 
Plk1 is involved in γ-TuRC recruitment to the centrosome and coordinates mitotic progression. The 
recruitment of Aurora A to the centrosome is mediated by Cep192, which simultaneously triggers 
the auto-activation of the kinase. Aurora A recruits TACC3 to the centrosome, which, when 
phosphorylated, recruits and interacts with the microtubule polymerase ch-TOG. Together both 
proteins might contribute to microtubule nucleation at the centrosome and promote microtubule 
polymerization at the plus tip. Additionally, TACC3 and ch-TOG interact with clathrin, which cross-
links microtubules and therefore, increases their stability. Furthermore, spindle assembly is 
promoted by the chromosome associated Ran GTP dependent pathway. The chromatin-associated 
nucleotide exchange factor RCC1 creates a Ran-GTP gradient around the chromosomes. Ran-GTP in 
turn triggers the release of TPX2 (and other spindle associated factors (SAFs)) from importins 
mediating its localization to spindle microtubules. Here TPX2 recruits Aurora A, facilitates its auto-
phosphorylation at T288 and initiates the formation of a complex containing γ-TuRCs, ch-TOG, 
HURP and Eg5. Thus, the Aurora A mediated phosphorylation of the complex components triggers 
centrosome separation and microtubule de novo nucleation at the mitotic spindle. Simultaneously 
the TPX2/Aurora A complex is involved in RHAMM dependent recruitment of γ-TuRCs to the mitotic 
spindle. Moreover, the HAUS complex mediates γ-TuRC dependent microtubule amplification on the 
basis of pre-existing microtubules. 
 
linking (Thakur et al. 2013; Royle 2012; Lin et al. 2010; Booth et al. 2011; Fu et al. 
2010). After nuclear envelope breakdown (NEB) microtubule nucleation is also 
centrosome independently controlled by the chromatin mediated Ran GTP dependent 
pathway (Gruss et al. 2002; Gruss et al. 2001; Meunier & Vernos 2012) (Figure 1.5). 
Present on chromatin the Ran guanine nucleotide exchange factor RCC1 (Karsenti & 
Vernos 2001; Li et al. 2003) creates a Ran-GTP gradient that is formed around the 
chromosomes triggering the release of importin α and ß from many spindle assembly 
factors and therefore enabling their function in spindle assembly (Meunier and Vernos 
2012). Most importantly, the Ran-GTP gradient in the vicinity of chromosomes leads 
 





Figure 1.6 Focussing γ-TuRCs at centrosomes. Centrosome independent spindle assembly 
pathways cause microtubule nucleation on the basis of γ-TuRCs within the mitotic spindle. Thus, γ-
TuRCs are distributed along spindle microtubules in proximal distance to the poles and have to be 
focussed at centrosomes. Their direct transport is mediated by the minus-end directed motor 
proteins dynein and HSET. Additionally, the poleward movement of γ-TuRCs is facilitated by the 
plus-end directed kinesin Eg5, which cross-links antiparallel microtubules and generates outward 
forces by antiparallel sliding. The incorporation of γ-TuRCs into the pericentriolar material is 
mediated by NuMA. Parts of the graphic were modified from (Lecland & Lüders 2014). 
 
to a release of TPX2 from importin ß, which then localizes to spindle microtubules (Gruss 
et al. 2002; Gruss et al. 2001) where it provides a binding platform for Aurora A (Eyers & 
Maller 2004; Eyers & Maller 2003; Neumayer et al. 2014). This interaction promotes a 
conformational change of Aurora A, hence, triggering its auto-activation and 
simultaneously protecting Aurora A from dephosphorylation by the protein phosphatase 1 
(PP1) (Neumayer et al. 2014). Bound to TPX2 the activity of Aurora A is required for the 
formation and activation of a complex consisting of TPX2, Eg5, HURP, ch-TOG, γ-tubulin 
and Aurora A itself being involved in spindle morphogenesis (Neumayer et al. 2014; Tsai 
et al. 2003; Wong & Fang 2006; Wong et al. 2008; Eyers & Maller 2003). Moreover, 
TPX2 was shown to be involved in RHAMM (HMMR) dependent recruitment of γ-TuRCs to 
the mitotic spindle, where the Aurora A mediated phosphorylation of NEDD1/GCP-WD40 
at S405 leads to microtubule nucleation (Scrofani et al. 2015; Pinyol et al. 2013).  
Another non-centrosomal pathway for microtubule amplification is dependent on pre-
existing microtubules and involves the Augmin or homologous to augmin subunits 
(HAUS) complex, which mediates the NEDD1/GCP-WD40 and γ-TuRC based microtubule 
nucleation within the spindle (Lawo et al. 2009; Goshima et al. 2008; Goshima & Kimura 
2010) (Figure 1.5).  
Thus, both, the Augmin/HAUS and the Ran-GTP dependent microtubule nucleation 
pathway result in microtubules being attached to γ-TuRCs, which are distributed along 
microtubules in proximal distance from the spindle poles. In order to cluster the minus 




ends at the centrosome γ-TuRCs are transported along microtubules by the minus-end 
directed motors dynein and HSET (Lecland & Lüders 2014) (Figure 1.6). Additionally, Eg5 
participates in poleward movement by connecting antiparallel microtubules at the central 
spindle and generating an outward force by sliding (Kapitein et al. 2005; Lecland & 
Lüders 2014; Tanenbaum & Medema 2010). Thus y-TuRCs accumulate at the centrosome 
where they are incorporated into the pericentriolar material by NuMA (Fant et al. 2004; 
Lecland & Lüders 2014). 
1.10 The centrosome and centriolar satellites 
The centrosome represents the major microtubule organizing centre (MTOC) in the cell 
being involved in the regulation and maintenance of cell motility, adhesion and polarity 
(Bettencourt-Dias & Glover, 2007; Nigg & Raff, 2009; Pihan 2013). Additionally it forms 
the basis for the establishment of the primary cilium (Hoyer-Fender 2010). While the 
MTOC enables intra cellular transport of proteins and organelles along microtubules in 
interphase (Stearns & Kirschner 1994), it plays a major role in mitosis where it ensures 
the proper segregation of chromosomes by establishing and anchoring the mitotic spindle 
(Bettencourt-Dias & Glover, 2007; Nam et al. 2014; Pihan, 2013).  
Centrosomes consist of two orthogonally arranged centrioles, which are formed by nine 
sets of microtubule triplets being organized in a cartwheel structure (Figure 1.7). The 
centrioles form the structural scaffold promoting the organization of the pericentriolar 
material (PCM), which consists of over 100 proteins implicated in protein degradation, 
cell cycle progression and cell division (Menella et al 2014, Pihan 2014, Andersen 2003, 
Bettencourt-Dias 2007, Bornens 2012, Lüders and Stearns 2007, Nam et al. 2014, Pihan 
et al. 2013). It provides a platform for protein signalling, regulation and redistribution, 
and functions to anchor microtubules. In contrast to the assumption that the PCM is an 
amorphous mass of proteins (Bornens 2012; Bärenz et al. 2011), new high resolution 
fluorescence microscopy revealed a highly organized structure of two organization layers 
(Menella et al. 2012; Sonnen et al. 2012; Fu & Glover 2012; Lawo et al. 2012; Menella et 
al. 2014). The so called proximal layer is organized as molecular fibres mainly consisting 
of pericentrin or Cep152, which are C-terminally anchored to centrioles, while their N-
terminal part localizes to the periphery (Figure 1.7). Around the centriole wall the second 
layer is organized in a matrix structure being interspersed with proteins like Cep192, 
CDK5RAP2/Cep215 and γ-tubulin (Menella et al. 2012; Sonnen et al. 2012; Fu & Glover 
2012; Lawo et al. 2012; Menella et al. 2014). When centrosomes maturate in late G2 
phase and early mitosis, the PCM drastically expands (Lee & Rhee, 2010; Nam et al., 
2014; Menella et al., 2014) accumulating proteins, including the mitotic kinases Plk1 and 
Aurora A, that regulate mitotic entry, spindle assembly, sister chromatid separation 
 





Figure 1.7 Centrosome structure. Centrosomes consist of two orthogonally arranged centrioles, 
which are formed by nine sets of microtubule triplets being arranged in a cartwheel structure. The 
pericentriolar material, which surrounds the centrioles is organized in two main layers. The 
proximal layer is organized as molecular fibres mainly consisting of pericentrin or Cep152. Around 
the centriole wall CDK5RAP2/Cep215 is arranged in a matrix structure, which is interspersed with 
proteins like Cep192 and γ-tubulin. When the centrosome undergoes maturation the PCM 
drastically expands and accumulates proteins involved in mitotic regulation. Both, the proximal and 
the matrix layer extend to the outer environment and γ-TuRCs are increasingly incorporated into 
the PCM matrix. Graphic modified from Menella et al., 2014. 
 
(Macůrek et al. 2008; Seki et al. 2008; Nigg 2002) and coordinate the progression 
through mitosis (Taylor & Peters 2008; Petronczki et al. 2008; De Cárcer et al. 2011; 
Hochegger et al. 2013). Additionally Plk1 phosphorylates the centrosomal regulator 
Kizuna, which is crucial for the stabilization of the PCM and thus, ensures its structural 
integrity. In order to form the mitotic spindle the amount of γ-TuRCs increases more 
than threefold during centrosome maturation (Khodjakov & Rieder, 1999; Lüders et al. 
2006). While γ-TuRCs are recruited to the centrosome by CDK5RAP2/Cep215, 
pericentrin/kendrin and AKAP450/CG-NAP, their anchorage is mediated by ninein and 
GCP-WD/NEDD1 (Haren et al. 2006; Lüders et al. 2006; Oshimori et al. 2009; Pihan 
2013; Delgehyr et al. 2005; Raynaud-Messina & Merdes 2007; Takahashi et al. 2002; 
Zimmerman et al. 2004; Fong et al. 2008). Tethered to the PCM, γ-TuRCs provide a 
platform for microtubule nucleation and polymerization being essential for mitotic spindle 
formation and anchorage (Raynaud-Messina & Merdes 2007; Wiese & Zheng 2006; 
Zheng et al. 1995). Since after cell division the emerging daughter cells only possess one 
centrosome consisting of a mother and a daughter centriole, the centrosome has to be 
 





Figure 1.8 The Centriole duplication cycle. As cells exit from mitosis the daughter centriole 
disengages from the mother centriole (marked with yellow appendages). In early S-phase both 
centrioles starts to form new centrioles which elongate until G2-phase. In late G2 centrosome 
maturation takes place. Upon linker dissolution, centrosomes separate in order to form a bipolar 
spindle. Parts of the graphic were modified from Nam et al. 2014 and Mardin & Schiebel 2012. 
 
duplicated once per cell cycle (Figure 1.8) During early G1 phase the daughter centriole 
disengages from the mother centriole, leading to the loss of the orthogonal arrangement 
(centriole disengagement). However, both centrioles remain connected by a linker. In 
early S phase a new daughter centriole is synthetized by each centriole (centriole 
duplication), which elongates until it reaches a final length in late G2 phase (centriole 
elongation). At the G2/M transition the two pairs of centrioles loose the flexible linker and 
run through the maturation process in early mitosis. Subsequently the two centrosomes 
separate and are finally segregated onto daughter cells where they start a new 
duplication cycle on their own (Nigg & Raff 2009; Nigg 2002; Holland et al. 2010; 
Bettencourt-Dias & Glover 2007; Mardin & Schiebel 2012; Nam et al. 2014). 
Around the centrosome centriolar satellites localize in a cell cycle dependent manner. 
While they are present throughout interphase, they gradually disappear in mitosis and 
re-accumulate in telophase (Kubo & Tsukita 2003; Bärenz et al. 2011). Moving along 
microtubules in a dynein and possibly kinesin dependent manner, centriolar satellites 
provide a networking platform for several different proteins (Bärenz et al. 2011).   




Since centriolar satellites contain a range of centrosomal proteins, they are proposed to 
fulfil a function in protein storage and delivery to the centrosome supporting key cellular 
processes that are dependent on a rapid change of the centrosomal protein composition 
such as cell division and primary cilium formation (Bärenz et al. 2011; Villumsen et al. 
2013). In accordance with this, the localization of several key centrosomal proteins like 
centrin, pericentrin and ninein was shown to be dependent on the pericentriolar protein 1 
(PCM1) forming the central molecular scaffold for centriolar satellites (Dammermann & 
Merdes 2002; Purohit et al. 1999). Interestingly PCM1 containing centriolar satellites 
have also been implicated in the transport of the Nek2 kinase involved in G2/M transition 
and proteins protecting the structural integrity of the centrosome against spindle 
mediated forces during mitosis like Kizuna, Cep72, Cep90 and SSX2IP (Bärenz et al. 
2011; Bärenz et al. 2013; Kim et al. 2012). Accordingly, interfering with the transport 
function of pericentriolar satellites effects centrosome structure and results in improper 
microtubule anchorage and organization (Bärenz et al. 2011). Moreover, many proteins 
involved in cilia formation such as BBS4, Cep290, Cep72, Cep131, FOR20, Ccdc13 and 
OFD1 localize to centriolar satellites and their delocalization is linked to the induction of 
ciliopathies indicating that centriolar satellites are crucial for ciliogenesis (Bärenz et al. 
2011; Staples et al. 2012; Staples et al. 2014). In the absence of PCM1 and, hence, 
centriolar satellites, proteins such as Cep290, Cep72, ODF1 and FOR20 accumulate at the 
centrosome, suggesting that centriolar satellites might also fulfil a function in restraining 
the direct centrosomal localization of such proteins, thus contributing to the regulation of 
the centrosome (Stowe et al. 2012; Lopes et al. 2011).  
1.11 Aneuploidy and chromosomal instability  
The proper progression through mitosis ensures the maintenance of a defined set of 
chromosomes and thereby the euploidy of a cell. However, only subtle defects in this 
tightly regulated process can lead to chromosome mis-segregation and aneuploidy, 
representing a common state of most solid tumours (Orr & Compton 2013). Actually, 
around the turn of the 18th to the 19th century, David Hansemann and Theodor Boveri 
already stated that abnormal cell division induces aneuploidy and tumourigenesis (Boveri 
1914; von Hansemann 1890). Nonetheless, the connection between aneuploidy and 
cancer remains controversially discussed (Ricke & van Deursen 2013; Holland & 
Cleveland 2012; Weaver et al. 2007). Beside the unique gain or loss of one or a few 
chromosomes, the perpetual mis-segregation of chromosomes during mitosis, which is 
defined as whole chromosomal instability (W-CIN), is a common cause for aneuploidy 
and represents a hallmark of human cancer. In contrast to W-CIN, in which cells are 
unable to properly segregate whole chromosomes, the susceptibility to structural 
rearrangement including translocations, inversions, deletions and duplications of 




chromosomal parts is referred to as structural chromosomal instability (S-CIN) (Ricke & 
van Deursen 2013; Thompson et al. 2010). However, the further course of this work 
focusses on whole chromosomal instability, so that the term CIN refers to W-CIN.  
In general, the rate of chromosome mis-segregation is crucial for the cells fate. While 
CIN at low levels (0.2 to maximal 1 chromosome per cell cycle) enables the accumulation 
of tumour promoting factors and the ability for environmental adaption (Orr & Compton 
2013; Thompson et al. 2010; Lengauer et al. 1997), high rates of chromosome mis-
segregation cause mitotic catastrophe and subsequent apoptosis (Vakifahmetoglu et al. 
2008; Manchado et al. 2012; Kops et al. 2004). Moreover, CIN was shown to be 
disadvantageous for cell proliferation and tumour growth, which might be due to the fact 
that altered chromosome numbers lead to proteotoxic stress and changes in the 
metabolism (Ertych et al. 2014; Sheltzer & Amon 2011; Williams et al. 2008; Weaver et 
al. 2007). However, CIN increases the genetic variability and adaptability of cells and 
tumours, hence, providing a trigger for tumour initiation and the basis for tumour 
formation and therapy resistance (Orr & Compton 2013; Thompson et al. 2010; Lengauer 
et al. 1997; Holland & Cleveland 2012). 
1.12 Routes to whole chromosomal instability 
Whole chromosomal instability is defined as the perpetual gain and loss of chromosomes 
during mitosis. Accordingly, various defects within this tightly regulated cell cycle phase 
can lead to continual mis-segregation. An impaired mitotic spindle assembly checkpoint 
represents the first lesion suspected to cause CIN (Cahill et al. 1998; Holland & Cleveland 
2012; Orr & Compton 2013). To ensure proper chromosome segregation the SAC senses 
proper kinetochore microtubule attachments and emits a diffusible “wait anaphase” 
signal until all chromosomes are amphitelically attached to microtubule emanating from 
two opposing spindle poles (Figure 1.3). Hence, an impaired SAC results in premature 
anaphase onset in the presence of mal-attached kinetochores, which in turn leads to 
chromosome mis-segregation during cell division. Nonetheless, mutations in SAC 
associated genes are very rare (Barber et al. 2008) and a total loss of the spindle 
assembly checkpoint leads to cell death (Kops et al. 2004). Therefore, the relevance of a 
weakened mitotic SAC for the induction of CIN in human cancer is controversial (Orr & 
Compton 2013). However, it is clear that the persistence of erroneous microtubule 
kinetochore attachments is associated with CIN (Silkworth & Cimini 2012; Gregan et al. 
2011). Especially merotelic attachments, in which a single kinetochore is concomitantly 
attached to spindle microtubules emanating from both poles (Figure 1.3) are critical for 
the maintenance of chromosomal stability. Since the kinetochores are bound to 
microtubules and tension between the two sister kinetochores is generated, merotely is 
 





Figure 1.9  Routes to whole chromosomal instability. An impaired spindle assembly 
checkpoint leads to premature anaphase onset and the perpetual missegregation of whole 
chromosome during mitosis (whole chromosomal instability). Moreover centrosome amplification, 
spindle geometry defects, cohesion defects or increased spindle microtubule plus end assembly 
rates trigger the formation of merotelic microtubule-kinetochore attachments and lagging 
chromosomes representing a main cause for CIN. Chromosomal instability increases the genetic 
variability and adaptability of a cell, thus, providing a trigger for tumour initiation and therapy 
resistance. 
 
not detected by the SAC and anaphase is initiated. As a consequence, the respective 
chromatid fails to be properly segregated and lags in the equatorial plane of the cell. 
Such ‘lagging chromosomes’ are subsequently distributed onto daughter cells by chance 
and represent a main cause for chromosomal instability (Orr & Compton 2013; Vitre & 
Cleveland 2012; Thompson et al. 2010; Silkworth & Cimini 2012; Gregan et al. 2011). 
Another route to CIN is the presence of supernumerary centrosomes, which mainly arises 
from defects in their biogenesis or by overduplication (Vitre & Cleveland 2012; Holland & 
Cleveland 2012), promoting the formation of merotelic attachments, lagging 




chromosomes and the induction of CIN (Orr & Compton 2013). Albeit enhanced numbers 
of centrosomes are usually clustered by the kinesin-14 family member HSET to allow the 
formation of a bipolar spindle before anaphase onset (Brinkley 2001), a transient 
multipolar intermediate state is sufficient to induce kinetochore-microtubule mal-
attachments (Ganem et al. 2009; Silkworth & Cimini 2012) (Figure 1.10). Similarly, 
altered centromere geometry caused by pericentric cohesion defects impedes the 
establishment of amphitelic attachments (Ng et al. 2010; Solomon et al. 2011). 
Additionally, the tight regulation of centrosome separation in prophase ensuring proper 
bi-oriented spindle geometry is crucial for the maintenance of chromosomal stability 
(Nam et al. 2014; Silkworth & Cimini 2012; Silkworth et al. 2012). Delayed centrosome 
separation results in a state where centrosomes are still located in close proximity when 
the nuclear envelope breaks down. By transient formation of monopolar or near-
monopolar spindle intermediates, kinetochores are accessible to microtubules emanating 
from both spindle poles, which promotes the formation of synthelic or merotelic 
attachments. When centrosomes separate in the further course of mitosis, mal-
attachments persist and facilitate chromosome mis-segregation in anaphase (Nam et al. 
2014; Silkworth & Cimini 2012). Moreover, both, delayed and accelerated centrosomes 
disjunction as well as improper anchoring of astral microtubules at the cell cortex can 
result in spindle asymmetry in metaphase that might additionally trigger the formation of 
merotelic kinetochore-microtubule attachments, lagging chromosomes and improper 
chromosome segregation (Nam et al. 2014). Importantly, our group identified enhanced 
spindle microtubule plus end assembly rates during mitosis as novel route to 
chromosomal instability. Like lesions described before, increased spindle microtubule 
polymerization triggers transient spindle geometry defects, which are accompanied by 
the establishment of hyper-stable kinetochore-microtubule attachments and lagging 
chromosomes (Ertych et al. 2014). Since error-correction is not affected by enhanced 
spindle microtubule dynamics it is supposed that the increased formation of erroneous 
microtubule-kinetochore attachments overwhelms the error-correction machinery (Ertych 
et al. 2014; Stolz et al. 2014). Remarkably, increased spindle microtubule plus end 
assembly seems to be a key trigger for the induction of CIN in human colorectal cancer. 
Whereas chromosomally stable colorectal cancer cell lines showed proper spindle 
microtubule polymerization rates during mitosis, it was determined to be significantly 
increased in all chromosomally instable cell lines analysed. Moreover, genetic lesions like 
loss of the tumour suppressor genes CHK2 and BRCA1 as well as amplification of the 
oncogene AURKA, which are found to be present in up to 70% of colorectal cancer 
patients are linked to the induction of elevated spindle microtubule assembly rates. Thus, 
increased microtubule polymerization during mitosis represent a fundamental mechanism 
influencing CIN (Ertych et al. 2014; Stolz et al. 2014). 
 





Figure 1.10 Spindle geometry defects lead to merotelic kinetochore-microtubule 
attachments and the formation of lagging chromosomes. a) Supernumerary centrosomes 
result in the formation of multipolar spindles. In order to form a bipolar spindle centrosomes are 
clustered, which promotes merotelic attachments and lagging chromosomes. b) Delayed 
centrosome separation and, hence, centrosomes located in close proximity when the nuclear 
envelope breaks down results in transient monopolar or near-monopolar spindles triggering the 
formation of merotelic attachments. In addition, accelerated centrosome separation as well as 
improper anchoring of astral microtubules and increased spindle microtubule plus end assembly 
rates causes (transient) spindle geometry defects promoting erroneous kinetochore-microtubule 
attachments and lagging chromosomes. Parts of the graphic were modified from Silkworth & Cimini 
2012. 
 




In addition to lagging chromosomes being a main reason for the mis-segregation of 
whole chromosomes during mitosis (W-CIN), other segregation errors like chromatin 
bridges and acentric chromatin can be observed during anaphase. These kinds of defects 
are mainly caused by DNA damage as well as replication stress and represent hallmarks 
of structural chromosomal instability (Burrell et al. 2013). Moreover, lagging 
chromosomes, which are finally not segregated onto daughter cells, are partitioned in 
micronuclei where they undergo severe DNA damage during interphase. Subsequently 
these chromosomes are partially reincorporated into daughter cells and thus, contribute 
to the emergence of S-CIN (Crasta et al. 2012). Apart from the well-founded assumption 
that W-CIN is mainly dependent on chromosome segregation errors during mitosis, a 
recent study proposed that pre-mitotic events like replication stress causing S-CIN are 
responsible for most anaphase defects (Burrell et al. 2013). Supporting this notion it was 
shown, that DNA-damage during mitosis partially triggers the DNA damage response by 
ATM dependent phosphorylation of the checkpoint kinase 2 (Chk2), which in turn results 
in Aurora A and Plk1 dependent hyper-stability of microtubule-kinetochore attachment, 
lagging chromosomes and W-CIN (Bakhoum et al. 2014). However, whether DNA 
damage is a cause or a consequence of W-CIN remains unclear.  
1.13 The tumour suppressor gene BRCA1 
The tumour suppressor gene breast cancer 1, early onset (BRCA1) was initially identified 
in 1994 as the first gene influencing the susceptibility to breast and ovarian cancer (Miki 
et al. 1994).  
Brca1 is a protein of 220 kDa exhibiting at least three different functional domains. The 
N-terminus features a RING domain, which allows the formation of a heterodimer with its 
obligatory binding partner Brca1 associated RING domain protein 1 (BARD1). This 
binding is crucial for interdependent protein stabilization and together Brca1 and BARD1 
complement an E3-ubiquitin ligase being responsible for the ubiquitination of numerous 
substrates (e.g. H2A, H2B, H3, H4, CtIP, NPM1, RPB8 and TFIIE) (Hashizume et al., 
2001; Wu et al. 2008; Savage & Harkin, 2014). Importantly the Brca1/BARD1 complex 
mainly mediates the uncommon K6-linked ubiquitination, which rather represents a 
protein modification than a signal for degradation (Morris & Solomon, 2004; Nishikawa et 
al., 2004; Wu-Baer et al. 2003). In addition to signals for the nuclear import and export 
(NLS and NES), Brca1 exhibits two BRCA1 C-Terminal (BRCT) domains representing 
phospho-protein specific binding motifs (Henderson 2012; Yu 2003). Thus, Brca1 forms a 
scaffold for the formation of various protein complexes being involved in numerous 
cellular processes throughout the cell cycle (Savage & Harkin 2014).  




Brca1 plays an important role in the cellular stress response upon DNA damage, where it 
is regulated by phosphorylation mediated by different serine/threonine kinases (e.g. 
ATM, ATR, CDK1, CDK2, Chk2) (Savage & Harkin 2014; Ouchi 2006; Scully et al. 2004). 
It is involved in the regulation of transcription and mRNA splicing in order to efficiently 
produce proteins being involved in DNA damage repair and cell cycle checkpoint arrest 
(Savage & Harkin 2014). By targeting RNA polymerase II for degradation, Brca1 
simultaneously inhibits the mRNA stabilizing 3’ polyadenylation and thus, blocks the 
protein translation after DNA damage (Kleiman et al. 2005). Additionally it is assumed 
that Brca1 participates in non-homologous end joining (NHEJ), however, its direct role 
remains unknown (Wei et al., 2008; Zhong, Boyer et al., 2002; Zhong, Chen et al., 
2002). In contrast, the function of Brca1 in homologous recombination (HR) is mainly 
characterized and defined by four independent Brca1 protein complexes: BRCA1-A 
including RAP80, MERIT40, BRCC36/45 and Abraxas, BRCA-B (Brca1, TopBP1 and 
BACH1), BRCA1-C consisting of Brca1, MRN (Mre11, Rad50, Nbs1) and CtIP and the 
BRCC complex (Brca1, Brca2, PALB and Rad51). DNA damage initially causes the 
formation of single stranded DNA, which is recognized and bound by the replication 
protein A (RPA) in order to prevent the formation of secondary structures (Savage & 
Harkin 2014). Based on Chk2-mediated phosphorylation of Brca1 at Ser988 (Scully et al. 
2004; J. Zhang et al. 2004), the BRCA1-C complex promotes HR compared to the error 
prone NHEJ. Moreover, BRCA1-C initiates and, in combination with BRCA1-B, Exo1 and 
DNA2, extends the resection of double strand break ends. Additionally BRCA1-B and -C 
activate the intra-S-phase checkpoint, whereas BRCA1-A prevents over-resection and 
stimulates the G2/M checkpoint. Subsequently, the BRCC complex mediates the 
exchange of RPA by Rad51, thereby initiating sister chromatid invasion and the formation 
of Holliday junctions. Based on the complementary DNA strand of the sister chromatid 
the DNA is replicated, whereupon the Holliday junction is resolved and the DNA ends are 
re-ligated (Savage & Harkin 2014; Liu et al. 2014; Escribano-Díaz et al. 2013; Sy et al. 
2009; Cruz-Garcia et al. 2014).  
Aside from its function in DNA damage repair, Brca1 plays an important role at the 
centrosome, where it is localized throughout the cell cycle (Starita & Parvin 2006). Here 
the Brca1/BARD1 complex together with Obg-like ATPase 1 (Ola1) interacts with and 
ubiquitinates γ-tubulin as well as an unknown adaptor protein during interphase, leading  
to a disassembly of γ-TuRCs from the centrosome and a low microtubule nucleation 
potential (Matsuzawa et al., 2014; Sankaran & Parvin, 2006; Sankaran et al., 2005; 
Sankaran et al., 2006; Starita et al., 2004). During mitosis Brca1 is phosphorylated by 
the Aurora A kinase at S308, which inhibits its E3-ubiquitin ligase activity (Ouchi et al. 
2004). Thus, the Brca1/BARD1 mediated ubiquitination of γ-TuRC subunits is abolished 
resulting in a high microtubule nucleation potential during mitosis (Sankaran et al., 




2007). Additionally, the ubiquitination activity of the Brca1/BARD1 heterodimer was 
shown to inhibit centrosome amplification and hyperactivation in breast cancer cell lines 
(Schlegel et al., 2003). However, this could not be observed in other cell types (Starita et 
al. 2004; Starita & Parvin 2006). 
While most studies only focus on its interphase function, Brca1 might play a major role 
during mitosis, where Brca1 is mostly localized at centrosomes (Hsu & White 1998). 
Here, the Chk2 mediated phosphorylation of Brca1 at S988 ensures the proper assembly 
of the mitotic spindle (Stolz et al. 2010). However, a loss of Brca1 or Chk2 leads to an 
accumulation of active Aurora A kinase at mitotic centrosomes, which in turn causes 
increased spindle microtubule plus end polymerization and spindle orientation defects 
resulting in chromosome mis-segregation and chromosomal instability (Stolz et al. 2010; 
Ertych et al. 2014). Nevertheless, the exact mechanism and how the pathway is 
regulated during mitosis remain elusive. Beside this centrosomal function, Brca1 was also 
shown to be involved in centrosome independent Ran-GTP mediated spindle formation 
during mitosis. Here it is assumed that the Brca1/BARD1 heterodimer ubiquitinates the 
microtubule associated protein RHAMM (HMMR) and modulates its function to form a 
bipolar mitotic spindle (Joukov et al. 2006; Maxwell et al. 2003).  
BRCA1 is a major tumour suppressor gene, which is mainly associated with breast and 
ovarian cancer where Brca1 mutations or a loss of the gene itself are most prominent. 
These lesions have been shown to be associated to cancer predisposition and formation, 
whereupon the exact reason and also the tissue specificity remains less understood 
(Savage & Harkin 2014). Since Brca1 exhibits various functions, it is unclear how Brca1 
exerts its tumour suppressive function. Additionally, it is controversially discussed, which 
domain of Brca1 is crucial for maintaining its tumour suppressive role. While some 
observations suggest that the ubiquitin-E3-ligase activity is needed to prevent tumour 
formation (Zhu et al. 2011), others claim that this function is dispensable and that the 
BRCT domains providing phospho-peptide binding motifs play the major role in tumour 
suppression (Shakya et al. 2011). In turn another study shows that the binding to Bard1 
might be most important for the tumour suppressing activity of Brca1 (Drost et al. 2011). 
1.14  The centrosomal protein Cep72 
Cep72 (centrosomal protein of 72 kDa) is a protein, which was initially identified in a 
mass-spectrometry based proteomic analysis of human centrosomes (Andersen et al. 
2003). It comprises 647 amino acids and harbours with two leucine-rich repeats (N-
terminal region) and a coiled coil domain (C-terminal region) two structural motifs, 
whose function remains unclear. To date Cep72 is a poorly studied protein, which was 
shown to exhibit at least two main functions.  




Cep72 localizes to centrosomes throughout the cell cycle. It was shown to be involved in 
the maintenance of the structural integrity by targeting the centrosomal regulator Kizuna 
to the centrosome, where it fulfils its function in stabilizing the pericentriolar material. 
Especially during mitosis, when the forces emerging from microtubules being attached to 
chromosomes are particularly high, this function prevents centrosome disintegration and 
the formation of multipolar spindles (Oshimori et al. 2009; Oshimori et al. 2006). 
Additional observations indicate that Cep72 is involved in the recruitment of γ-tubulin 
ring complexes to the centrosomes where it also maintains their microtubule potential by 
simultaneous recruitment of the centrosomal scaffolding protein CG-NAP/AKAP450 
conferring microtubule nucleation activity (Oshimori et al. 2009; Takahashi et al. 2002). 
Moreover, Cep72 was shown to interact with the scaffolding component of centrosomal 
satellites PCM1. Consequently, Cep72 also localizes to centrosomal satellites where it is 
involved in proper cilium formation of resting cells. Cep72 is crucial for the localization of 
the ciliopathy associated protein Cep290 and together both proteins mediate the 
relocalization of the Bardet-Biedl syndrome (BBS)ome component BBS4 from centriolar 
satellites to the centrosome in order to form the BBSome complex. Additionally Cep72 
was shown to maintain a normal distribution of centrosomal satellites, however, an 
overexpression results in their disassembly and the formation of cytoplasmic aggregates. 
The depletion of PCM1 and thus, the destruction of centrosomal satellites leads to an 
accumulation of Cep72 to centrosomes, indicating that centrosomal satellites might 
sequester Cep72 and prevent its pericentriolar localization (Stowe et al. 2012). Our 
group has identified Cep72 as a protein interacting with Brca1 during mitosis, which 










1.15  Scope of the study 
BRCA1 is a major tumour suppressor gene, which is mainly associated with breast and 
ovarian cancer (Miki, Y. et al. 1994). Since Brca1 represents a multifunctional protein 
being involved in a variety of cellular processes throughout the cell cycle, the way Brca1 
exerts its tumour suppressive function remains a topic of debate. During mitosis, Brca1 is 
required to ensure proper spindle microtubule polymerization and chromosome 
segregation, thereby maintaining the whole chromosomal stability of the cell (Ertych et 
al. 2014). However, how Brca1 is regulated during mitosis remains largely elusive. 
Importantly, our group identified the centrosomal protein Cep72 as a novel interaction 
partner of Brca1. Thus, the aim of this study was to investigate whether Cep72 
participates in the function of Brca1 to regulate chromosome segregation during mitosis 










2 MATERIAL AND METHODS 
2.1 Materials 
2.1.1 Equipment 
The equipment, which was used for this study is listed in Table 2.1. 
Table 2.1 Equipment 
Equipment Model Purchased from 
   
Cell culture materials   Sarstedt, Nümbrecht, Germany 
Ibidi, Martinsried, Germany 
Centrifuge, cooling Multicentrifuge X3R Thermo Fisher Scientific, 
Karsruhe, Germany 
Electroporation system  GenePulser XcellTM BioRad, Hercules; CA, USA 
Flow cytometer BD FACSCantoTM II Becton Dickinson 
San Jose, CA, USA 
Gel documentation Gel iX Imager Intas, Göttingen, Germany 
Heating block Thermomixer Comfort R & 
TDB-120 Dry Block Thermostat 
Eppendorf, Hamburg, Germany 
Biosan, Riga, Latvia 
Horizontal gel 
electrophoresis 
Sub-Cell GT cell BioRad Laboratories, 
München, Germany 
Incubator HERAcell 240 CO2 incubator Thermo Fisher Scientific,  
Karlsruhe, Germany 
Laboratory scale Sartorius Research R200D  Sartorius , Göttingen, Germany 
Magnetic stirrer IKAMAG® RCT IKA Labortechnik,  
Staufen, Germany 




A3474-07 HAMAMATSU Photonics, 
Hamamatsu, Japan 








Equipment Model Purchased from 
   
Microscope cameras sCMOS camera & 
 
Leica DFC360 FX & 




Chalfont St. Giles, Great Britain  
Leica, Wetzlar, Germany 
Hamamatsu Photonics, Herrsching 
am Ammersee, Germany 
Multilable reader VICTORTM X3 PerkinElmer, Rodgau, Germany 
Semidry blotting system PerfectBlueTM Peqlab, Erlangen, Germany 
PVDF membrane  ImmobilionR-P (PVDF) Merck Millipore, 
Darmstadt,Germany 
Nitrocellulose membrane Protran BA 85 GE Healthcare,  
Chalfont St. Giles, Great Britain   
Pipettes Pipetman® 
P2, P10, P20, P200, P1000 
Gilson International,  
Limburg-Offheim, Germany 
Pipettor PIPETBOY acu Integra Biosciences,  
Fernwald, Germany 
Power supply Power Supply EV231 Peqlab, Erlangen, Germany 
Sterile workbench  HERAsafe® 
 
Thermo Fisher Scientific, 
Karsruhe, Germany 
Spectrophotometer NanoDrop 2000 Thermo Fisher Scientific, 
Karsruhe, Germany 




Biofuge fresco Thermo Fisher Scientific, 
Karsruhe, Germany 
Tank blotting system  Own manufacturing 
Vertical electrophoresis  
system 
 Own manufacturing 
Vortex mixer VORTEX-GENIE® 2 Scientific Industries Inc., 
Bohemia, NY, USA 
X-Ray film processor Optimax Protec, Oberstenfeld, Germany 
   
 
 




The data collected in this study was analysed by using the software listed in Table 2.2. 
2.1.2 Software 
Table 2.2 Software 
Software Company 
  
BD FACSDivaTM Becton Dickinson, San Jose, CA, USA 
Leica LAS-AF software  Leica, Wetzlar, Germany 
NanoDrop 2000/2000c software Thermo Fisher Scientific, 
Karsruhe, Germany 
softWoRx Explorer1.3.0 Applied Precision, a GE Healthcare Company, 
Chalfont St. Giles, Great Britain 
SoftWorx 6.0 Applied Precision, a GE Healthcare Company, 
Chalfont St. Giles, Great Britain 
Hokawo Launcher 2.1 Hamamatsu Photonics,  




All standard chemicals used in this study were purchased from Amersham Biosciences 
(Buckinghamshire, England), AppliChem (Darmstadt, Germany), BD Biosciences 
(Heidelberg, Germany), Biomol (Hamburg, Germany), BioRad (Hercules, CA, USA), Carl 
Roth (Karlsruhe, Germany), Enzo Life Sciences inc. (New York, USA), Fermentas (St. 
Leon-Rot, Germany), GE Healthcare (Uppsala, Sweden), Invitrogen (Carlsbad, CA, USA), 
Merck (Darmstadt, Germany), New England Biolabs (Beverly, MA, USA), PAA 
Laboratories (Pashing, Australia), Polyplus-transfection SA (Illkirchen, France), Promega 
(Madison, WI, USA) Roche Diagnostics GmbH (Mannheim, Germany), Sigma Aldrich (St. 
Louis, MO, USA), Thermo Fisher Scientific (Waltham, MA, USA), Th. Geyer (Renningen, 
Germany), VWR International (West Chester, PA, USA), in a quality for analysis or 
molecular biological applications. 
2.1.3.1 Inhibitors 
All inhibitors used in this study including their working concentrations are listed in Table 
2.3. Potential aberrations are specified separately in the respective experiment. 
 








       
Dimethylenastron 2 µM Inhibition of the  
Eg5/KSP-kinesin 
PAA Laboratories, 
Pasching, Australia  
Enzo Life Sciences  
inc., New York, USA 




MG132 20 µM Inhibition of the proteasome Enzo Life Sciences  
Inc., New York, USA 
MLN8054 0.5 µM Inhibition of the  
Aurora A kinase 
Millennium 
Pharmaceuticals Inc., 
Cambridge, MA, USA 
Nocodazole 300 nM Interferes with microtubule 
dynamics, depolymerizes  
microtubules 
Sigma-Aldrich, 
St. Louis, MO, USA 
Puromycin 1 µg/ml Inhibition of the  
mRNA translation 
Sigma-Aldrich, 
St. Louis, MO, USA 
Taxol® 0.2 – 150 nM Interferes with microtubule 
dynamics, stabilizes 
microtubules by binding of  
ß-tubulin 
Sigma-Aldrich, 
St. Louis, MO, USA 
Thymidine 2 mM Inhibition of nucleotide-
synthesis, blocks DNA 
synthesis 
Sigma-Aldrich, 
St. Louis MO, USA 




All primary antibodies used in this study including the host species, the antibody type as 
well as the used dilution, are listed in Table 2.4. 
 




Table 2.4 Primary antibodies 
Antigen Host Antibody type Dilution Purchased from 
     
ANA (anti-nuclear 
antibody) Crest 
human polyclonal IF 1:800 Europa Bioproducts, 
Wicken, Ely, UK 
Aurora A (35C1) mouse  monoclonal WB 1:1000 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
ß-Actin (AC-15) mouse monoclonal WB 1:10000 Sigma Aldrich, 
St. Louis, MO, USA 
Bard1 (H-300) rabbit  polyclonal WB 1:1000 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
Brca1 (D-9) mouse monoclonal WB 1:350 





Dallas, TX, USA 
Brca1 (C-20) rabbit polyclonal WB 1:350 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
Cep72 (A301-297A) rabbit polyclonal WB 1:1000 







rabbit polyclonal WB 1:1000 Bethyl Laboratories, 
Inc., Montgomery, 
TX, USA 
Chk2 (DSC-270) mouse monoclonal WB 1:800 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
CKAP5 (H4)  
(ch-TOG) 
mouse monoclonal WB 1:1000 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
MPM-2 mouse  monoclonal FC 1:1600 Millipore, 
Billerica, MA, USA 
-Tubulin (B5-1-2) mouse monoclonal IF 1:650 Santa Cruz 
Biotechnology, Inc., 
Dallas, TX, USA 
     




Antigen Host Antibody type Dilution Purchased from 
     
-Tubulin (T6557) mouse monoclonal WB 1:2000 
 
Sigma Aldrich, 
St. Louis, MO, USA 
-Tubulin (T3559) rabbit polyclonal IF 1:550 Sigma Aldrich,  
St. Louis, MO, USA 
Tpx2 (18D5) 
 
mouse monoclonal WB 1:1000 Santa Cruz 
Biotechnology, Inc.,  
Dallas, TX, USA 
P-Aurora A 
(Thr288)/ 
Aur B (Thr232)/  
Aur C (Thr198)  
(D13A11) 
rabbit polyclonal WB 1:1000 Cell Signaling, 
Beverly, MA, USA 
P-Tacc3 (S558) rabbit  polyclonal WB 1:1000 Cell Signaling,  
Beverly, MA, USA 
     
 
Secondary antibodies 
The secondary antibodies used for the detection of all primary antibodies (Table 2.4) are 
listed in Table 2.5. The table shows all secondary antibodies used in this study including 
the host species, the antibody type, the conjugated molecule as well as the used dilution. 
Table 2.5 Secondary antibodies 
Antigen Host antibody 
type 
Conjugated with Dilution Purchased from 
     
Anti-human goat 
polyclonal 
AlexaFluor594 IF 1:1000 Invitrogen,  





WB 1:10000 Jackson 
ImmunoResearch 
Laboratories Inc., 




AlexaFluor488 IF 1:1000 
FC 1:2000 
Invitrogen,  
Carlsbad, CA, USA 
     
 




Antigen Host antibody 
type 
Conjugated with Dilution Purchased from 
     
Anti-mouse goat 
polyclonal 
AlexaFluor594 IF 1:1000 Invitrogen,  





WB 1:10000 Jackson 
ImmunoResearch 
Laboratories Inc., 




AlexaFluor488 IF 1:1000 Invitrogen,  
Carlsbad, CA, USA 
Anti-rabbit goat 
polyclonal 
AlexaFluor594 IF 1:1000 Invitrogen,  
Carlsbad, CA, USA 
     
 
2.1.3.3 Chromosome enumeration probes 
The chromosome enumeration probes (CEP), which were used in this study for the 
detection of specific chromosomes via CEP-FISH including the locus and the chromosome 
region are listed in Table 2.6. 
Table 2.6 Chromosome enumeration probes 
Chromosome  Locus Chromosome Region Purchased from 
    
7 D7Z1 7q11.1-q11.1 Cytocell aquarius,  
Cambridge, UK 
15 D15Z4 157q11.1-q11.1 Cytocell aquarius,  
Cambridge, UK 
    
 
2.1.3.4 Oligonucleotides 
The oligonucleotides used in this study were synthetized by Sigma Aldrich (Taufkirchen, 
Germany). They were diluted to a concentration of 100 µM in H2O dest. and stored at  
-20°C. 
DNA oligonucleotides 
The primer used for this study including their sequence and application are listed in Table 
2.7. 




Table 2.7 DNA oligonucleotides 
Primer Primer sequence Application 
   
Brca_I26A_for 5’-CTTAGAGTGTCCCGCC 
TGTCTGGAGTTG-3’ 
forward primer for the 
mutagenesis of the Brca1 RING-
domain, exchange of isoleucine  
26 to alanine 
Brca_I26A_rev 5’-CAACTCCAGACAGGC 
GGGACACTCTAAG-3’ 
reverse primer for the 
mutagenesis of the Brca1 RING-
domain, exchange of isoleucine  
26 to alanine 
Cep72_HindIII_pEGFP_for  5’-TATAAGCTTCGATGGC 
GCGGGCTGG-3’ 
amplification of human CEP72, 
adds a HindIII restriction site 
to N-terminus 
Cep72_KpnI_rev  5’-TATCCATGGTCAGCAG 
GCCTGGCAG-3’ 
amplification of human CEP72 
including stop codon, adds a  






shRNA (Table 2.11) for stable 







shRNA (Table 2.11) for stable 
expression of shRNA against  
human CEP72 
   
 
shRNA 
The shRNAs used for this study including their sequence and the corresponding reference 
are listed in Table 2.8. 
Table 2.8 shRNAs 
shRNA against shRNA sequence Reference 
   
BRCA1 5’- GGAACCUGUCUCCACAAAG -3’ 
5’- GAAAGUACGAGAUUUAGUC -3’ 
Stolz et al., 2010 
CEP72 5’- GCAGATCGCTGGACTTCAA -3’ Oshimori et al. 2009 
   




shRNA against shRNA sequence Reference 
   
SCRAMBLED 5’- CAUAAGCUGAGAUACUUCA -3’ Brummelkanp et al. 2002 
   
 
siRNA 
The siRNAs used for this study including their sequence and the corresponding reference 
are listed in Table 2.9. 
Table 2.9 siRNAs 
siRNA against shRNA sequence Reference 
   
AURKA 5’-GGCAACCAGTGTACCTCAT-3’ Macůrek et al., 2008 
BARD1 5’-CATTCTGAGAGAGCCTGT-3’ Ryser et al., 2009 
BRCA1 5’-GGAACCUGUCUCCACAAAG(DT)(DT)-3’ Lou et al. 2003 
CEP72 5’-TTGCAGATCGCTGGACTTCAA-3’ Oshimori et al. 2009 
CEP192 5’-AGCAGCUAUUGUUUAUGUUGAAAA-3’ Gomez-Ferreria et al., 2007 
CHK2 5’-CCUUCAGGAUGGAUUUGCCAAUC-3’ Invitrogen 
CH-TOG/CKAP5 5’-GAGCCCAGAGTGGTCCAAA-3’ van der Vaart et al., 2011 
KIF2A  5’-GGAAUGGCAUCCUGUGAAA-3’ Jang et al., 2008 
TACC3 5’-GTGGATTACCTGGAGCAGT-3’ Schneider et al., 2007 
TPX2 5´-GAAUGGAACUGGAGGGCUU-3’ Gruss et al. 2002 
LUCIFERASE 5´-CUUACGCUGAGUACUUCGAUU-3’ Elbashir et al., 2001 




The plasmids used for this study are listed in Table 2.10. Additionally the table shows 
their application as well as the corresponding tag and resistance gene. A reference is 
given for plasmids provided by others. For plasmids, which were constructed in this 
study, the corresponding cloning strategy is listed in Table 2.11. 
 




Table 2.10 Used Plasmids 
Plasmid Tag Resistance Encoding for Reference 
     
pcDNA3 none neomycin 
(G418) 
ampicillin 
Human expression  












Human expression plasmid 
with CMV promotor and 
attB sites for site-specific 
integration of genes in the 
human genome via phage  
integrase 










Human expression plasmid 
with CMV promotor and 
attB sites for site-specific 
integration of CEP72 in the 










Expression plasmid for the 
overexpression of human 
BRCA1, full length, which 
cannot be targeted by  









Temporary vector for the 
cloning of a BRCA1-
shRNA-resistant cassette 
this study 









Expression plasmid for the 
overexpression of human 
HA-3xFLAG-tagged Brca1-
I26A mutant in mammalian 
cells. The I26A mutant of 
Brca1 is deficient for the E3-
ubiquitin-ligase activity. 
provided by Dr. 
Kristoffer Valerie, 
Richmond, VA, USA 








Plasmid Tag Resistance Encoding for Reference 








Expression plasmid for the 
overexpression of HA-
tagged sh/si-resistant 
I26A-mutant of human  
BRCA1. 
this study 
see Table 2.11 
pCEF-Chk2-wt none puromycin 
ampicillin 
Human expression plasmid 
with EF1 promotor for the 
overexpression of human  
CHK2 in mammalian cells  







plasmid with CMV pro-
motor for the overex-
pression of phage inte-
grase (phiC31).  phiC31 
enables the efficient site-
specific integration of 
genes harbouring attB 
sites in the genome of  
human cells. 






FLAG kanamycin Mammalian expression 
plasmid with CMV 
promotor for the 
overexpression of  
PLK4 in human cells 







Vector with covalently 
bound topoisomerase I for 
fast cloning and 
recombinants including 
3´-T overhangs for direct 
ligation of Taq-amplified  
PCR products 








Temporary vector for the 
subcloning of CEP72 cDNA 
this study 
see Table 2.11 








Plasmid Tag Resistance Encoding for Reference 
     




vector with CMV 
promoter and GFP gene 
for the overexpression of 
EB3 in human cells. The 
expression of GFP-
tagged Eb3 enables the 
tracking of MT plus-ends 
in live cell microscopy 
provided by Prof. Dr. 
Linda Wordemann, 
Seattle, USA 
pRetroSuper none puromycin 
ampicillin 
Mammalian expression 
vector with H1 promoter 
for the expression of 
shRNA constructs. 









vector with H1 promoter 
for the expression of 
shRNA (scrambled) 
without any target 
sequence in the human 
genome 






vector with H1 promoter 
for the stable expression 
of shRNA against human 
CEP72 
this study 
see Table 2.11 
     
 
Cloning of used plasmids 
In Table 2.11 the plasmids generated in this study are listed. The table also shows the 
donor and target plasmids as well as the applied restriction enzymes. 





The double stranded CEP72 shRNA oligo (Cep72_sh_forward + 
Cep72_sh_reverse (Table 2.7)) was cloned into the BglII / HindIII 
restriction sides of pRetroSuper 
  






pCR2.1-CEP72 CEP72 was amplified from the DNA of the MGC premier cDNA clone  
for CEP72 (BC000132, Biocat, Heidelberg, Germany) using the  
primers Cep72_HindIII_pEGFP_for and Cep72_KpnI_rev (Table 2.7). 




The fragment of CEP72 (STOP codon inclusive) was released from 
pCR2.1-CEP72 by HindIII / XbaI digest and cloned into the HindIII /  
XbaI restriction site of pcDNA3.1-attB-FA-Myc-His 
pcDNA3- BRCA1-sh-
resistant-cassette 
The sh-resistant (nt 96ff) fragment of BRCA1 was released from pcDNA-
Brca1-sh-resistant-HA by HindIII / EcoRI and subcloned 
 into the HindIII / EcoRI restriction site of pcDNA3  
pcDNA3-HA-Brca1-
I26A siRNA resistant 
An in vitro mutagenesis was performed on pcDNA3- BRCA1-sh-
resistant-cassette with oligos Brca_I26A_for and Brca_I26A_rev (Table 
2.7). The I26A mutated and sh-resistant fragment of BRCA1 was then 
released by HindIII / EcoRI and cloned into HindIII / EcoRI  
restriction site of pcDNA-Brca1_sh-resistant-HA. 
  
 
2.1.3.6 Human cell lines 
Human cell lines 
The human cell lines used for this study are listed in Table 2.12 . Additionally the table 
provides information about their origin and the used culture medium, which was 
purchased from Sigma-Aldich (Taufkirchen, Germany) and PAA (Cölbe, Germany). 
Table 2.12 Human cell lines 
Cell line Origin Medium Selection Reference 
     
HCT116 colon Roswell Park Memorial  
Institute 1640 (RPMI-1640) 
none Brattain et al. 1981 
HCT116-
CHK2-/- 
colon Roswell Park Memorial  
Institute 1640 (RPMI-1640) 
neomycin 
(G418) 




colon Roswell Park Memorial 
Institute 1640 (RPMI-1640) 
puromycin Stolz et al., 2010 
     
 




Stable cell lines 
All cell lines, which were generated in this study are listed in Table 2.13. The table also 
provides information about the parental cell line, the used plasmid and the respective 
selection of the cell lines. 
Table 2.13 Constructed stable cell lines 
Cell line Parental 
cell line 
Plasmid Selection 
    
HCT116-scr-shRNA HCT116 pRetroSuper-scrambled-shRNA puromycin 
HCT116-CEP72-shRNA HCT116 pRetroSuper-CEP72-shRNA puromycin 
HCT116-ctr HCT116 pcDNA3.1-attB-FA-Myc-His neomycin (G418) 
HCT116-CEP72 HCT116 pcDNA3.1-attB-FA-Myc-His-CEP72 neomycin (G418) 
    
 
2.1.3.7 Microorganisms 
Escherichia coli strain 
DH5α F- Φ80lacZ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rk-, mk+) 
phoAsupE44 thi-1 gyrA96 relA1λ-. 
 
2.2 Methods 
2.2.1 Cell culture 
All cell lines were cultivated in RPMI1640 medium supplemented with 10% (v/v) fetal calf 
serum, 100 μg/ml streptomycin and 100 U/ml penicillin (Sigma Aldrich) using a 
humidified incubator with 5% CO2 at 37°C. The selection medium additionally contained 
300 µg/ml G418 and 1 µg/ml puromycin, respectively. For experimental setups medium 
without any antibiotics was used. 
Cells in permanent culture were passaged three times a week to enable sufficient 
nutrient supply and enough space for proliferation. For long term storage were 
cryopreserved. Therefor cells were harvested and resuspended in RPMI1640 containing 
20% (v/v) FCS and 10% (v/v) DMSO. The cell suspension was slowly cooled down to -
80°C using a cryo 1°C freezing container and stored at -196°C. 




2.2.2 Cell cycle synchronization of human cells 
Cells were synchronized in the cell cycle at the G1/S transition via double thymidine 
block. For this, the cells were treated with 2 µM thymidine in RPMI1640 for 16h. To 
release the cells from the block, they were washed with PBS over a time period of 30 min 
(approximately 6 times) and subsequently supplied with fresh medium. After 8 h the cells 
were again treated with 2 µM thymidine in RPMI1640 for 16h. The cells were released 
from the block by repeated washing steps with PBS. Provided with fresh medium the cells 
re-enter the cell cycle and progress through S phase, G2 phase, mitosis and G1 phase. 
To further arrest the cells in mitosis they were treated with 20 µM of the proteasome 
inhibitor MG132 for another 3 h, 6.5 h after being released. In this manner the 
degradation of cyclin B is inhibited and the cells are blocked in metaphase. 
For mitotic synchronization cells were treated with 150 nM Taxol®, 300 nM nocodazole or 
2 µM dimethylenastron (DME) for 16 h. 
2.2.3 Transfection of human cells 
2.2.3.1 Electroporation 
2.5 million cells were harvested and resuspended in 400 µl RPMI1640 without any 
supplements. The cell suspension was mixed with 1 – 20 µg of plasmid and transferred 
into an electroporation cuvette with 4 mm in diameter (BioRad, Hercules, CA, USA). 
Using the electroporation system GenePulser XcellTM (BioRad, Hercules, CA, USA) the 
electroporation was performed with 300 V, 500 µF and ∞ resistance. The cells were 
seeded into prewarmed fresh medium and the medium was changed after 4 h. The 
analysis of the cells was done 48 h after transfection. 
2.2.3.2 PEI Transfection 
Cells were seeded at 70% density in 6-well plates. The cells were washed with PBS and 
supplemented with 1 ml of fresh medium without any FCS and antibiotics. 0.0025% (v/v) 
PEI, pH7.0 in 100 µl PBS was mixed with 0.5 – 5 µg of plasmid in 100 µl PBS by pipetting 
up and down for 10 s. The mixture was incubated at RT for 20 min and added dropwise 
to the prepared cells. The medium was changed after 4 h and the cells were analysed 48 
h after transfection.  
2.2.3.3 siRNA transfection  
Cells were seeded at 70% density in 6-well plates. The cells were washed with PBS and 
supplemented with 1 ml of fresh medium without any FCS and antibiotics. For the siRNA 
transfection exclusively RNAse-free reaction tubes and pipet tips were used. A final 
volume of 200 µl RPMI1640 medium was supplemented with 40 – 60 pmol siRNA and 4 – 
6 µl of InterferinTM (Polyplus-transfection SA, Illkirchen, France). Subsequently the 




mixture was vortexed for 10 s and incubated at RT for 10 min. The solution was added 
dropwise to the prepared cells and after 6 h the medium was changed. The cells were 
analysed 48 h after transfection. 
2.2.3.4 Metafectene® transfection 
To generate cell lines with a stable expression of certain plasmids, the cells were 
transfected using Metafectene® according to the manufacturer’s protocol (Biontex 
Laboratories GmbH, Martinsried, Germany).  
2.2.4 Generation of stable cell lines  
For the generation of stable cell lines, cells were transfected using Metafectene® (2.2.3). 
To select stable cells, they were seeded into selection medium (1 µg/ml Puromycin, 300 
µg/ml G418) 24 h after transfection. A resistance gene encoded on the respective 
plasmid enables a selection for cells which were successfully transfected. In order to 
ensure the generation of clones based on a single cell, different dilutions (1:50, 1:100, 
1:200, 1:500, 1:1000,  1:1500 and 1:2000) were seeded. After 7 days small colonies 
from single cells appear. This single cell clones were transferred to 24-well plates and 
further cultivated. 
2.2.5 Karyotype analyses via metaphase chromosome counting 
For the analysis of the karyotype, single cell clones were cultivated for 30 generations 
and seeded in 6-well plates. To arrest cells in mitosis, they were treated with 300 nM 
nocodazole for 5 h. Afterwards the cells were harvested and centrifuged at 2000 rpm for 
5 min. The cells were resuspended in 700 µl 40% RPMI / 60% H2O dest. and incubated at 
RT for 30 min. The incubation process in the hypotonic solution leads to a swelling of the 
cells, which were subsequently prefixed by addition of 300 µl ice cold Carnoy’s fixative 
(25% (v/v) methanol, 75% (v/v) glacial acetic acid (Mehlhop and Gardner 1982). The 
cell suspension was centrifuged at 2000 rpm for 5 min. After removal of the supernatant, 
1 ml ice cold Carnoy’s fixative was gently added to the cells. This step was repeated 
once. Then the cells were either stored at -20°C until further usage or directly processed. 
The cell suspension was again centrifuged at 2000 rpm for 5 min and the cell pellet was 
resuspended in 100 µl - 500 µl glacial acetic acid. Afterwards 3 drops of the cell 
suspension were dropped onto wet and precooled object slides from a vertical height of 
about 30 cm. The object slides were incubated in a wet chamber at 42°C for 5 minutes. 
After the object slides had been thoroughly dried at RT, the chromosomes were stained 
by incubation in a 10% (v/v) Giemsa staining solution (Merck, Darmstadt, Germany) for 
20 min and rinsed subsequently with H2O dest. The stained object slides were dried and 
the chromosome spreads were embedded in Euparal (Carl Roth, Karlsruhe, Germany). 
The chromosome counting was performed using a Zeiss Axioscope FS microscope (Zeiss, 




Oberkochen, Germany) equipped with a Hamamatsu C4742-95 camera and the Hokawo 
Launcher 2.1 software (Hamamatsu Photonics, Herrsching am Ammersee, Germany).  
2.2.6 Karyotype analyses via CEP-FISH analysis 
For CEP-FISH analysis chromosome enumeration probes (CEP), which chromosome 
specifically hybridize to highly repetitive human satellite DNA sequences, were applied. In 
this study probes specifically recognizing chromosome 7 and 15 (Aquarius®Kit, Cytocell, 
Cambridge, Great Britain) were used.  
Cells were swollen in hypotonic medium and fixed using Carnoy’s fixative as described in 
2.2.5. The cell suspension was centrifuged at 2000 rpm for 5 min and the cell pellet was 
resuspended in 100 µl - 500 µl glacial acetic acid. Then 1 drop of the cell suspension was 
dropped onto a wet, precooled cover slip (10 x 10 mm) and dried at RT. Afterwards the 
cover slip was incubated in 2x SSC solution (0.3 M sodium chloride, 30 mM trisodium 
citrate, pH 7) for 2 min at room temperature followed by dehydration in an ethanol series 
(70 %, 85 % and 100 %, each for 2 min at RT) and drying. For two-probe hybridization 
0.6 µl of each CEP-FISH probe and 0.8 µl hybridization solution were mixed and pipetted 
onto a pre-warmed object slide. Subsequently the cover slip containing the cells was 
placed up site down onto the drop. To avoid evaporation the cover slip was sealed with 
nail polish. For denaturation the object slide was placed on a 75°C heating block for 2 
min. Afterwards it was transferred to a humid lightproof chamber and incubated for 2 h 
in an incubator at 37°C. The cover slip was removed from the object slide, transferred 
into a 24-well containing pre-warmed 0.25x SSC and incubated for 6 min in a 75°C water 
bath. Subsequently the slide was washed with 2x SSC + 0.05% Tween20 and stained 
with Hoechst 33342 (1:15000 in 2x SSC + 0.05% Tween20) for 5 min each. After three 
further washing steps with 2x SSC + 0.05% Tween20, the coverslip was dried, 
embedded in Vectashield® (Vector Laboratories, Burlingame, California, USA) and finally 
sealed with nail polish. Counting signals was done using immunofluorescence microscopy 
as described in 2.2.8. 
2.2.7 Flow Cytometry 
Fluorescence activated cell sorting (FACS) analysis was performed using a BD FACS 
Canto II (Becton Dickinson, San Jose, CA, USA). The analysis was performed using the 
BD FACS DivaTM (Becton Dickinson, San Jose, CA, USA) software.  
Cells were harvested, transferred to a 1.5 ml reaction tube, centrifuged at 2000 rpm for 
5 min and resuspended in 200 µl PBS. The cells were fixed with 1 ml ice cold 70% 
ethanol, which was added dropwise while the suspension was continuously vortexed. 
Subsequently the cells were stored at 4°C overnight. 
 






For the detection of the DNA content the DNA intercalating dye propidium iodide (PI) was 
used. Fixed cells were centrifuged at 2000 rpm for 5 min, the cell pellet was washed with 
1 ml PBS, resuspended in 100 µl RNAse A (1µg/ml in PBS) and incubated at RT for 15 
min. 50 µg/ml PI in PBS was added and the cells were analysed.  
MPM2 staining 
To detect mitotic cells anti-MPM2 antibody was used. This antibody specifically recognizes 
mitotic phospho-epitopes at kinetochores, chromosome arms, the midbody and spindle 
poles (Tapia et al. 2006). Fixed cells were centrifuged at 2000 rpm for 5 min, washed 
with 1 ml washing buffer (0.05% Triton- X-100 in PBS) and incubated in 80 – 100 µl of 
an anti-MPM2 antibody solution (1:1600 in 2% (v/v) FCS, 0.2% Triton-X-100 in PBS) at 
4°C for 2h. Afterwards the cells were washed twice with 1 ml washing buffer and 
incubated in 80 – 100 µl of a fluorochrome-coupled secondary antibody solution (1:2000 
AlexaFluor488 in 2% (v/v) FCS, 0.2% Triton-X-100 in PBS) at 4°C for 2h. The cells were 
washed twice with washing buffer and once with PBS. After the cells had been incubated 
with 100 µl RNAse A solution (1µg/ml in PBS) for 15 min, 200 – 600 µl PI (50 µg/ml in 
PBS) was added and the samples were analysed. 
2.2.8 Immunofluorescence microscopy 
Cells were seeded onto 10x10 mm cover slips, which were placed in a 24-well plate. The 
next day the cells were fixed with 2% paraformaldehyde (PFA) in 1x PHEM (60 mM PIPES 
pH7.0, 27 mM HEPES, 10 mM EGTA and 4 mM MgSO4) at RT for 5 min. For 
permeabilization and extraction the cells were subsequently treated with ice cold 100% 
methanol at -20°C for further 5 min. The cover slips were washed three times with PBST 
(0,75% (v/v) Tween-20 in PBS). To avoid unspecific antibody binding the cells were 
incubated with 5% (v/v) FCS in PBST for 30 min. After washing with PBST, they were 
incubated with the primary antibody (3% (v/v) FCS in PBST) (primary antibodies see 
Table 2.4) either at RT for 2h or at 4°C overnight. The cells were washed three times 
with PBST and incubated with the secondary antibody (3% (v/v) FCS in PBST) 
(secondary antibodies see Table 2.5) again either at RT for 2h or at 4°C overnight. Then 
the cells were stained with Hoechst33342 (1.33 µg/ml in PBST) for 5 min. After three 
further washing steps with PBST and two washing steps with PBS, the cover slips were 
dried and the cells were embedded in Vectashield® (Vector Laboratories, Burlingame, 
California, USA). Finally the cover slips were sealed with nail polish. 




Microscopy was done on a Leica DM6000B microscope (Leica, Wetzlar, Germany) and a 
DeltaVision–ELITE microscope (Applied Precision / GE Healthcare, Chalfont St- Giles, 
Great Britain) equipped with a CoolSnap-HQ2 (Photometrics, Tucson, Arizona, USA) or 
PCO Edge sCMOS (PCO, Kelheim, Germany) camera. Images were taken by means of an 
Olympus 60x 1.40 NA or Olympus 100x 1.40 NA objective with a Z-optical spacing of 0.2 
µm. Subsequently the images were deconvolved and analysed using the SoftWorx 
5.0/6.0 and softWoRx Explorer 1.3.0 software (Applied Precision / GE Healthcare, 
Chalfont St- Giles, Great Britain). 
2.2.9 Live cell microscopy 
Measurement of microtubule plus-end assembly rates 
The microtubule plus-end assembly rates were measured by tracking the plus-end 
binding protein EB3 conjugated to GFP in living cells. (Stepanova et al. 2003; Ertych et 
al. 2014). Cells were transfected via electroporation with 9 µg of pEGFP-EB3 (Table 2.10) 
and seeded onto glass-bottom dishes µ-dish (Ibidi, Martinsried, Germany). 24h after the 
transfection the cells were treated with 2 µM of the Eg5/Kif11 inhibitor dimethylenastron 
(DME) for 2 h. This synchronization step was useful to ensure the measurement of 
mitotic spindles in the same mitotic state, but did not affect the microtubule plus-end 
assembly rate per se (Ertych et al. 2014). For the image acquisition a Deltavision ELITE 
microscope equipped with a CoolSnap-HQ2 (Photometrics, Tucson, Arizona, USA) or a 
PCO Edge sCMOS camera (PCO, Kehlheim, Germany) was used. By means of an Olympus 
100x 1.40 NA objective four sections with a Z-optical spacing of 0.4 µm were taken every 
2 sec. The images were deconvolved and analyzed using the SoftWorx 5.0/6.0 and 
softWoRx Explorer 1.3.0 software (Applied Precision/ GE Healthcare, Chalfont St- Giles, 
Great Britain). Average microtubule plus-end assembly rates were calculated on the basis 
of 20 microtubules per cell.  
2.2.10 Determination of lagging chromosomes 
For the determination of lagging chromosomes, cells were synchronized in G1/S-phase 
via double thymidine block and released into fresh medium. To achieve an accumulation 
of cells in anaphase, cells were fixed 9.5 h after being released. Subsequently the cells 
were analysed using immunofluorescence microscopy by quantification of CREST positive 
chromosomes lagging in the middle of the equatorial plane. Only chromosomes clearly 
separated from the two pole-oriented chromosome groups were counted as lagging. 
2.2.11 Determination of abnormal spindles 
Cells were synchronized in G1/S-phase via double thymidine block and released into 
fresh medium. To synchronize the cells in metaphase they were treated with 20 µM 
MG132 for 3 h, 6.5 h after release from the block. Cells were fixed in total 56 h after 




transfection and stained for spindles (-tubulin), kinetochores (CREST) and DNA 
(Hoechst33342). Subsequently the spindle morphology was evaluated. 
2.2.12 Determination of pole-to-pole distance and the average microtubule 
length  
Cells were synchronized in metaphase as described in 2.2.2. using MG132 treatment, 
fixed and stained for spindles (-tubulin), centrosomes (-tubulin) and DNA 
(Hoechst33342). Using an Olympus 100x 1.4 NA objective images of sections with a Z-
optical spacing of 0.2 µm were acquired. The distance between the two centrosomes as 
well as the average microtubule length from pole to pole was determined (Figure 2.1 
using the SoftWoRx 6.0 and the softWorX Explorer 1.3.0 software (Applied Precision/ GE 
Healthcare, Chalfont St- Giles, Great Britain). 
 
Figure 2.1 Schematic depiction for the determination of the average microtubule length 
from pole to pole. 
 
2.2.13 Determination of centrosome numbers  
Cells were fixed and stained for spindles (-tubulin), centrosomes (-tubulin) and DNA 
(Hoechst33342). Subsequently the centrosome number in interphase cells was 
determined via immunofluorescence microscopy and the percentage of cells harboring 
more than 2 centrosomes was determined. 
2.2.14 Analysis of monopolar spindle assembly 
As a readout for abnormal microtubule plus end assembly (Stolz et al. 2015) the 
monopolar spindle morphology was determined. For this, cells were treated with 2 µM 
DME (PAA Laboratories, Pashing, Australia) for 4h. Afterwards the cells were fixed with 
PFA/Methanol and stained for spindles (α-tubulin), kinetochores (Crest) and DNA 
(Hoechst33342) (see 2.2.8 and Table 2.4). The analysis was done by 
immunofluorescence microscopy (2.2.8).  
2.2.15 Cultivation of E. coli cells 
Escherichia coli (E. coli) cells were cultivated in LB-Medium (1% (w/v) peptone 140, 
0.5% (w/v) yeast extract, 0.5% (w/v) NaCl) in an incubator shaker with 140 rpm at 




37°C or on plates containing 1.5% (w/v) agar. For the selection of transformed bacteria 
the respective antibiotics were added with a final concentration of 100 mgl/l for ampicillin 
and 50 mg/l for kanamycin. 
2.2.16 Generation of chemically-competent E. coli cells 
For the generation of chemically-competent E. coli cells 2 x 10 ml LB-medium (1% (w/v) 
peptone 140, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl) were inoculated with E. coli 
DH5α and grown overnight at 37°C. The next day 2 x 250 ml of SOB medium (2% (w/v) 
tryptone, 0.5% (w/v) yeast extract, 10 mM MgSO4, 10 mM NaCl, 10mM MgCl2) were 
prewarmed to 25°C and inoculated with 10 ml of the overnight culture. Then the bacteria 
were grown at 25°C to an OD600 = 0.6, filled into 50 ml tubes and cooled on ice for 10 
min. The bacteria were centrifuged at 3000 rpm and 4°C for 15 min, the cell pellet of 
each tube was resuspended in 20 ml icecold TB buffer (55 mM MnCl2, 250 mM KCl, 10 
mM PIPES / KOH pH7.0, 15 mM CaCl2) and incubated on ice for 10 min. After 
centrifugation for further 15 min, the pellets of all tubes were pooled and resuspended in 
a total volume of 40 ml icecold TB buffer. The E. coli suspension was incubated on ice for 
10 min. Quickly, aliquots with 100 µl were prepared in pre-cooled reaction tubes, which 
were immediately frozen in liquid nitrogen and stored at -80°C. 
2.2.17 Transformation of E. coli cells 
Chemically competent E. coli cells were thawed on ice and 20 µl of ligation reaction or 1 
µl of pure plasmid was added and gently mixed. The mixture was incubated on ice for 20 
min and the cells were heat shocked for 1 min at 42°C. Subsequently the cell suspension 
was incubated on ice for further 2 min. Then 1 ml pre-warmed LB medium (1% (w/v) 
peptone 140, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl) was added and the mixture 
was incubated for 45 – 60 min at 37°C and 350 rpm in a Thermomixer Comfort R 
(Eppendorf, Hamburg, Germany). The E. coli suspension was transferred to 5 ml or 200 
ml LB medium supplemented with the appropriate selection marker or plated on the 
respective LB agar plates and incubated at 37°C overnight. The next day the plasmids 
were prepared from the E. coli cells as described in 2.2.18. 
2.2.18 Plasmid preparation from E. coli cells 
Mini-preparation 
4 ml E. coli cells from an overnight culture were pelleted in a 2 ml reaction tube by 
centrifugation at 14800 rpm for 30 sec. The pellet was resuspended in 200 µl 
resuspension buffer (50 mM Tris / HCL pH8.0, 10 mM EDTA pH8.0, 100 µg / ml RNaseA). 
Subsequently 200 µl of lysis buffer (200 mM NaOH, 1% (w/v) SDS) were added and the 
suspension was gently inverted 5 times. After incubation for 3 min at RT, 200 µl of 
neutralization buffer (3M potassium acetate pH 5.5) were added. The mixture was 




immediately inverted 5 – 10 times and centrifuged at 14800 rpm for 10 min. Afterwards 
the supernatant was transferred to a new 1.5 ml reaction tube and 400 µl isopropanol 
was added. The precipitated DNA was pelleted by centrifugation at 14800 rpm for 20 min 
and washed with 800 µl 70% (v/v) ethanol. After another centrifugation step at 14800 
for 5 min, the supernatant was removed. The pellet was dried at RT and subsequently 
resuspended in 30 µl H2O dest. 
Midi-preparation 
For midi-preparation of plasmid DNA the NucleoBond® Xtra Midi Kit (Machery-Nagel, 
Düren, Germany) was used according to the manufacturer’s protocol. 
2.2.19 Polymerase chain reaction (PCR) 
The standard PCR protocols for the Phusion® High Fidelity Polymerase (New England 
Biolabs, Beverly, Massachusetts, USA) and the GoTaq® polymerase (Promega, Madison, 
Wisconsin, USA) are listed in Table 2.14 and Table 2.15, respectively. 
Table 2.14 PCR protocol Phusion High Fidelity DNA Polymerase 
Component Concentration 
  
5x HF Phusion® Buffer 1x 
dNTPs je 200 µM 
primer forward 0,1 µM 
primer reverse 0,1 µM 
Phusion® High fidelity  
DNA Polymerase 
2 U 
template 1 ng 
dH2O ad. 50 µL 
  
 
Table 2.15 PCR protocol Go®Taq DNA Polymerase 
Component Concentration 
  
5x Green GoTaq®  
Reaction Buffer 
1x 
dNTPs je 100 µM 
primer forward 0,5 µM 
primer reverse 0,5 µM 
MgCl2 20 mM 
GoTaq® DNA Polymerase 0,25 U 
colony  
  




For the PCR reactions the two following programs were used (Table 2.16 and Table 2.17). 
X is defined as the optimal annealing temperature for the respective pair of primers.  
Table 2.16 PCR programm Phusion® High Fidelity DNA Polymerase 
Step Temperature Time Cycles 
    
initial denaturation 98 °C 2 min 1x 
denaturation 98 °C 10 s  
annealing X  °C 30 s 30x 
elongation 72 °C 15 – 30 s / kb  
final Elongation 72 °C 10 min 1x 
cooling 16 °C ∞ 1x 
    
 
Table 2.17 PCR programm Go®Taq Polymerase 
Step Temperature Time Cycles 
    
initial denaturation 95 °C 2 min 1x 
denaturation 94 °C 15 s  
annealing X   °C 20 s 25x 
elongation 72 °C 1 min / kb  
final Elongation 72 °C 10 min 1x 
cooling 16 °C ∞ 1x 
    
2.2.20 Restriction digest of DNA 
Purified DNA was mixed with the specific enzyme and the required supplements 
according to the manufacturer’s protocol (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA).  
2.2.21 Cloning 
Digested plasmids were dephosphorylated by FastAP Thermosensitive Alkaline 
Phosphatase (Thermo Fisher Scientific, Waltham, Massachusetts, USA) according to the 
manufacturer’s protocol. The ligation of DNA fragments was done via T4-DNA ligase 
(Promega, Madison, Wisconsin, USA) and a vector:insert ratio of 1:3 was chosen. The 
calculation for the required amount of DNA is shown below. 
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The ligation reaction was incubated at 16°C overnight. Subsequently the ligation was 
stopped by incubation at 65°C for 10 min. A typical ligation protocol is shown in Table 
2.18. 
Table 2.18 Composition of a typical ligation reaction 
 
 
2.2.22  Generation of whole cell lysates 
Cells were harvested and lysed in Boehringer lysis buffer containing 50 mM Tris-HCl, 
pH7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) Igepal (NP-40), 0.1% (w/v) 
sodium dodecylsulfate (SDS), 0.1% sodium desoxycholate, 20 mM Na2VO4, 25 mM ß-
glycerophosphate, 50 mM NaF, 5 mM Na2MoO4, 0.5 nM microcystin-LR and complete 
protease inhibitor cocktail EDTA-free (Roche, Switzerland) (1:25). The lysis was 
performed on ice for 20 min and cell debris were separated by centrifugation at 148000 
rpm for 20 min.  
2.2.23 Protein determination 
To determine the exact amount of protein within the cell lysate, the Bio-Rad DCTM Assay 
was applied according to the manufacturer’s protocol. BSA was used as a standard. The 
photometric measurement at a wavelength of 705 nm was performed using the 
VictorTMX3 (PerkinElmer, Rodgau, Germany). 
2.2.24 Immunoprecipitation (IP) of proteins 
Cells were harvested and lysed in IP lysis buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl, 
0.25% Igepal (NP-40), 0.1 mM EDTA, 10% (v/v) glycerol, 20 mM Na2VO4, 25 mM ß-
glycerophosphate, 50 mM NaF, 5 mM Na2MoO4, 0.5 nM microcystin-LR, complete 
protease inhibitor cocktail EDTA-free (Roche, Switzerland) (1:25)). For the 
immunoprecipitation 2 mg whole cell lysate with a concentration of 7 mg/ml was 
incubated with 1.5 µg of the respective antibody (see Table 2.4) in a rotator at 4°C for 
1.5 h. The protein-antibody mixture was supplemented with 15 µl a 50% solution of 
protein G sepharose beads and incubated in a rotator at 4°C for additional 1.5 h. By 
gentle inversion and centrifugation at 2000 rpm for 1 min the beads were washed three 
Component Concentration 
  
10x ligation buffer 1x 
vector 50 – 500 ng 
insert Y 
T4-DNA ligase 0,5 - 1 µl 
dH2O ad. 50 µl 
  




times with 800 µl of lysis buffer. Then 20 µl SDS sample buffer (15% (w/v) SDS, 15% ß-
mercaptoethanol, 50% (v/v) glycerol, 0.25% (w/v) bromophenol blue) was added to the 
beads and they were incubated at 95°C for 5 min. 
2.2.25  Sodium dodecylsulfate polyacrylamide gel electrophoresis 
2.2.25.1 (SDS-PAGE) 
For the separation of proteins according to their molecular weight a discontinuous SDS-
PAGE was performed (Laemmli, 1970). The gel composed of a 5% stacking gel (300 mM 
Tris-HCl pH 6.8, 0.1% (w/v) SDS, 5% (v/v) Rotiphorese® Gel 30) and a 7.5% resolving 
gel (600 mM Tris-HCl pH8.8, 0.1% (w/v) SDS, 7.5% (v/v) Rotiphorese® Gel 30). For 
sample preparation 50 µg of protein lysate was mixed with 5x SDS sample buffer (15% 
(w/v) SDS, 15% ß-mercaptoethanol, 50% (v/v) glycerol, 0.25% (w/v) bromophenol 
blue), incubated for 5 min at 95°C and loaded onto the gel. For the determination of the 
molecular weight 5 µl of a prestained protein standard (PageRulerTM Prestained Protein 
Ladder (Fermentas, St. Leon-Rot, Germany) was used. By means of running buffer (25 
mM Tris-HCl pH 6.8, 192 mM glycine 0.15% (w/v) SDS) the proteins were separated in a 
SDS-PAGE device at 28 mA for 1h and subsequently at 38 mA for approximately 4h. 
2.2.26  Western blotting 
After the proteins had been separated by SDS-PAGE, the protein transfer and 
immobilization on a polyvinyliden fluoride (PVDF) (Immobilion-P, Millipore, USA) or 
nitrocellulose (ProtranTM, Whatman®, Germany) membrane was performed using a tank 
blot system. The PVDF membrane was activated by incubation in 100% methanol for 3 
sec and the blot was built up. The SDS-PAGE gel was put on the membrane between 
three layers of Whatman paper, respectively and placed in the tank blot system filled 
with transfer buffer (0.0025% (w/v) SDS, 24.8 mM Tris-HCl pH 8.0, 170 mM glycine, 
20% (v/v) methanol). The transfer was performed at 450 mA for 2h 45 min. To visualize 
the immobilized proteins the membrane was stained with Ponceau S solution (0.1% 
(w/v) Ponceau S in 5% (v/v) glacial acedic acid) 
To avoid unspecific antibody binding the membrane was incubated with 5% milk in TBS-T 
(0.05% (v/v) Tween-20 in TBS (50 mM Tris-HCl pH 7.2, 160 mM NaCl) for 30 min. 
Subsequently the membrane was washed and incubated with the respective primary 
antibody (in 5% (w/v) BSA in TBS) at 4°C overnight. The next day the membranes were 
washed for 30 min with TBS-T and subsequently incubated with the appropriate HRP-
conjugated secondary antibody (in 5% milk in TBS) at RT for 2 h. The membranse were 
washed three times with TBS-T and TBS and the immunodetection was done by 
enhanced chemo luminescence. For this, the membrane was incubated in 0.1 M Tris-HCl, 
pH 8.5 containing 0.6% (w/v) luminol, 0.3% (w/v) coumaric acid and 0.02 (v/v) H2O2 




and the membrane was exposed to Fuji Medical X-Ray Films which were processed using 
the OPTIMAX X-Ray Film Processor. 
 





3.1 Identification of Cep72 as a novel Brca1 interacting protein  
Previous results from our group showed, that the E3-ubiquitin ligase Brca1 plays an 
essential role in mitotic progression, where the Chk2-mediated phosphorylation of Brca1, 
ensures proper spindle formation and accurate chromosome segregation. Consequently 
Brca1’s function during mitosis is crucial for the maintenance of chromosomal stability 
(Stolz et al. 2010). Therefore, it is of major importance to identify proteins that 
participate in the mitotic Chk2-Brca1 pathway.  
To identify novel proteins interacting with Brca1 during mitosis, Brca1 was 
immunoprecipitated from whole-cell lysates by Dr. Norman Ertych (AG Bastians, 
Göttingen, Germany). In collaboration with Dr. Oliver Valerius (Göttingen, Germany), 
Brca1 interacting proteins were identified by LC-MS/MS analysis. Importantly, 13 unique 
peptides for the centrosomal protein Cep72 were discovered. Thus Cep72 was clearly 
identified as a new interaction partner of Brca1 during mitosis (Lüddecke et al. 2015). 
For validation of the results obtained by LC-MS/MS, immunoprecipitations of Brca1 from 
mitotic HCT116 cell lysates were performed and the (co)-immunoprecipitated proteins 
were analysed by western blot. In order to investigate the specificity of the interaction, 
cells transfected with CEP72 siRNA were compared with control transfected cells 
(Figure 3.1 a). In addition to an enrichment of Brca1 protein, the Brca1 associated 
protein BARD1, serving as a control, was co-immunoprecipitated, showing that the 
immunoprecipitation was successful. Additionally a co-purification of Cep72 was clearly 
detected. After repression of CEP72 a reduction in the amount of co-precipitated Cep72 
protein was confirmed, so that the interaction between Cep72 and Brca1 can be 
considered as specific.  
Moreover, the interaction between Cep72 and Brca1 in interphase was examined. For 
this, Brca1 immunoprecipitations were performed using cell lysates of asynchronously 
growing cells. Interestingly, the western blot analysis revealed an interaction between 
Cep72 and Brca1 in interphase cells, which was even higher than the interaction detected 
in mitotic cells (Figure 3.1 b). 
In order to further investigate, whether the Brca1-Cep72 interaction is influenced by the 
mitotic, Chk2-mediated phosphorylation of Brca1, anti-Brca1 immunoprecipitations were 
 





Figure 3.1 Identification of Cep72 as a novel Brca1 interacting protein. (a) For the analysis 
of the protein interaction between Cep72 and Brca1 anti-Brca1 immunoprecipitations of mitotic 
HCT116 cell lysates were performed and analysed by western blot. (b) To analyse the protein 
interaction between Cep72 and Brca1 in mitosis and interphase, anti-Brca1 immunoprecipitations 
of mitotic and interphase HCT116 cell lysates were performed and analysed by western blot. (c) In 
order to investigate the interaction between Brca1 and Cep72 in dependency of Chk2, anti-Brca1 
immunoprecipitations were performed using mitotic lysates of HCT116 cells transfected with control 
or CHK2 siRNA. The immunoprecipitation was analysed by western blot. 
 
performed with mitotic lysates of cells, which were transfected with control or CHK2 
siRNA. The subsequent western blot analysis revealed that a repression of CHK2 reduced 
the interaction between Brca1 and Cep72, whereas the interaction between Brca1 and its 
associated protein BARD1 remained unchanged (Figure 3.1 c). 
These results showed that Brca1 and Cep72 interact both, during mitosis and even more 
pronounced during interphase. Additionally the mitotic interaction between Brca1 and 
Cep72 is positively influenced by Chk2. 
Furthermore the protein levels of Brca1 and Cep72 were analysed during the cell cycle. 
For this, HCT116 cells were synchronized via double thymidine block at G1/S transition. 
0, 3, 4, 6, 7, 8, 9, 10 and 11 h after thymidine removal, the protein levels of Brca1 and 
Cep72 were analysed by western blot (Figure 3.2 a) and linked to the respective cell 
cycle phases, which were determined by FACS analysis (Figure 3.2 b). It revealed that 
the protein levels of both, Brca1 and Cep72 gradually increased during S- and G2-phase. 
Brca1 levels reached a maximum after 8 h when cells started to enter mitosis. An 
increase in the mitotic index was further accompanied by the appearance of a double 
band, indicating the mitotic phosphorylation of Brca1 (Liu et al. 2002; Scully et al. 1997). 
Moreover the western blot showed maximal Cep72 protein levels at time points 8 and 9, 
which then gradually decreased again. The constant increase of Cep72 protein levels 
from S-phase to mitosis suggest, that Cep72 might have an important function during 
mitosis. 





Figure 3.2 Brca1 and Cep72 protein levels peak during mitosis. (a) For the analysis of Brca1 
and Cep72 protein levels during the cell cycle, cells were synchronised in G1/S phase by double 
thymidine block. After thymidine removal, Brca1 and Cep72 protein levels were analysed by 
western blot at indicated time points. (b) For the determination of the cell cycle phase FACS 
analysis using PI and MPM2 staining was performed at indicated time points.    : 
 
3.2 Overexpression of CEP72 
3.2.1 CEP72 is frequently overexpressed in human colorectal cancer 
Since Cep72 is interacting with the prominent tumour suppressor Brca1 throughout the 
cell cycle, the question arises, whether CEP72 expression is altered in human cancer. 
Thus, an mRNA expression analysis using microarray hybridization was performed in 
collaboration with PD Dr. Jochen Gaedcke from the University Medical Centre Göttingen, 
Germany. For this, biopsies of pretherapeutic rectal tumours, which were localized in the 
lower and middle rectum and biopsies of the corresponding distant mucosa (at least 4 
cm) were collected from >181 patients. Excluding biopsies containing less than 50% of 
tumour cells, RNA was isolated (RNA integrity number >5) and the mRNA expression of 
181 tumour samples was analysed via microarray hybridization. The data, which were 
further analysed by Dr. Jerzy Dyczkowski (University Medical Centre Göttingen, 
Germany), revealed a highly significant, 3.2 fold increase in the log2(expression) of 
CEP72 (Figure 3.3 a). 
Furthermore the CEP72 expression was analysed by means of immunohistochemistry in 
collaboration with Prof. Dr. Wilko Weichert from the University Medical Centre Heidelberg. 
For this, Cep72 protein levels were visualized in normal colorectal mucosa and in 
colorectal adenocarcinoma tissues of 357 patients, respectively, whereupon the staining  
 
 





Figure 3.3 CEP72 is frequently overexpressed in human colorectal cancer. (a) For the 
determination of the CEP72 expression in rectal cancer, biopsies of pretherapeutic rectal tumours 
and the corresponding distant mucosa were collected from 181 patients. Subsequently the mRNA 
expression of CEP72 was evaluated using microarray hybridization. (b) The CEP72 expression was 
visualized in normal mucosa and colorectal adenocarcinoma via immunohistochemistry staining. 
While a red staining marks a CEP72 expression per se, the expression level can be determined by 
means of the staining intensity. (c) Based on a classification by semi-quantitative 
 
 




immunoreactivity scoring (IRS) ranging from 0-12, all analysed tumour samples were divided into 
tumours with a low (IRS=0) and a high (IRS>0) CEP72 expression, respectively. (d) In order to 
determine the proliferation status of the analysed colorectal adenocarcinoma samples, the Ki-67 
levels, serving as a proliferation marker, were determined. The bar plot shows the mean Ki-67 
levels (± s.d.; t-tes) of n=23-57 tumour samples analysed. (e) In order to analyse the mRNA 
expression of CEP72 in tissue samples from breast tumors and normal tissues, microarray data 
were downloaded from TCGA website (https://tcga-data.nci.nih.gov/tcga/dataAccessMatrix.htm), 
the CEP72 expression was extracted from whole microarrays, log2 transformed and compared by 
paired two samples t-test (n=63 and 531). These data were kindly provided by PD Dr. Jochen 
Geadcke (a), Dr. Jerzy Dyczkowski (University Medical Centre Göttingen) (a+e), Dr. Albrecht 
Stenzinger and Prof. Dr. Wilko Weichert (University Medical Centre Heidelberg) (b-d). 
 
intensity reflects the CEP72 expression (Figure 3.3 b). Whereas in normal colorectal 
mucosa Cep72 was only detectable in proliferating cells at the crypt basis, poorly 
differentiated colorectal carcinoma showed a strong homogenous, predominantly 
nucleolar expression of CEP72. Moreover, a strong diffuse nuclear CEP72 expression 
could be detected in moderately differentiated colorectal carcinomas. Subsequently the 
staining intensity and the percentage of immunoreactive cells were evaluated. 
Additionally, the tumour samples were classified by semi-quantitative immunoreactivity 
scoring (IRS) (Weichert et al. 2008) on the basis of the obtained data. This analysis 
revealed an IRS ranging from 0 – 12, whereupon the CEP72 expression in normal 
colorectal mucosa was assessed as 0. All tumour samples were divided into tumours with 
low CEP72 expression resembling normal colorectal mucosa (IRS=0) and tumours with 
high levels of Cep72 (IRS >0), respectively. This classification revealed high CEP72 
expression in 57% of all tumour samples analysed (Figure 3.3 c). In order to exclude 
that the enhanced protein levels of Cep72 are solely dependent on a higher amount of 
proliferating cells in the tumour tissue, a co-staining for the proliferation marker Ki-67 
was performed. While tumours with low CEP72 expression showed a Ki-67 level of 40.4, 
the Ki-67 intensity in tumour samples with high levels of Cep72 (35.4) was even lower 
(Figure 3.3 d). Thus, an influence of the proliferation rate on CEP72 expression could be 
excluded.   
Finally the CEP72 expression was additionally analysed in breast cancer tissues, where 
BRCA1 mutations are frequently present. Dr. Jerzy Dyczkowski (University Medical 
Centre Göttingen) extracted normalized Agilent microarray data for breast tumour and 
matching control samples from The Cancer Genome Atlas (TCGA) website (https://tcga-
data.nci.nih.gov/tcga/dataAccessMatrix.htm) and compared the log2 expression for 
CEP72 in control and breast tumour samples. While control samples revealed a log2 
CEP72 expression of -1.78, the log2 expression was only 1.2 fold increased in breast 
tumour samples (-1.41).   
In summary, the data show that CEP72 is frequently overexpressed in human colorectal 
cancer but not in breast cancer. 





3.2.2 Overexpression of CEP72 causes enhanced spindle microtubule plus-end 
assembly in mitosis  
Since CEP72 was shown to be frequently upregulated in human colorectal cancer tissues, 
this phenotype might be relevant for tumour biology. Thus, it is important to elucidate 
the cellular consequences of CEP72 overexpression. Colorectal cancer cells are 
characterized by chromosomal instability, which in turn has been associated with 
tumourigenesis, poor patient prognosis and the development of therapy resistance 
(Bakhoum & Compton 2012). One cause for chromosomal instability is the occurrence of 
increased spindle microtubule plus-end assembly rates during mitosis and importantly, 
this phenotype could be directly linked to cells showing reduced expression of CHK2 and 
BRCA1 (Ertych et al. 2014). Thus, Chk2 and Brca1 were shown to play an important role 
in the regulation of spindle microtubule polymerization during mitosis. However, their 
exact function in this process remains elusive. 
For the validation of the results obtained by Ertych et al., the spindle microtubule plus-
end assembly of HCT116 cells with a transient repression of either CHK2 or BRCA1 was 
determined. To further elucidate the function of Brca1 in spindle assembly, its associated 
protein BARD1 (Hashizume et al. 2001) was included in the analysis. Together both 
proteins form a heterodimer, which is crucial for the exertion of E3 ubiquitin ligase 
activity. The measurement of the spindle microtubule polymerization was done by means 
of the end binding protein 3 (EB3), which exclusively binds to growing microtubule plus 
tips (Stepanova et al. 2003). By overexpression of an EB3-GFP fusion protein, growing 
microtubule ends can be tracked using live cell microscopy. Subsequently the distance, 
which the labelled protein covered within a defined time span, was determined (µm/min) 
(Figure 3.4).  
The spindle microtubule assembly rates were measured in cells, which were synchronized 
in mitosis by inhibition of the kinesin Eg5/Kif11 using dimethylenastron (DME) (Müller et 
al. 2007). By treatment with 2 µM DME the centrosome separation is inhibited, which 
results in the formation of monoastral spindles exhibiting fully functional microtubules 
(Kapoor et al. 2000). The analysis of control transfected cells revealed mean microtubule 
polymerization rates of 18.1 µm/min, which was increased by 15.5%, 9.4% and 15.5% 
upon BRCA1, BARD1 and CHK2 knock down, respectively (Figure 3.5 a).  
One way to reduce microtubule polymerization is the low dose application of the 
microtubule stabilizing drug Taxol® (Ertych et al. 2014). Belonging to the group of 
taxanes, it directly binds to microtubule subunits and stabilizes microtubules by inhibiting 
their dynamic properties (Jordan & Wilson 2004). In order to determine, whether the  
 





Figure 3.4 Schematic depiction of EB3 measurement for the determination of spindle 
microtubule plus-end assembly rates. For the measurement of spindle microtubule plus-end 
assembly it was taken advantage of the end binding protein 3 (EB3), which exclusively binds to 
growing microtubule plus tips. The overexpression of an EB3-GFP fusion protein allows the 
detection of polymerizing microtubules by live cell analysis. Images were acquired with a Z-optical 
spacing of 0.4 µm over a time period of 40 sec and every 2 sec one picture was taken. After the 
pictures had been deconvolved, the distance, which the EB3-protein covered within 2 sec was 
measured and converted into the unit µm/min. Subsequently, average microtubule plus-end 
assembly rates were measured on the basis of 20 microtubules per cell. The EB3 measurements 
were performed on monoastral mitotic spindles, which were induced by inhibition of the Eg5/Kif11 
mediated centrosome separation. For this the cells were treated with 2 µM of the Eg5/Kif11 
inhibitor dimethylenastron for 2 h prior to live cell analysis. The Eg5/Kif11 inhibition does not 
interfere with spindle microtubule assembly per se, but allows by monopolar spindle formation an 
easy measurement of microtubule polymerization rates of mitotic cells being located in the same 
mitotic phase. 
 
increased microtubule plus-end assembly induced by repression of BRCA1, BARD1 and 
CHK2 can be reversed, cells were treated with 0.2 nM Taxol® for 24 h prior to EB3 
measurements. The protein expression was verified by western blot analysis and an 
influence of 0.2 nM Taxol® on protein levels was excluded (Figure 3.5 b). Additionally, no 
difference was detectable in the microtubule polymerization between control transfected 
cells treated with either DMSO or Taxol®. However, the increased spindle microtubule 
assembly rates upon BRCA1, BARD1 and CHK2 knock down could be reduced by 0.2 nM 
Taxol® from 20.9 µm/min, 19.8 µm/min and 20.9 µm/min to 17.9 µm/min, 17.7 µm/min 
and 18.0 µm/min, respectively. 
These results validate that the repression of BRCA1 and CHK2 leads to increased spindle 
microtubule plus-end assembly during mitosis (Ertych et al. 2014). Additionally it was 
shown that also the repression of BARD1 results in the same phenotype. Since Brca1 and 
BARD1 together exhibit an E3 ubiquitin ligase activity this leads to the hypothesis that 
the E3 ubiquitin ligase function of Brca1 might be crucial for the regulation of spindle 
microtubule polymerization during mitosis. To further investigate this issue, either the 
Brca1 mutant I26A or Brca1 wild type (WT) (shRNA resistant) was re-expressed in 
HCT116 stably repressing BRCA1 (HCT116-BRCA1-shRNA cells). The exchange of 
isoleucine to alanine on position 26 inhibits the E3 ubiquitin ligase activity, but does not 
affect the formation of the Brca1-BARD1 heterodimer (Brzovic et al. 2003). Cells 
transfected with an empty vector were used as a control. 





Figure 3.5 The knock down of BRCA1, BARD1 and CHK2 leads to enhanced spindle 
microtubule plus-end assembly rates during mitosis. (a) For the measurement of mitotic 
spindle microtubule plus-end assembly rates after transient knock down of BRCA1, BARD1 and 
CHK2, cells were transfected with 40 pmol siRNA. Furthermore, the cells were treated with either 
DMSO or 0.2 nM Taxol® for 24 h prior to live cell analysis. The cells were synchronized in mitosis 
by treatment with 2 µM DME for 2h and the EB3 measurement was performed on monoastral 
spindles. The results were visualized by scatter dot plots showing the average plus-end assembly 
rates based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 cells from 
three independent experiments). (b) The protein repression for BRCA1, BARD1 and CHK2 was 
verified by western blot analysis. ß-actin was used as a loading control. The western blots shown 
are representative examples. (c) Determination of spindle microtubule plus-end assembly rates in 
stable HCT116-BRCA1-shRNA cells with a re-expression of either BRCA1-WT or the BRCA1-I26A 
mutant, which is defective for the E3 ubiquitin ligase activity. The cells were transfected with 
empty vector or with plasmids for CMV promoter driven expression of BRCA1-WT or BRCA1-I26A, 
48h prior to live cell analysis. Additionally the cells had been treated with either DMSO or 0.2 nM 
Taxol® for 24 h before the cells were analysed. EB3 measurement was performed on monoastral 
spindles and the results were visualized by scatter dot plots showing the average plus-end 
assembly rates based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 
cells from three independent experiments). (d) The protein overexpression for BRCA1 was verified 
by western blot analysis. ß-actin was used as a loading control and the western blots shown are 
representative examples. 
 
By western blot analysis the protein expression was verified (Figure 3.5 d). While cells 
with a stable knock down of BRCA1 showed an increased mean spindle microtubule 
polymerization rate of 20.2 µm/min, the re-expression of BRCA1-WT restored normal 
spindle microtubule assembly rates of 18.0 µm/min, which was also measured in control 




transfected HCT116 cells. In contrast, reconstitution of Brca1 levels by Brca1-I26A 
revealed a mean microtubule polymerization rate of 20.3 µm/min, resembling the value 
measured in control transfected HCT116-BRCA1-shRNA cells. This suggests that the E3 
ubiquitin ligase activity of Brca1 is needed for proper spindle microtubule plus-end 
assembly during mitosis. 
The previous results showed that Cep72 is interacting with Brca1 during mitosis, which 
might indicate a similar function. Additionally a role for Cep72 in spindle microtubule 
nucleation was already described (Oshimori et al. 2009). Thus, it is interesting to 
examine, whether CEP72 overexpression influences the plus-end polymerization of 
spindle microtubules during mitosis. For this CEP72 was transiently overexpressed in the 
human colon cancer cell line HCT116. To investigate different expression levels, cells 
were transfected with 1 µg, 3 µg and 5 µg of plasmid for CMV promoter driven 
expression of CEP72 (pcDNA3-CEP72). Cells transfected with an empty vector were used 
as a control. The protein levels were checked by western blot, whereupon rising protein 
levels by transfection of 1 µg – 5 µg plasmid could be observed (Figure 3.6 a). For the 
determination of spindle microtubule plus-end assembly rates, the microtubule binding 
protein EB3 fused to GFP was co-expressed in CEP72 overexpressing cells. The analysis 
by live cell microscopy revealed an increase in spindle microtubule polymerization rates 
from 17.1 µm/min measured in control cells to 18.2 µm/min, 20.1 µm/min and 19.4 
µm/min in cells transfected with 1 µg, 3µg and 5µg pcDNA3-CEP72 plasmid, respectively 
(Figure 3.6 b). To further investigate whether the increase in spindle microtubule 
polymerization is specific for the overexpression of CEP72, the overexpression levels 
were simultaneously repressed by CEP72 siRNA knock down to protein levels comparable 
to control transfected cells (Figure 3.6 a). A subsequent EB3-measurement of cells with a 
simultaneous CEP72 repression revealed spindle microtubule plus-end polymerization 
rates of 17.3 µm/min (1µg), 16.5 µm/min (3µg) and 16.7 µm/min (5µg), which equal 
microtubule assembly rates detected in control cells (Figure 3.6 b). This shows that a 
CEP72 overexpression specifically leads to increased spindle microtubule plus-end 
assembly during mitosis. 
In order to determine, whether normal spindle microtubule plus-end assembly rates in 
cells overexpressing CEP72 can be restored by application of low dose Taxol®, they were 
treated with either DMSO or 0.2 nM Taxol® for 24 h prior to EB3-measurement. The 
protein expression was verified by western blot analysis (Figure 3.7 a, left panel). 
Furthermore the treatment with low dose Taxol® did not affect the microtubule 
polymerization rate of control cells (17.7 µm/min (DMSO) versus 17.8 µm/min (0.2 nM 
Taxol®). The overexpression of CEP72 increased the spindle microtubule polymerization  
 





Figure 3.6 The transient overexpression of CEP72 leads to increased spindle microtubule 
plus-end assembly rates during mitosis. (a) A transient overexpression of CEP72 was achieved 
by transfection of either 1 µg, 3 µg or 5 µg plasmid. In order to restore normal Cep72 levels, the 
protein expression was simultaneously repressed by transfection of 40 pmol CEP72 siRNA. The 
protein levels were verified by western blot analysis using ß-actin as a loading control. A 
representative example is shown. (b) For the investigation of mitotic spindle microtubule plus-end 
assembly rates upon CEP72 overexpression, cells were synchronized in mitosis by treatment with 2 
µM DME for 2h. To restore normal Cep72 protein levels, the overexpression was reduced by 
simultaneous CEP72 repression. The EB3 measurements were performed on monoastral spindles. 
The scatter dot plots show average plus-end assembly rates based on measurement of 20 
microtubules per cell (mean ± s.e.m., t-test, n=30 cells from three independent experiments).  
 
to 20.0 µm/min (1 µg), 20.1 µm/min (3 µg) and 19.9 µm/min (5 µg), which could be 
reduced by treatment with 0.2 nM Taxol® to 17.6 µm/min, 17.5 µm/min and 17.3 
µm/min, respectively (Figure 3.7 a, right panel). 
Microtubule assembly is dependent on the microtubule polymerase ch-TOG, which 
catalyses the addition of tubulin dimers to the microtubule plus-end (Brouhard & Rice 
2014; Ertych et al. 2014). Thus, it is likely that microtubule polymerization can also be 
lowered by the reduction of ch-TOG protein levels. In order to elucidate, whether 
enhanced spindle microtubule plus-end assembly rates induced by CEP72 overexpression 
can also be restored by inhibiting the microtubule polymerase, CH-TOG/CKAP5 was 
downregulated in cells simultaneously overexpressing CEP72. Using western blot analysis 
the knock down efficiency was controlled, whereupon a 86-96% reduction of the ch-TOG 
protein levels could be determined (Figure 3.7 b, left panel). The EB3 measurement of 
CEP72 overexpressing cells revealed an increase in spindle microtubule assembly rates to 
18.2 µm/min (1 µg), 19.9 µm/min (3 µg) and 19.5 µm/min (5 µg). By simultaneous 
downregulation of CH-TOG/CKAP5 the microtubule polymerization was reduced to 16.5 
µm/min (1 µg), 16.5 µm/min (3µg) and 16.3 µm/min (5 µg), resembling spindle 
microtubule assembly rates measured in control transfected cells (17.0 µm/min) (Figure 
3.7 b, right panel). 





Figure 3.7 The increased spindle microtubule plus-end assembly rates caused by CEP72 
overexpression can be restored by either treatment with low dose Taxol® or by 
repression of CH-TOG. (a) To determine the influence of low dose Taxol® on spindle microtubule 
plus-end assembly rates after CEP72 overexpression at indicated concentrations, cells were treated 
with either DMSO or 0.2 nM Taxol® for 24h prior to live cell analysis. The EB3 measurements were 
performed on mitotic monoastral spindles and the results are shown in form of scatter dot plots 
showing the average plus-end assembly rates based on measurement of 20 microtubules per cell 
(mean ± s.e.m., t-test, n=30 cells from three independent experiments). The protein expression 
was verified by western blot analysis using ß-actin as a loading control. A representative western 
blot is given. (b) In order to investigate the influence of the microtubule polymerase ch-TOG on 
spindle microtubule plus-end assembly rates after CEP72 overexpression at indicated 
concentrations, cells were simultaneously transfected with 40 pmol of either control or CH-
TOG/CKAP5 siRNA 48h prior to live cell analysis. The EB3 measurement was performed on mitotic 
monoastral spindles and the results are presented in form of scatter dot plots showing the average 
plus-end assembly rates based on measurement of 20 microtubules per cell (mean ± s.e.m., t-
test, n=30 cells from three independent experiments). The protein expression was verfied by 
western blot analysis using ß-actin as a loading control. A representative example is shown. 
 
Thus, enhanced spindle microtubule plus-end assembly induced by CEP72 overexpression 
can be suppressed by interfering with microtubule polymerization using low dose of 
Taxol® and by downregulation of the microtubule polymerase CH-TOG/CKAP5. 
To further investigate the overexpression of CEP72 in a stable cell system, HCT116 cells 
were transfected with either an empty vector or a CEP72 expression plasmid being  
 





Figure 3.8 The stable overexpression of CEP72 leads to enhanced spindle microtubule 
plus-end assembly rates during mitosis. (a) HCT116 cells were transfected with a control and 
a CEP72 overexpression plasmid, respectively. Single cell clones were generated via G418 selection 
and the protein expression was verified by western blot analysis using ß-actin as a loading control. 
A representative example is shown. (b) For the investigation of mitotic spindle microtubule plus-
end assembly rates upon CEP72 overexpression, four independent single cell clones as well as two 
control clones were analysed. The EB3 measurements were performed on monoastral spindles and 
the results are represented as scatter dot plots showing the average plus-end assembly rates 
based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 cells from three 
independent experiments). 
 
equipped with attB sites. By simultaneous expression of the phage integrase phiC31, the 
vectors were integrated into the human genome in a site-specific manner (Groth et al. 
2000). Subsequently single cell clones stably overexpressing CEP72 were generated via 
G418 selection and identified by western blot (Figure 3.8 a). Compared to control cells, 
the Cep72 protein levels of stable cell clones overexpressing CEP72 were enhanced by 
7.4 – 14.3-fold. Additionally the microtubule plus-end assembly was determined in 
monoastral spindles. While control clones showed a microtubule polymerization of  
17.2 µm/min and 17.4 µm/min, the microtubule assembly rates in stable CEP72 
overexpression clones was enhanced by 15.0%, 20.2%, 15,6% and 17.3% (Figure 3.8 
b). 
Moreover, the effect of Taxol® on enhanced spindle microtubule plus-end assembly in 
cells stably overexpressing CEP72 was examined. To this end, based on the stable control 
clone 1 and the CEP72 overexpression clone 2, single cell subclones were generated and 
cultivated in the presence of either DMSO or 0.2 nM Taxol® (Figure 3.9 a). Western blot 
analysis after 30 generations revealed that the cultivation in the presence of 0.2 nM 
Taxol® did not affect the Cep72 protein levels (Figure 3.9 b). By measuring spindle 
microtubule polymerization rates, no difference was detectable between control 
subclones cultivated in either DMSO (18.7 µm/min and 19.1 µm/min) or 0.2 nM Taxol® 
(both 18.4 µm/min). However, the spindle microtubule plus-end assembly of CEP72  
 





Figure 3.9  Generation of cells stably overexpressing CEP72 in the presence and absence 
of 0.2 nM Taxol®. (a) Schematic overview of the generation of cell clones with a stable 
overexpression of CEP72 grown for 30 generations in the presence of either DMSO or 0.2 nM 
Taxol®. (b) Based on the cell clone 2 stably overexpressing CEP72 as well as on control clone 1 
independent single cell clones were generated in the presence of DMSO (D) or 0.2 nM Taxol® (T) 
(shown in (a)). The protein levels of Brca1 and Cep72 were verified by western blot analysis 
(representative example is given). ß-actin was used as a loading control. 
 
overexpressing subclones generated in the presence of 0.2 nM Taxol® resembled with 
18.8 µm/min, 18.7 µm/min and 18.8 µm/min the microtubule polymerization rates 
measured in control cells, whereupon subclones cultivated in the presence of DMSO still 
exhibited increased spindle microtubule plus-end assembly rates of 21.6 µm/min and 
22.6 µm/min.  
As already shown in Figure 3.5 the knock down of BRCA1 leads to enhanced spindle 
microtubule plus-end assembly rates during mitosis. In order to draw a direct comparison 
between BRCA1 knock down and the overexpression of CEP72, also subclones of 
HCT116-BRCA1-shRNA cells were generated in the presence of DMSO and 0.2 nM Taxol®, 
respectively. Determination of microtubule plus end assembly rates after 30 generations 
revealed similar microtubule polymerization rates as observed for CEP72 overexpression. 
Whereas cell subclones with a stable knock down of BRCA1 cultivated in the presence of 
DMSO showed increased spindle microtubule assembly rates of 21.5 µm/min, 21.2 
µm/min and 22.0 µm/min, the spindle microtubule polymerization of subclones cultivated 
in 0.2 nM Taxol® could be reduced to 19.3 µm/min, 19.0 µm/min and 19.2 µm/min, 
 





Figure 3.10 CEP72 overexpression mirrors BRCA1 repression in respect to increased 
spindle microtubule plus-end assembly. (a) Measurements of mitotic spindle microtubule plus-
end assembly rates in stable cell clones with an overexpression of CEP72 generated in the presence 
or absence of 0.2 nM Taxol® (depicted in Figure 3.9 a). The cells were synchronized in mitosis by 
treatment with 2 µM DME for 2h and the EB3 measurement was performed on monoastral spindles. 
The scatter dot plots show average plus-end assembly rates based on the measurement of 20 
microtubules per cell (mean ± s.e.m., t-test,  n=10 cells). (b) Measurements of mitotic spindle 
microtubule plus-end assembly rates in stable cell clones with a knock down of BRCA1 generated in 
the presence or absence of 0.2 nM Taxol®. The cells were treated as described in (a) and the 
results were represented as scatter dot plots showing average plus-end assembly rates based on 
the measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=10 cells). 
 
respectively. Control transfected subclones showed spindle microtubule polymerization 
rates from 18.7 µm/min – 19.0 µm/min, whereupon no difference could be detected 
between cell clones cultivated in the presence of either DMSO or 0.2 nM Taxol®.  
In order to elucidate whether overexpression of CEP72 or BRCA1 repression influences 
the microtubule polymerization beyond mitosis, microtubule plus end assembly rates 
were determined in interphase cells. EB3 measurement of cells with a transient 
overexpression of CEP72 or BRCA1 knock down revealed average spindle microtubule 
plus end assembly rates of 18.3 µm/min and 18.4 µm/min resembling the rates 
measured in control transfected cells (18.3 µm/min) (Figure 3.11). 
Thus, a stable CEP72 overexpression causes enhanced spindle microtubule plus-end 
assembly rates during mitosis, which can be restored to control levels by treatment with 
low dose Taxol®. A direct comparison between cells with an overexpression of CEP72 and 
cells with a knock down of BRCA1 revealed that both conditions cause a very similar 
deregulation of microtubule assembly in mitosis, but not in interphase. 





Figure 3.11 CEP72 overexpression and BRCA1 repression does not interfere with 
microtubule plus end polymerization in interphase. Measurement of microtubule plus end 
assembly rates upon transient overexpression of CEP72 or BRCA1 repression in interphase cells. 
The scatter dot plots show average plus-end assembly rates based on the measurement of 20 
microtubules per cell (mean ± s.e.m., t-test,  n=10 cells). 
 
3.2.3 Overexpression of CEP72 causes abnormal mitotic spindle assembly 
The dynamics of microtubules essentially participates in the formation and maintenance 
of the mitotic spindle (Vicente & Wordeman 2015). To clarify the effects of enhanced 
microtubule plus-end assembly during mitosis caused by CEP72 overexpression, the 
morphology of mitotic spindles was investigated. Cells with a transient overexpression of 
CEP72 were synchronized in metaphase by double thymidine block and subsequent 
treatment with the proteasome inhibitor MG132. When cells enter mitosis in the presence 
of MG132 a normal spindle formation is warranted while the metaphase to anaphase 
transition is inhibited. Thus, cells were arrested in metaphase and analysed by 
immunofluorescence microscopy. Cells with a transient overexpression of CEP72 
exhibited an aberrant spindle morphology (Figure 3.12 a). While control cells showed 
normal, ball-like spindles, cells with a CEP72 overexpression exhibited curved and 
distorted spindle microtubules, which appeared to be longer. The quantification revealed 
4.5% curved spindles in control cells, which was increased by CEP72 overexpression to 
14.5% (1µg), 15.0% (3 µg) and 14% (5µg) (Figure 3.12 b).  
In addition, cells with a transient BRCA1 repression were compared to cells in which 
CEP72 was transiently overexpressed. To further elucidate, whether the spindle 
morphology aberrations are caused by increased spindle microtubule plus-end assembly, 
the cells were simultaneously treated with either DMSO or 0.2 nM Taxol®. The analysis 
revealed that also cells with a transient knock down of BRCA1 exhibited curved spindles 
in 21.3%, which was comparable to 20% of curved spindles in cells overexpressing 
CEP72 (Figure 3.12 c). Additionally the portion of curved spindles was reduced to 9% in  
 





Figure 3.12 The overexpression of CEP72 leads to spindle morphology alterations during 
mitosis, which is dependent on increased spindle microtubule plus-end assembly. (a) 
Representative images showing the mitotic spindle morphology of HCT116 cells stably transfected 
with either an empty vector or a plasmid for CMV promoter driven expression of CEP72. The cells 
were synchronized in G1/S phase via double thymidine block, released into medium for 6.5 h and 
arrested in mitosis by treatment with 20 µM MG132 for further 3 h. By immunofluorescence 
staining the spindles (α-tubulin, green), kinetochores (Crest, red) and the DNA (Hoechst33342, 
blue) were visualized. Scale bar: 10 µm. (b) Quantification of curved spindles in HCT116 cells after 
transient CEP72 overexpression at indicated concentrations. Cells were treated as described in (a). 
Subsequently the spindle morphology was detected and quantified by immunofluorescence analysis 
(mean ± s.d.; t-test, n=300 bipolar spindles of three independent experiments). (c) Quantification 
of curved spindles in HCT116 cells with a transient overexpression of CEP72 or BRCA1 knock down. 
The cells were treated either with DMSO or 0.2 nM Taxol® for 24h prior to immunofluorescence 
analysis (mean ± s.d.; t-test, n=300 bipolar spindles of three independent experiments). 
 
cells with a repression of BRCA1 and to 8% in CEP72 overexpressing cells by treatment 
with low dose Taxol®. In control transfected cells no difference could be detected 
between cells treated with DMSO (8.3%) and 0.2 nM Taxol® (8%).  
 





Figure 3.13 Cells showing spindle morphology alterations after CEP72 overexpression 
exhibit an enhanced inter centrosomal distance and an increase in the average 
microtubule length. (a) In order to determine the pole-to-pole distance of normal and curved 
spindles in cells transiently overexpressing CEP72, cells were synchronized in G1/S phase via 
double thymidine block, released into medium for 6.5 h and arrested in mitosis by treatment with 
20 µM MG132 for further 3 h. Subsequently, the distance between the centrosomes was measured 
on the basis of immunofluorescence images (spindles, anti-α-tubulin: green; centromeres,  
-tubulin: red; chromosomes, Hoechst 33342: blue; scale bar, 10 μm). The box and whisker plot 
shows the range, mean and quartile of the measurements (t-test, n=61-64 cells from three 
independent experiments). (b) Schematic depiction for the determination of the average 
microtubule length from pole to pole. (c) For the measurement of the average microtubule length 
from pole to pole of normal and curved spindles in cells with a transient CEP72 overexpression, 
cells were arrested in mitosis as described in (a). Subsequently the average microtubule length 
form pole to pole was determined on the basis of immunofluorescence images as depicted in (b). 
The box and whisker plot shows the range, mean and quartile of the measurements ( t-test, n=61-
64 cells from three independent experiments). 
 
Since the aberrant spindles appear to be longer when compared to control ones, the 
distance between the centrosomes was determined in proper spindles of control and 
CEP72 overexpressing cells and compared to the pole-to-pole distance of spindles with a 
curved morphology. The measurement revealed an inter-centrosomal distance of  
11.1 µm for normal spindles of control transfected cells (Figure 3.13 a). Compared to 
this, no difference in the pole-to-pole distance of proper spindles in cells overexpressing 
CEP72 (11.3 µm) was detectable. However, curved spindles in control and CEP72 
overexpressing cells showed a significantly increased pole-to-pole distance of 14.6 µm 
and 15.0 µm, respectively.  
Furthermore, the length of microtubules from pole to pole was measured following the 
curved morphology. For this the microtubule length was determined at both outer sides 
as well as in the middle of the spindle as depicted in Figure 3.13 b. Subsequently, the 
average microtubule length from pole to pole was calculated. Whereas normal spindles 
showed an average microtubule length of 14.4 µm in control and 14.7 µm in CEP72 




overexpressing cells, the microtubule length from pole to pole of curved spindles was 
enhanced to 17.2 µm and 18.0 µm, respectively (Figure 3.13 c) 
These data indicate that a CEP72 overexpression or repression of BRCA1 lead to 
aberrations of the mitotic spindle morphology, which is characterized by a curved and 
distorted phenotype, an enhanced inter-centrosomal distance and elongated 
microtubules. Additionally these abnormal spindles are dependent on increased spindle 
microtubule plus-end assembly rates. 
 
3.2.4 Overexpression of CEP72 causes the generation of lagging chromosomes 
Alterations in the mitotic spindle formation, which are accompanied by spindle geometry 
defects can lead to erroneous attachments between spindle microtubules and 
kinetochores (Silkworth & Cimini 2012; Nam et al. 2014). One important example are 
merotelic attachments, which are characterized by the simultaneous attachment of 
spindle microtubules emanating from the two opposing poles to one kinetochore. This 
kind of malattachment cannot be detected by the spindle assembly checkpoint and cells 
enter anaphase in the presence of chromosomes being simultaneously attached to both 
poles. As a consequence, chromosomes cannot be separated correctly leading to 
chromosomes, which lag in the equatorial plane of the cell. These “lagging chromosomes” 
are a main cause for subsequent chromosome mis-segregation in cancer cells (Gregan et 
al. 2011). 
To examine whether alterations in spindle assembly caused by CEP72 overexpression 
lead to unresolved merotelic attachments, lagging chromosomes were quantified. Cells 
were synchronized in G1/S phase by double thymidine block and released into fresh 
medium for 9.5 h. Subsequently the cells were analysed by immunofluorescence 
microscopy. In this way lagging chromosomes were observed in cells overexpressing 
CEP72 (Figure 3.14 a). To further investigate whether the occurrence of lagging 
chromosomes is dependent on increased spindle microtubule plus-end assembly, control 
and CEP72 overexpressing cells were simultaneously treated with DMSO and 0.2 nM 
Taxol®, respectively. The quantification revealed a 2.9 fold (1µg) – 4 fold (3µg) increase 
in the percentage of lagging chromosomes after CEP72 overexpression when compared 
to control transfected cells (Figure 3.14 c). However, the treatment with low dose Taxol® 
reduced the enhanced amounts of lagging chromosomes in CEP72 overexpressing cells 
from 4.3% (1µg), 6.1% (3µg) and 5.0% (5µg) to 2.0% (1µg), 2.0% (3µg) and 1.3% 
(5µg), respectively. In contrast, Taxol® treatment did not affect the percentage of 
 





Figure 3.14 The overexpression of CEP72 leads to chromosome mis-segregation, which 
can be reversed by restoration of normal spindle microtubule plus-end assembly rates. 
(a) Representative example of immunofluorescence images showing proper anaphase morphology 
in control transfected cells and lagging chromosomes (indicated by white arrow) in cells with an 
overexpression of CEP72. The cells were synchronized in G1/S phase via double thymidine block 
and released into medium for 9.5 h. By immunofluorescence staining kinetochores (Crest, red) and 
the DNA (Hoechst33342, blue) were visualized. Scale bar: 10 µm. (b) For the quantification of 
lagging chromosomes in cells with a stable overexpression of CEP72, four independent single cell 
clones were analysed and compared to control transfected cells. The cells were treated as 
described in (a) and, subsequently, lagging chromosomes were quantified by immunofluorescence 
analysis (n=200 cells). (c) To investigate the influence of low dose Taxol® on the generation of 
lagging chromosomes, CEP72 was transiently overexpressed at indicated concentrations and the 
cells were cultivated in either DMSO or 0.2 nM Taxol® for 26 h prior to immunofluorescence 
analysis. The cells were treated as decribed in (a) and lagging chromosomes were quantified by 
immunofluorescence analysis (mean ± s.d.; t-test, n=600 cells of three independent experiments). 
 
lagging chromosomes in control transfected cells (1.5% DMSO versus 1.7% 0.2 nM 
Taxol®). 
Moreover, lagging chromosomes were quantified in the single cell clones stably 
overexpressing CEP72 and a 4.0 – 6.0 fold enhancement in the percentage of lagging 
chromosomes was found when compared to the control cell clone (Figure 3.14 b). To 
compare the induction of lagging chromosomes after CEP72 overexpression and BRCA1 
repression, the percentage of lagging chromosomes was additionally determined in single  
 





Figure 3.15 CEP72 overexpression mirrors BRCA1 repression with respect to the 
generation of lagging chromosomes. (a) Quantification of lagging chromosomes in stable cell 
clones with overexpression of CEP72 grown in the presence or absence of 0.2 nM Taxol® (as 
depicted in Figure 3.9 a. The cells were synchronized in G1/S phase via double thymidine block, 
released into medium for 9.5 h and analysed by immunofluorescence microscopy. The graph shows 
mean values ± s.e.m  (n=3 independent experiments with 300 cells evaluated in total). (b) 
Quantification of lagging chromosomes in stable cell clones with a BRCA1 knock down grown in the 
presence or absence of 0.2 nM Taxol®. The cells were synchronized in G1/S phase via double 
thymidine block, released into medium for 9.5 h and analysed by immunofluorescence microscopy. 
The graph shows mean values ± s.e.m (n=3 independent experiments with 300 cells evaluated in 
total). 
 
cell subclones generated in the presence of either DMSO or 0.2 nM Taxol®, which were 
already described in 3.2.2. In the presence of DMSO, subclones with CEP72 
overexpression exhibited a 3.1 - 3.7 fold increase in the percentage of lagging 
chromosomes when compared to control clones (Figure 3.15 a). Comparably, the number 
of cells with lagging chromosomes was enhanced to 3.3 – 3.7 fold in subclones with a 
stable BRCA1 knock down (Figure 3.15 b). In both cases the long term treatment with 
0.2 nM Taxol® suppressed the generation of lagging chromosomes. While in cells with an 
overexpression of CEP72 the amount of lagging chromosomes was reduced from 5%, 
4.7% and 5.5% to 1.8%, 1.5% and 1.7% (Figure 3.15 a), the Taxol® treatment of 
subclones with a BRCA1 repression led to a reduction from 6.0%, 6.7% and 6.3% to 
2.7%, 2.7% and 1.7% (Figure 3.15 b). In contrast, no difference in the percentage of 
lagging chromosomes was detected in subclones that were grown either in DMSO or 0.2 
nM Taxol® (Figure 3.15 a: 1.3% and 1.7% versus 1.8% and 2%; Figure 3.15 b: 2.3% 
and 1.3% versus 2.0% and 2.7%). 
These results show, that the overexpression of CEP72 leads to chromosome mal-
attachments, which results in the generation of lagging chromosomes that are caused by 
increased spindle microtubule plus-end assembly rates during mitosis. Moreover the data 
show that a stable BRCA1 repression mirrors the phenotype observed in CEP72 
overexpressing cells. 




3.2.5 Overexpression of CEP72 causes chromosomal instability 
The results obtained so far show that CEP72 overexpression triggers the formation of 
lagging chromosomes. Since chromosomes, which lag in the equatorial plane are finally 
distributed onto daughter cells by chance, the appearance of lagging chromosomes can 
lead to chromosome mis-segregation and the induction of chromosomal instability 
(Lengauer et al. 1997; Gregan et al. 2011). To determine the effect of CEP72 
overexpression on the maintenance of chromosomal stability, the karyotype of the single 
cell clones was analysed by means of metaphase chromosome spreads (Figure 3.16 a). 
Since HCT116 cells exhibit a near diploid and chromosomally stable karyotype, they are 
well suitable for the detection of chromosome mis-segregations. To be able to detect 
changes in the karyotype, single cell clones were established and cultivated for 30 
generations prior to karyotyping (as already described in 3.2.2). The subsequent analysis 
of cells stably expressing CEP72 revealed a much broader distribution of individual 
chromosome numbers compared to control cells, whereas the modal number of 45 
chromosomes remained unchanged (Figure 3.16 b). While control cells showed 
chromosome numbers deviating from the modal of 12% and 16%, the amount of 
aneuploid cells in single cell clones with a stable CEP72 overexpression was increased to 
40%, 49%, 30% and 40% (Figure 3.16 c).  
 
 





Figure 3.16 The overexpression of CEP72 leads to chromosomal instability. (a) 
Representative example image of a metaphase chromosome spread acquired by transmitted light 
microscopy. Scale bar 10 µm. (b) The karyotype analysis of four independent cell clones with a 
stable overexpression of CEP72 as well as two control clones was performed after 30 generations. 
The amount of chromosomes was determined for 100 cells via metaphase spread analysis and  
 
 




visualized as a bar plot showing the amount of cells with indicated chromosome numbers (n=100 
cells). The modal chromosome number of HCT116 cells was determined to be 45. (c) On the basis 
of the chromosome numbers shown in (a), the percentage of cells deviating from the modal was 
calculated and visualized in a bar plot (n=100 cells). (d) CEP-FISH analysis for chromosome 7 and 
15 of four independent cell clones with a stable overexpression of CEP72 as well as two control 
clones was performed after 30 generations. The graphs show the numbers of copies for 
chromosome 7 and 15 for 100 cells analysed. The modal chromosome number of HCT116 cells for 
chromosome 7 and 15 was determined to be 2. (e) The proportion of cells that deviate from the 
modal chromosome number of chromosome 7 and chromosome 15 was calculated on the basis of 
CEP-FISH data shown in (d) (n=100 cells). A representative CEP-FISH image for chromosome 7 
and chromosome 15 is given above. Scale bar: 10 µm 
 
This indicates a perpetual gain and loss of whole chromosomes after CEP72 
overexpression. To further investigate chromosome mis-segregation events, the number 
of individual chromosomes was determined. For this, single cell clones were subjected to 
fluorescence in situ hybridisation (FISH) using chromosome enumeration probes (CEP). 
The application of fluorescence labelled probes, which specifically hybridize with 
centromeric regions of defined chromosomes, allows the detection of single 
chromosomes in mitotic cells and interphase nuclei.  
The CEP-FISH analysis of the single cell clones stably overexpressing CEP72 was 
performed in interphase nuclei with probes targeting chromosome 7 and 15 (Figure 3.16 
e, top). The quantification revealed for both chromosomes a modal number of 2. In total, 
both, chromosome gains and losses were observed, whereupon the appearance of 
chromosome loss prevailed (Figure 3.16 d). For the calculation of chromosome numbers 
deviating from the modal, chromosome 7 and 15 were included. Whereas control cell 
clones showed with 3% and 5% a low amount of chromosome number alterations, the 
number of cells with chromosome numbers deviating from 2 was increased to 10%, 16%, 
12% and 13% in single cell clones stably overexpressing CEP72 (Figure 3.16 e, bottom). 
Moreover, it was investigated, whether the perpetual chromosome mis-segregation in 
cells overexpressing CEP72 can be reversed by restoration of normal spindle microtubule 
plus-end assembly rates.  
 










Figure 3.17 Chromosomal instability caused by CEP72 overexpression and BRCA1 
repression is dependent on increased spindle microtubule assembly rates. (a) 
Determination of the karyotype of six independent cell clones with a stable overexpression of 
CEP72 generated in the presence of either DMSO or 0.2 nM Taxol®. The chromosome 
quantification was performed after 30 generations by means of metaphase spreads (n=50 cells 
evaluated). (b) Karyotype analyses of six independent cell clones with a stable repression of 
BRCA1 generated in the presence of DMSO or 0.2 nM Taxol® were performed after 30 generations 
using metaphase spreads. (n=50 cells evaluated). (c) CEP-FISH analysis for chromosome 7 and 15 
of six independent cell clones with a stable overexpression of CEP72 generated in the presence of 
DMSO or 0.2 nM Taxol®. The karyotype was determined after 30 generations. The graphs show 
the copy numbers for chromosome 7 and 15 for 100 cells analysed. The modal chromosome 
number of HCT116 cells for chromosome 7 and 15 was determined to be 2. (d) For the further 
determination of the chromosome number variability the proportion of cells that deviate from the 
modal chromosome number of chromosome 7 and chromosome 15 was calculated on the basis of 
the data shown in (a) (n=100 cells). 
 
For this, the karyotype of the single cell subclones with a CEP72 overexpression 
generated in the presence of either DMSO or low dose Taxol® (3.2.2) was determined 
after 30 generations. Cell clones with a CEP72 overexpression and grown in the presence 
of DMSO showed with 40%, 40% and 36% significantly increased amounts of aneuploid 
cells, whereas the number of chromosomes deviating from the modal in CEP72 
overexpressing cell clones grown in the presence of 0.2 nM Taxol® (16%, 14% and 16%) 
did not differ from control cells (DMSO 14% and 12%, 0.2nM Taxol® 14% and 14%) 
(Figure 3.17 a). A comparison with cell clones stably repressing BRCA1 (3.2.2) revealed 
the same phenotype as observed in CEP72 overexpressing cell clones. The stable 
repression of BRCA1 induced 34%, 38% and 32% aneuploid cells (Figure 3.17 b). In 
contrast, the amount of cells with chromosome numbers deviating from the modal grown 
in the presence of 0.2 nM Taxol® resembled with 18%, 22% and 12% the ones quantified 
in control cells (DMSO 20% and 18%, 0.2 nM Taxol® 18% and 12%). To further validate 
the results, the CEP72 overexpressing subclones were additionally analysed by CEP-FISH. 
The analysis revealed that cells with a CEP72 overexpression exhibited in the presence of 
DMSO with 12%, 10% and 14% significantly increased numbers of cells with 
chromosome numbers deviating from the modal, whereas only 5%, 6% and 6% of cells 
overexpressing CEP72, which were grown in the presence of low dose Taxol® showed 
abnormal copy numbers of chromosome 7 and 15 (Figure 3.17 c and d). 
To ensure that the induction of chromosomal instability upon CEP72 overexpression is 
not due to centrosome amplification, centrosome numbers in interphase cells 
overexpressing CEP72 were determined. As a positive control for the induction of 
centrosome amplification cells with a PLK4 overexpression were analysed. In control 
transfected cells 4.8% exhibited more than two centrosomes and importantly, the 
percentage was not significantly increased in cells overexpressing CEP72 (Figure 3.18). 
In contrast cells with an overexpression of PLK4 exhibited centrosome amplification in 
21.5% of the cells analysed. 





Figure 3.18 The chromosomal instability caused by CEP72 overexpression is not 
dependent on centrosome amplification. Determination of centrosome numbers in cells 
overexpressing CEP72 or PLK4. The analysis was performed on interphase cells by 
immunofluorescence analysis of centrosomes visualized by γ-tubulin staining. The bar plot shows 
the percentage of cells with more than 2 centrosomes (mean values ± s.e.m n=600 cells analysed 
in three independent experiments). 
 
Thus, karyotype analysis by two independent methods showed that CEP72 
overexpression leads to chromosomal instability, which is dependent on increased spindle 
microtubule plus-end assembly during mitosis and not due to centrosome amplification. 
Moreover the data show that a stable BRCA1 repression mirrors the phenotype observed 
in CEP72 overexpressing cells. 
 
3.3 Cep72 counteracts Chk2 and regulates Brca1 in an inhibitory fashion 
The previous results showed that both, overexpression of CEP72 and BRCA1 repression 
causes enhanced spindle microtubule polymerization, which results in spindle morphology 
alterations, chromosome mis-segregation and the induction of chromosomal instability 
(3.2.2 - 3.2.5). In addition, partial loss of the positive Brca1 regulator Chk2 alters 
microtubule dynamics (Figure 3.5 a) and influences the interaction between Cep72 and 
Brca1 (Figure 3.1 c). Thus, Cep72 overexpression mirrors the consequences of Brca1 
repression or reduced Chk2 mediated Brca1 stimulation leading to the hypothesis that 
Cep72 might negatively regulate Brca1’s function during mitosis thereby antagonizing the 
positive Brca1 regulator Chk2 (Figure 3.19).  
If this model is true, simultaneous overexpression of CHK2 is expected to restore normal 
microtubule plus-end assembly when CEP72 is overexpressed. Vice versa, a concurrent 
knock down of CEP72 might reverse spindle microtubule polymerization defects caused 
by CHK2 repression.   
 





Figure 3.19 Model: The balanced regulation of Brca1 mediated by Chk2 and Cep72 
ensures proper spindle microtubule plus-end assembly during mitosis.  
 
on western blots (Figure 3.20 a). For the determination of spindle microtubule plus-end 
assembly rates during mitosis, the EB3-GFP fusion protein was co-expressed. Additionally 
the cells were treated with 2 µM DME for 2h prior to live cell microscopy. The analysis 
revealed significantly increased spindle microtubule polymerization for cells 
overexpressing CEP72 (19.4 µm/min) when compared to control transfected cells (17.0 
µm/min) (Figure 3.20 b). Interestingly, the simultaneous overexpression of CHK2 
restored normal spindle microtubule growth rates. In contrast downregulation of CHK2 in 
CEP72 overexpressing cells did not further increase spindle microtubule polymerization 
(18.7 µm/min). Moreover it was examined, whether a concomitant overexpression also 
prevents the induction of spindle morphology alterations and erroneous kinetochore- 
microtubule attachments. Thus, curved spindles and lagging chromosomes were 
quantified as already described in 3.2.3 and 3.2.4. Whereas, overexpression of CEP72 
results in an increase of the amount of cells with curved spindles from 5.3 % to 19.7 %, 
this effect was suppressed by concomitant overexpression of CHK2 (Figure 3.20 c). In 
contrast, a concurrent downregulation of CHK2 (18.7 %) did not influence the induction 
of altered spindle formation in cells overexpressing CEP72. The quantification of lagging 
chromosomes also revealed that only 1.7% of the cells with a simultaneous 
overexpression of CEP72 and CHK2 showed chromosome mal-attachments, whereas the 
sole overexpression of CEP72 enhanced the amount of lagging chromosomes to 4.7% 
(Figure 3.20 d). In contrast, the concomitant downregulation of CHK2 (5%) did not 
prevent the induction of lagging chromosomes in cells with a CEP72 overexpression. 
Moreover, CEP72 was either repressed or overexpressed in the presence of a CHK2 
downregulation. The knock down and overexpression efficiency was verified by western 
blot analysis (Figure 3.20 e). The determination of spindle microtubule assembly rates 
revealed an increase to 18.7 µm/min by CHK2 knock down, which was not influenced by 
simultaneous CEP72 overexpression (18.7 µm/min) (Figure 3.20 f). In contrast, cells with 
a concurrent repression of CHK2 and CEP72 exhibited with 16.8 µm/min spindle  
 




microtubule polymerization rates resembling control levels (16.1 µm/min). The analysis 
of the spindle morphology and the quantification of lagging chromosomes showed that 
the simultaneous repression of CHK2 and CEP72 re-established proper values. Whereas 
both, the sole CHK2 knock down (20.3%) and the simultaneous overexpression of CEP72 
(18.7%) led to enhanced amounts of cells showing spindle morphology alterations, cells 
with a concurrent downregulation of CHK2 and CEP72 exhibited only 5.3% of curved 
spindles resembling the value measured in control cells (5.0%) (Figure 3.20 g). The 
quantification of lagging chromosomes revealed an increase from 1.7% to 5.3% induced 
by CHK2 knock down, whereupon normal levels could be restored by simultaneous 









Figure 3.20 Cep72 and Chk2 act antagonistically for the regulation of mitotic microtubule 
plus end assembly, spindle formation and chromosomal stability (a) HCT116 cells were 
transfected with 40 pmol siRNA 4 h prior to PEI mediated transfection of 2 µg plasmid. 48 h later 
the cells were analysed and the protein levels were checked by western blot. The given western 
blots are representative examples using ß-actin as a loading control. (b) Measurements of mitotic 
spindle microtubule plus-end assembly rates after either CHK2 repression or overexpression in cells 
transiently overexpressing CEP72. The EB3 measurements were performed on monoastral spindles 
with cells synchronized in mitosis by treatment with 2 µM DME for 2 h. Scatter dot plots show 
average plus-end assembly rates based on measurement of 20 microtubules per cell (mean ± 
s.e.m., t-test, n=30 cells from three independent experiments). (c) Quantification of curved 
spindles in cells with a transient overexpression of CEP72 and in combination with a CHK2 knock 
down and overexpression. Cells were synchronized in G1/S phase via double thymidine block, 
released into medium for 6.5 h and arrested in mitosis by treatment with 20 µM MG132 for further 
3 h. Subsequently the spindle morphology was detected and quantified by immunofluorescence 
analysis (mean ± s.d.; t-test, n=300 bipolar spindles of three independent experiments). (d) 
Quantification of lagging chromosomes in cells transiently overexpressing CEP72 after repression or 
downregulation of CHK2. The cells were synchronized in G1/S phase via double thymidine block, 
released into medium for 9.5 h and analysed by immunofluorescence microscopy. The graph shows 
mean values ± s.e.m (t-test, n=3 independent experiments with 300 cells evaluated in total). (e) 
Representative western blots showing the protein levels of cells which were transfected as 
described in (a). (f) Measurement of mitotic spindle microtubule plus-end assembly rates after 
 
 




transient CHK2 knock down and concomitant CEP72 downregulation or overexpression, 
respectively. The EB3 measurements were performed as described in (b) and average plus-end 
assembly rates based on measurement of 20 microtubules per cell were plotted (mean ± s.e.m., t-
test, n=30 cells from three independent experiments). (g) Quantification of curved spindles in cells 
repressing CHK2 after concurrent CEP72 downregulation or overexpression. Cells were treated as 
described in (c) (mean ± s.d.; t-test, n=300 bipolar spindles of three independent experiments. 
(h) Detection and quantification of lagging chromosomes in cells with a transient knock down of 
CHK2 and in combination with a knock down and overexpression of CEP72. The cell treatment was 
carried out as described in (d) (mean values ± s.e.m, t-test,  n=3 independent experiments with 
300 cells evaluated in total).  
 
Assuming that Chk2 per se is essential for the function of Brca1 to ensure proper spindle 
microtubule assembly, reducing the inhibitory effect of Cep72 should not be sufficient 
anymore to restore normal spindle microtubule growth after total loss of CHK2. In order 
to verify this hypothesis, CHK2 deficient (HCT116-CHK2-/-) cells were transfected with 
either control or CEP72 siRNA and the protein levels were checked by western blot 
(Figure 3.21 a). The subsequent determination of spindle microtubule plus-end assembly 
rates revealed that simultaneous CEP72 repression did not restore normal spindle 
microtubule growth when CHK2 was completely lost. In the presence and in the absence 
of a simultaneous CEP72 repression, HCT116-CHK2-/- cells showed enhanced spindle 
microtubule polymerization rates (19.8 µm/min and 19.5 µm/min) (Figure 3.21 b). 
 
 
Figure 3.21 The presence of residual Chk2 is essential for the proper regulation of 
microtubule plus-end assembly during mitosis. (a) HCT116 and HCT116-CHK2-/- cells were 
transfected with 40 pmol CEP72 siRNA 48 h prior to analysis. In order to verify the knock down 
efficiency, the protein levels were checked by western blot. The given western blots are 
representative examples using ß-actin as a loading control. (b) Measurement of mitotic spindle 
microtubule plus-end assembly rates in HCT116 and isogenic CHK2 deficient cells  
(HCT116-CHK2-/-) after transfection with control and CEP72 siRNA. Scatter dot plots show average 
plus-end assembly rates of monoastral spindles based on measurement of 20 microtubules per cell 
(mean ± s.e.m., t-test, n=30 cells from three independent experiments). 
 





Figure 3.22 The fine tuning of Brca1 activation is essential for proper spindle microtubule 
plus-end assembly. (a) HCT116 cells were transfected with 40 pmol siRNA 4 h prior to PEI 
mediated transfection of 2 µg plasmid. After 48 h the protein levels were determined by western 
blot analysis. A representative example is given using ß-actin as a loading control. (b) 
Measurements of mitotic spindle microtubule plus-end assembly rates after transient BRCA1 knock 
down and in combination with a CEP72 or CHK2 knock down and overexpression, respectively. The 
EB3 measurements were performed on monoastral spindles with cells, which were synchronized in 
mitosis by treatment with 2 µM DME for 2 h. Scatter dot plots show average plus-end assembly 
rates based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 cells from 
three independent experiments). (c) Measurements of mitotic spindle microtubule plus-end 
assembly rates upon CHK2 overexpression. The cells were treated as described in (b). Scatter dot 
plots show average plus-end assembly rates based on measurement of 20 microtubules per cell 
(mean ± s.e.m., t-test, n=30 cells from three independent experiments). 
 
Moreover, the question was addressed whether the increase in microtubule growth upon 
BRCA1 repression can be prevented by entirely stimulating the remaining Brca1 protein. 
Thus, spindle microtubule plus-end assembly was determined in cells with a transient 
BRCA1 knock down, in which simultaneously either the positive regulator CHK2 was 
overexpressed or the potential Brca1 inhibitor CEP72 was repressed. Cells with 
repression of BRCA1 in combination with concomitant CHK2 overexpression and CEP72 
knock down, respectively, were used as control. Compared to control transfected cells 
(16.1 µm/min), an siRNA mediated knock down of BRCA1 resulted in increased spindle 
microtubule polymerization rates of 18.1 µm/min (Figure 3.22 a). Interestingly, a 




simultaneous CHK2 overexpression and CEP72 repression, respectively, restored normal 
microtubule growth rates in cells with reduced BRCA1 expression. In contrast, the 
concurrent repression of CHK2 or CEP72 overexpression did not further influence the 
enhanced spindle microtubule assembly rates caused by BRCA1 down regulation. 
To further investigate the consequences of a Brca1 hyperstimulation, CHK2 was 
overexpressed in HCT116 cells. Here, the subsequent EB3 measurement revealed an 
increase in spindle microtubule plus-end assembly of 15.6% upon CHK2 overexpression 
when compared to control transfected cells (Figure 3.22 c) 
These results support the theory, that the Chk2 mediated positive regulation of Brca1 is 
counteracted by Cep72 (Figure 3.19). Moreover, balancing the stimulation of Brca1 
during mitosis seems to be crucial for the maintenance of proper microtubule dynamics 
and accurate spindle assembly.  
 
3.4 Repression of CEP72 in human colorectal HCT116 cells 
While it was shown by (Stolz et al. 2010) that Brca1’s function during mitosis is positively 
regulated by Chk2 mediated phosphorylation at Ser988, the previous studies indicate an 
inhibitory function for Cep72. The overexpression of the Brca1 stimulating kinase CHK2 
resulted in increased spindle microtubule growth, suggesting that a tight regulation of 
the Brca1 stimulation is needed to ensure a proper assembly of the mitotic spindle. In 
order to estimate how important the presence of Cep72 is, the causes of a CEP72 
repression were investigated in the following sections. 
 
3.4.1 The repression of CEP72 causes enhanced spindle microtubule plus-end 
assembly 
Initially, spindle microtubule plus end assembly rates were analysed. For that purpose 
the EB3-GFP was expressed in cells with a transient repression of CEP72 and control 
transfected cells and the protein levels were verified by western blot analysis (Figure 
3.23 a). The spindle microtubule plus-end assembly rates were measured in monoastral, 
mitotic spindles. Whereas control transfected cells showed an average microtubule 
polymerization of 18.1 µm/min, the microtubule assembly rates in cells repressing CEP72 
were significantly increased to 20.2 µm/min (Figure 3.23 b). Furthermore the 
microtubule dynamics were investigated in interphase. Cells with a repression of CEP72 
showed with 18.1 µm/min a microtubule polymerization, which was not significantly 
 





Figure 3.23 The transient repression of CEP72 leads to enhanced spindle microtubule 
plus-end assembly rates during mitosis. (a) HCT116 cells were transfected with 40 pmol 
siRNA 48h prior to analysis. The protein repression was verified by western blot analysis, 
whereupon ß-actin was used as a loading control. A representative example is shown. (b) For the 
investigation of the spindle microtubule plus-end assembly rates in mitosis after knock down of 
CEP72, cells were synchronized in mitosis by treatment with 2 µM DME for 2h. The EB3 
measurement was performed on monoastral spindles. The scatter dot plots show average plus-end 
assembly rates based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 
cells from three independent experiments). (c) To investigate spindle microtubule plus-end 
assembly rates in interphase upon knock down of CEP72, the EB3 measurement was performed on 
interphase cells. The scatter dot plots show average plus-end assembly rates based on 
measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=20 cells from two independent 
experiments). 
 
enhanced in comparison to microtubule assembly rates measured in control cells  
(17.3 µm/min) (Figure 3.23 c).  
These results show, that the repression of CEP72 leads to an increase of the microtubule 
plus-end assembly in mitotic spindles, but not in interphase cells. 
In order to determine, whether increased spindle microtubule polymerization induced by 
CEP72 knock down can be restored by interfering with microtubule dynamics, mitotic 
cells repressed for CEP72 and control cells were treated with DMSO or 0.2 nM Taxol®. 
The protein levels were analysed by western blot and an influence of Taxol® on protein 
levels was excluded (Figure 3.24 a). Additionally, the low dose Taxol® did not affect the 
microtubule polymerization in control cells exhibiting a rate of 18.2 µm/min after 
treatment with DMSO and 0.2 nM Taxol®, respectively. In cells with a transient knock 
down for CEP72, the treatment with 0.2 nM Taxol® reduced the enhanced spindle 
microtubule plus-end assembly from 20.1 µm/min to 18.0 µm/min (Figure 3.24 b).  
To further investigate the repression of CEP72 in a stable cell system, HCT116 cells were 
stably transfected with plasmids expressing either control shRNA or CEP72 shRNA. 





Figure 3.24 The enhanced spindle microtubule plus-end assembly rates during mitosis 
caused by CEP72 repression can be suppressed by treatment with low dose Taxol®. (a) A 
transient knock down of CEP72 was achieved by siRNA transfection using 40 pmol siRNA. 
Simultaneously, the cells were treated with either DMSO or 2.0 nM Taxol® prior to EB3 
measurement. The protein repression was verified by western blot analysis (a representative 
example is given). ß-actin was used as a loading control. (b) To determine the influence of low 
dose Taxol® on spindle microtubule plus-end assembly rates after CEP72 knock down, cells were 
treated with either DMSO or 2.0 nM Taxol® for 24h prior to live cell analysis. The EB3 
measurement was performed on mitotic monoastral spindles and the results are represented in 
form of scatter dot plots showing the average plus-end assembly rates based on measurement of 
20 microtubules per cell (mean ± s.e.m., t-test, n=30 cells from three independent experiments). 
 
 
Figure 3.25 Stable repression of CEP72 leads to increased spindle microtubule plus-end 
assembly rates during mitosis. (a) HCT116 cells were transfected with a control or CEP72 
shRNA expressing plasmid and single cell clones were generated via puromycin selection. The 
protein repression was checked by western blot analysis, whereupon ß-actin was used as a loading 
control. A representative example is shown. (b) For the investigation of the spindle microtubule 
plus-end assembly rates in mitosis after stable knock down of CEP72, three independent single cell 
clones were analysed. The EB3 measurement was performed on monoastral spindles and the 
results are represented in form of scatter dot plots showing the average plus-end assembly rates 
based on measurement of 20 microtubules per cell (mean ± s.e.m., t-test, n=30 cells from three 
independent experiments). 
 




By puromycin selection single cell clones with a stable repression of CEP72 were 
generated and identified by western blot (Figure 3.25 a). Compared to control cells, the 
Cep72 protein levels of the single cell clones stably repressing CEP72 were reduced to 
29%, 37% and 17%. The EB3-measurement of the three independent single cell clones 
in mitosis revealed a significant increase of the microtubule polymerization of 15.6%, 
19.3% and 23.5% compared to stable control cells (Figure 3.25 b).  
Hence, both, the transient and the stable repression of CEP72, lead to increased spindle 
microtubule plus-end assembly during mitosis, which can be reversed by treatment with 
low dose Taxol®.  
 
3.4.2 The repression of CEP72 leads to alterations in the spindle morphology 
In 3.2.3 it was shown, that increased spindle microtubule plus-end assembly can lead to 
spindle morphology alterations during mitosis. In order to investigate the spindle 
morphology upon CEP72 repression, cells with a stable knock down of CEP72 were 
synchronized in metaphase by double thymidine block and subsequent treatment with 
the proteasome inhibitor MG132. By immunofluorescence analysis it could be observed 
 
Figure 3.26 The stable repression of CEP72 leads to spindle morphology alterations 
during mitosis. (a) Representative example of immunofluorescence images showing the mitotic 
spindle morphology of HCT116 cells stably expressing control and CEP72 shRNA, respectively. The 
cells were synchronized in G1/S phase via double thymidine block, released into medium for 6.5 h 
and arrested in mitosis by treatment with 20 µM MG132 for further 3 h. By immunofluorescence 
staining the spindles (α-tubulin, green), kinetochores (Crest, red) and the DNA (Hoechst33342, 
blue) were visualized. Scale bar: 10 µm. (b) For the quantification of curved spindles in cells with a 
stable repression of CEP72, three independent single cell clones were analysed and compared to 
control transfected cells. The cells were treated as described in (a) and subsequently the spindle 
morphology was detected and quantified by immunofluorescence analysis (mean ± s.d.; t-test, 
n=550 metaphase spindles of three independent experiments). 
 




that cells with a stable repression of CEP72 exhibited an aberrant spindle morphology 
(Figure 3.26 a), which resembled the phenotype seen upon CEP72 overexpression 
(Figure 3.12 a). While control cells exhibited almost round mitotic spindles with a uniform 
shape, cells with a CEP72 repression showed curved spindles, which were partially S-
shaped. The quantification revealed 4.6% curved spindles in control cells, which was 
increased to 42.4 %, 23.7% and 29.3% in cells with a stable CEP72 knock down (Figure 
3.26 b). 
These results show that the presence of Cep72 is important for the proper spindle 
formation during mitosis. 
 
3.4.3 The repression of CEP72 causes lagging chromosomes  and 
chromosomal instability 
In order to investigate whether the alterations in mitotic spindle formation caused by 
repression of CEP72 lead to merotelic attachments and subsequent chromosome mis-
segregation, cells were analysed with respect to the induction of lagging chromosomes. 
For this, independent single cell clones stably expressing either control or CEP72 shRNA 
were synchronized in G1/S phase via double thymidine block and released into medium 
for 9.5 h. Subsequently anaphase cells were analysed by immunofluorescence  
 
 
Figure 3.27 Stable repression of CEP72 leads to the generation of lagging chromosomes. 
(a) Representative example of immunofluorescence images showing lagging chromosomes in 
anaphase cells stably expressing CEP72 shRNA. Cells were released from a double thymidine block 
for 9.5 h and cells in anaphase were evaluated by immunofluorescence staining (kinetochores 
(Crest, red), DNA (Hoechst33342, blue)). Scale bar: 10 µm. (b) For the quantification of lagging 
chromosomes in cells with a stable repression of CEP72, three independent single cell clones were 
analysed and compared to control transfected cells. The cells were treated as decribed in (a) and 
subsequently lagging chromosomes were quantified by immunofluorescence analysis (mean ± s.d.; 
t-test, n=500 cells of three independent experiments). 
 





Figure 3.28 The stable repression of CEP72 leads to chromosomal instability. (a) 
Karyotype analyses of the three independent cell clones with a stable repression of CEP72 and 
cultivated for 30 generations. The amount of chromosomes was determined for 100 cells and 
visualized as a bar plot showing the amount of cells exhibiting the indicated chromosome numbers 
(n=100 cells). The modal chromosome number of HCT116 cells was determined to be 45. (b) On 
the basis of the chromosome numbers shown in (a), the percentage of cells deviating from the 
modal was calculated and visualized in a bar plot (n=100 cells). 
 
microscopy. Whereas only 1.5% of control transfected cells exhibited lagging 
chromosomes, the percentage was increased to 4.2%, 4.5% and 4.6% in the single cell 
clones with a stable CEP72 knock down (Figure 3.27 a and b).  
To determine the effect of CEP72 repression on the maintenance of chromosomal 
stability, the karyotype of the single cell clones was analysed after 30 generations by 
means of metaphase chromosome counting. The analyses revealed that cells with a 
stable knock down of CEP72 showed a much broader distribution on different 
chromosome numbers compared to control cells, whereupon the modal number of 45 
chromosomes remained unchanged (Figure 3.28 a). While 19% of the control cells 
showed an aneuploid phenotype, the amount of cells exhibiting a chromosome number 
deviating from the modal increased to 42%, 44% and 45% in in cells stably repressing 
CEP72 (Figure 3.28 b).  
Summarized it can be noted that the presence of Cep72 is important for proper 
chromosome segregation and the maintenance of chromosomal stability. 
 
3.4.4 Chromosomal instability induced by CEP72 repression is caused by 
increased spindle microtubule plus-end assembly  
To further examine, whether the increase in spindle microtubule plus-end assembly is 
responsible for the induction of chromosomal instability after partial loss of CEP72, 
HCT116-CEP72-shRNA clone 1 and control cells were cultivated in the presence of either  
 





Figure 3.29 Chromosomal instability caused by stable CEP72 repression can be 
suppressed by restoration of normal spindle microtubule plus-end assembly rates. (a) 
The karyotype analysis of the three independent cell clones with a stable repression of CEP72 and 
grown in in the presence of DMSO or 0.2 nM Taxol®, was performed after 30 generations. The 
number of whole chromosomes was determined for 100 cells and visualized as a bar plot showing 
the distribution of cells on different chromosome numbers (n=100 cells). The modal chromosome 
number of HCT116 cells was determined to be 45. (b) On the basis of the chromosome numbers 
shown in (b), the percentage of cells deviating from the modal was calculated and visualized in a 
bar plot (n=100 cells). 
 
DMSO or 0.2 nM Taxol for 30 generations. Subsequently, the karyotype of the subclones 
was re-examined. The analysis revealed that treatment with low dose Taxol® largely 
prevented the mis-segregation of chromosomes caused by CEP72 knock down (Figure 
3.29 a and b). In contrast to CEP72 repressing subclones generated in the presence of 
DMSO exhibiting 50%, 42% and 34% of aneuploid cells, the treatment with low dose 
Taxol® maintained aneuploidy of 8% - 20%. Control clones showed in the presence and 
in the absence of 0.2 nM Taxol® 20% and 16% aneuploid cells, respectively. 
These results show that the chromosomal instability induced by CEP72 repression is 
dependent on enhanced spindle microtubule polymerization during mitosis. 




3.4.5 Increased spindle microtubule assembly rates seen after CEP72 
repression are dependent on elevated Aurora A kinase activity 
Previous studies from our lab revealed that in colorectal cancer cells enhanced Aurora A 
kinase activity is a common cause for increased spindle microtubule plus-end assembly 
and the formation of chromosomal instability. Additionally, it was shown that Chk2 
restrains Aurora A kinase activity through the phosphorylation of Brca1 during mitosis. A 
loss of CHK2 or BRCA1 caused elevated levels of phosphorylated and thus, active Aurora 
A at centrosomes, which in turn results in increased spindle microtubule polymerization 
(Ertych et al. 2014). Since a repression of CEP72 also leads to enhanced spindle 
microtubule plus-end assembly and the occurrence of chromosomal instability in the 
colorectal cancer cell line HCT116, the question arises, whether this is dependent on 
increased Aurora A kinase activity. In order to investigate this, it was taken advantage of 
a monopolar spindle assay, which was previously introduced by Stolz et al. 2015. This 
assay allows the detection of cells with enhanced spindle microtubule plus-end assembly 
rates by analyzing the morphology of monopolar spindles. In fact, by inhibition of the 
Eg5/Kif11 kinesin using DME, the centrosome separation is inhibited and monopolar 
spindles are formed. Importantly, cells with increased spindle microtubule plus-end 
assembly rates show highly asymmetric monopolar spindles, while cells with normal 
growth rates exhibit ball-like monoasters  (Stolz et al. 2015). 
To test whether the increase in microtubule plus end assembly after repression of CEP72 
can be detected by this assay, the cell clones with a stable CEP72 knock down were 
analysed regarding increased spindle microtubule plus-end assembly during mitosis. For 
this purpose, the cells were treated with 2 µM DME for 4 h and subsequently analysed by 
immunofluorescence microscopy. Here, asymmetric monopolar spindles were observed in 
cells with a stable repression of CEP72 (Figure 3.30 a). The quantification revealed an 
amount of 6.8% asymmetric spindles in control cells, which increased to 20.0%, 16.6% 
and 19.4% in cells with a stable CEP72 knock down (Figure 3.30 b). Additionally, cells 
with asymmetric spindles were quantified upon transient knock down of either CEP72 or 
CHK2, treated with DMSO and Taxol®, respectively. However, in contrast to all previous 
studies performed using 0.2 nM Taxol®, the concentration for the monopolar spindle 
assay was elevated to 2 nM according to Stolz et al. 2015. Whereas the repression of 
CEP72 and CHK2 caused 29.5% and 22.2% of cells with asymmetric spindles, this 
numbers were reduced to 1.9% and 1.4% by treatment with 2 nM Taxol® (Figure 3.30 c). 
Control transfected cells exhibited 10.7% of asymmetric spindles in the presence of 
DMSO, whereupon the percentage was reduced to 0.5% upon treatment with 2 nM 
Taxol®. This significant decrease might be explained by the proportionally high Taxol® 
concentration used. In general, the results match the data obtained by EB3 
measurement in 3.2.2 and 3.4.1.  





Figure 3.30 The knock down of CEP72 leads to the formation of asymmetric monopolar 
spindles, which can be reversed by low dose Taxol® and inhibition of Aurora A kinase 
activity. (a) Representative example of immunofluorescence images upon Eg5/Kif11 inhibition 
showing the monopolar spindle morphology of HCT116 cells stably expressing control or CEP72 
shRNA. The cells were synchronized in mitosis by treatment with 2 µM DME for 4 h. By 
immunofluorescence staining spindles (α-tubulin, green), kinetochores (Crest, red) and DNA 
(Hoechst33342, blue) were visualized. Scale bar: 10 µm. (b) For the quantification of asymmetric, 
monopolar spindles in cells with a stable repression of CEP72, three independent single cell clones 
were analysed and compared to control transfected cells. The cells were treated as described in (a) 
 
 




and subsequently, the spindle morphology was detected and quantified by immunofluorescence 
analysis (mean ± s.d.; t-test, n=500 monopolar spindles). (c) For the quantification of 
asymmetric, monopolar spindles in cells with a transient knock down of CEP72 and CHK2 cells were 
arrested in mitosis by treatment with 2 µm DME for 4 h. To further determine the influence of 
Taxol® on the formation of asymmetric monopolar spindles after CEP72 and CHK2 knock down, 
cells were treated with either DMSO or 2 nM Taxol® for 24h prior to immunofluorescence analysis 
(mean ± s.d.; t-test, n=1500 monopolar spindles of three independent experiments). (d) In order 
to investigate whether active Aurora A can be efficiently inhibited by MLN8054, cells were initially 
arrested in mitosis by treatment with 2µM DME for 15 h. This process ensures the phosphorylation, 
meaning activation of Aurora A. Subsequently, the cells were treated with DMSO or 0.5 µM of the 
Aurora A inhibitor MLN8054 for 1 h. The phosphorylation status of Aurora A, serving as a marker 
for the activation, was checked by western blot in mitotic cells. Untreated cells were taken as a 
control. (e) Cells were treated with either DMSO or 0.5 µM MLN8054 for 1 h. Additionally TPX2 or 
CEP192 were simultaneously repressed by siRNA. The cells were synchronized in mitosis by 2µM 
DME treatment for 4 h. Subsequently the spindle morphology was detected and quantified by 
immunofluorescence analysis (mean ± s.d.; t-test, n=1500 monopolar spindles of three 
independent experiments). (f) HCT116 cells were transfected with control, CEP72, CEP192 and 
TPX2 siRNA (30 pmol each). The protein repression was checked by western blot analysis, 
whereupon ß-actin was used as a loading control. A representative example is shown. 
 
In order to see, whether the increased spindle microtubule polymerization caused by 
CEP72 repression is dependent on elevated Aurora A kinase activity, cells with a transient 
knock down of CEP72 and CHK2 were treated with 0.5 µM of the Aurora A kinase small 
molecule inhibitor MLN8054 (Stolz et al. 2015; Ertych et al. 2014; Manfredi et al. 2007). 
A significant reduction of the Aurora A phosphorylation upon treatment with 0.5 µM 
MLN8054 was verified by western blot (Figure 3.30 d). The subsequent 
immunofluorescence analysis revealed that cells with a transient repression of CEP72 
only show 2.2% asymmetric spindles by simultaneous inhibition of Aurora A (Figure 3.30 
e). This mirrors the result obtained upon CHK2 knock down (2.4%), where, as already 
described by Stolz et al. 2015, the inhibition of the Aurora A activity restores normal 
spindle microtubule polymerization rates. 
The activation of Aurora A is mediated by auto-phosphorylation at Thr288. The proteins 
Cep192 (Joukov et al. 2010) and Tpx2 (Eyers & Maller 2004) has been shown to 
stimulate this auto-phosphorylation during mitosis. In order to exclude unspecific effects 
of the small molecule inhibitor, the Aurora A activity was reduced in CEP72 repressing 
cells by simultaneous knock down of either CEP192 or TPX2. The knock down efficiency 
was ensured by western blot analysis (Figure 3.30 f) and the cells were analysed by the 
monopolar spindle assay. While the simultaneous knock down of CEP192 in cells 
transiently repressing CEP72 reduced the amount of asymmetric cells from 29.5% to 
7.3%, the downregulation of TPX2 lead to a decrease to 4% (Figure 3.30 e).  
These results indicate that the increased spindle microtubule plus-end assembly, which 
can be observed after downregulation of CEP72, is dependent on enhanced Aurora A 
kinase activity. 
 





Brca1 is a major tumour suppressor gene, which is particularly associated with breast 
and ovarian cancer (Miki, Y.et al. 1994). However, the way Brca1 exerts its tumour 
suppressive function is still unclear and controversially discussed. During mitosis, Brca1 
ensures proper spindle assembly and chromosome segregation, thereby maintaining 
whole chromosomal stability (Stolz et al. 2010). It is positively regulated by Chk2 
mediated phosphorylation at S988 and restrains the accumulation of active Aurora A at 
mitotic centrosomes. Thus, Brca1 prevents increased microtubule polymerization that is 
responsible for abnormal spindle formation, chromosome mis-segregation and 
chromosomal instability (Stolz et al. 2010; Ertych et al. 2014). Nevertheless, other 
regulators of the Chk2-Brca1 tumour suppressor pathway remain elusive and the 
mechanism how Brca1 regulates spindle microtubule dynamics is so far unknown.  
In this thesis, the centrosomal protein Cep72 was identified as a new protein interacting 
with Brca1 during interphase and mitosis (3.1). Cep72 is a poorly studied protein, which 
was shown to be essential for maintaining microtubule nucleation and the structural 
integrity of the centrosome (Oshimori et al. 2009). Moreover, Cep72 localizes to 
centriolar satellites and participates in the formation of the primary cilium (Stowe et al. 
2012). However, functions beyond remain undetected. Importantly, we demonstrated 
that CEP72 is highly overexpressed in human colorectal cancer (3.2.1) suggesting that it 
represents a hitherto unknown, putative oncogene. The overexpression of CEP72 leads to 
increased spindle microtubule polymerization, which causes spindle assembly defects and 
results in lagging chromosomes and CIN (3.2.2 - 3.2.5). Since chromosomal instability is 
a hallmark of human cancer, which contributes to tumourigenesis, therapy resistance and 
a poor patient prognosis (Orr & Compton 2013), the identification of CEP72 as a new 
bona fide CIN gene is of great importance. Furthermore, CEP72 overexpression mirrors 
the consequences of a Brca1 repression leading to the hypothesis that Cep72 negatively 
regulates Brca1’s function during mitosis, thereby antagonizing the positive Brca1 
regulator Chk2 (Figure 4.1). In fact, CHK2 repression and overexpression of CEP72 cause 
the same mitotic defects, which are reversible by adjusting the protein levels of the 
respective antagonist (Figure 3.20). More precisely, elevating the levels of the positive 
regulator Chk2, when negative regulation by Cep72 is enhanced and, vice versa, 
reducing the levels of the inhibitor when the activator is repressed, restores proper 
spindle assembly rates and prevents chromosome mis-segregation. Moreover, either 
overexpression of CHK2 or repression of CEP72 can restore normal microtubule 
polymerization rates upon partial repression of BRCA1 (Figure 3.22) supporting the 
 





Figure 4.1 Model: Regulation of Brca1 during mitosis. The balanced regulation of Brca1 
mediated by Chk2 and Cep72 ensures proper spindle microtubule plus-end assembly during 
mitosis. While Cep72 negatively regulates Brca1’s function during mitosis, it is positively stimulated 
by Chk2 and restrains mitotic spindle microtubule plus end assembly. Moreover, phosphorylated 
Brca1 confines the accumulation of active Aurora A at mitotic centrosomes, which in turn promotes 
microtubule polymerization and inhibits Brca1 by phosphorylation at S308. 
 
notion that Chk2 and Cep72 act in an opposing manner on Brca1 during mitosis. Beyond 
that, also the overexpression of CHK2 or the repression of CEP72 causes increased 
spindle microtubule polymerization (Figure 3.22 and 3.4) indicating that not only a 
reduced stimulation, but also a hyperstimulation of Brca1 is detrimental for spindle 
assembly. Thus, in addition to the Chk2 mediated phosphorylation, the inhibitory effect 
of Cep72 balancing the stimulation of Brca1 seems to be essential for accurate mitotic 
progression and the maintenance of chromosomal stability (Figure 4.2).  
During mitosis Chk2 supports the binding between Cep72 and Brca1 (Figure 3.1). Since 
Cep72 acts antagonistically to Chk2 (3.3), this finding appears to be quite surprising. 
However, as the balanced regulation of Brca1 by Chk2 and Cep72 seems to be crucial for 
proper regulation of spindle assembly, Chk2 might facilitate the binding between Brca1 
and Cep72 in order to equilibrate positive and negative stimuli. 
Although, I showed that the regulation of spindle microtubule plus end assembly by 
Cep72 and Brca1 is specific for mitosis (Figure 3.11), the interaction between Brca1 and 
Cep72 is more prominent in interphase (Figure 3.1). This indicates that Cep72 might also 
play a role in regulating Brca1 with regard to other functions during interphase. Since in 
interphase Cep72 localizes to centrosomes and centriolar satellites, a Cep72-dependent 
regulation of Brca1 with respect to its function in the cellular stress response upon DNA 
damage which takes place in the nucleus seems to be unlikely. 
However, at interphase centrosomes Brca1 was shown to restrain microtubule nucleation 
activity by promoting the disassembly of γ-tubulin and other γ-TuRC subunits (Sankaran 
et al. 2005; Sankaran et al. 2007). 






Figure 4.2 The balanced regulation of Brca1 mediated by Chk2 and Cep72 ensures proper 
mitotic spindle assembly and the maintenance of euploidy. In contrast, insufficient 
stimulation of Brca1 caused by overexpression of CEP72 or repression of CHK2 as well as Brca1 
hyperstimulation by CHK2 overexpression or CEP72 repression leads to enhanced spindle 
microtubule plus-end assembly which in turn results in aberrant spindle formation, lagging 
chromosomes and chromosomal instability. 
 
Conversely, Cep72 is involved in recruiting γ-TuRCs to the centrosome and maintains 
their microtubule nucleation potential by simultaneous recruitment of CG-NAP/AKAP450 
(Oshimori et al. 2009). Thus, it might be possible that Cep72 promotes microtubule 
nucleation in interphase not only by recruiting the respective proteins to the centrosome, 
but also by negatively modulating Brca1’s function to limit microtubule formation.   
Nevertheless, the way Cep72 exerts its inhibitory function on Brca1 remains speculative. 
It was shown that the Chk2 mediated phosphorylation of Brca1 at S988 is essential to 
stimulate Brca1’s function during mitosis (Figure 3.21) (Stolz et al. 2010). Thus, in order 
to antagonize this positive modification, Cep72 might be involved in removal of the 




phosphate group, conceivably by recruitment of a protein phosphatase. Interestingly, 
matching this theory, Cep72 has been identified to interact with several regulatory and 
catalytical subunits of the serine / threonine protein phosphatase 1 (PP1) (The BioGRID3.2 
Interaction Database, www.thebiogrid.org; Hutchins et al., 2010). The holoenzyme PP1 
forms a complex with one of three catalytical subunits (α, γ, and δ). Their activity is 
modulated by regulatory subunits, which activate or inhibit the phosphatase or, 
alternatively, mediate its subcellular localization (Yu et al. 2008; Liu et al. 2002; Hsu 
2007; Figueiredo et al. 2014). Together, PP1 complexes have been shown to be involved 
in the regulation of  diverse cellular processes including cell cycle progression, DNA 
damage response, chromosome segregation and cytokinesis (Ceulemans & Bollen 2004; 
Yu et al. 2008). Importantly, Brca1 contains a binding site for PP1 (Hsu 2007) and the 
catalytical subunit PP1α was shown to specifically dephosphorylate multiple serine 
residues that are phosphorylated by ATM (S1423), ATR (S1524) and Chk2 (S988) 
indicating that PP1 may serve as general regulator for Brca1 phosphorylation (Yu et al. 
2008; Liu et al. 2002; Hsu 2007; Figueiredo et al. 2014). Moreover, during mitosis, both, 
PP1α and Brca1 localize to centrosomes (Liu et al. 2002; Starita & Parvin 2006) 
supporting the idea that Cep72 might regulate the removal of the Chk2 mediated 
phosphorylation of Brca1 at S988 by serving as a recruitment factor for PP1α. In 
addition, it is possible that Cep72 serves as linker between Brca1 and PP1α, hence, 
facilitating Brca1 dephosphorylation. Nevertheless, this function of Cep72 remains 
unclear and due to the lack of specific S988 antibodies further investigations on this have 
not been possible, yet. 
Moreover, the partial localization of Cep72 in non-centrosomal structures could shed light 
on its mode of action. Pericentriolar satellites gradually disappear when cells enter 
mitosis. However, they are visibly present until metaphase, almost disappear in 
anaphase and re-assemble in telophase (Kubo & Tsukita 2003). They were shown to act 
as storage sites for proteins, which are delivered to the centrosome by dynein mediated 
transport in times when the centrosome is subject to rapid changes of its composition. In 
this context, centriolar satellites are likely to be of major importance for centrosome 
maturation prior to mitosis, centriole duplication and ciliogenesis (Bärenz et al. 2011; 
Villumsen et al. 2013). Furthermore, it was proposed that pericentriolar satellites also 
play a role in the temporal sequestration of different proteins in order to prevent their 
localization to centrosomes and other cell compartments (Stowe et al. 2012; Lopes et al. 
2011; Tollenaere et al. 2014). Thus, also the temporary sequestration of activating and 
inhibitory proteins, which needs to be duly delivered to the centrosome by pericentriolar 
satellites could contribute to Brca1 regulation during mitosis. In such a scenario the 
Chk2-mediated phosphorylation of Brca1 during mitosis might trigger the centrosome- 
 






Figure 4.3 Possible mechanisms for the Cep72 mediated regulation of Brca1. a) Whereas 
the Chk2 mediated phosphorylation of Brca1 at S988 positively regulates Brca1’s function during 
mitosis, Cep72 might counteract Chk2 by serving as a recruitment factor or linker protein for a 
protein phosphatase like PP1, which removes the Brca1 phosphorylation at S988. b) Pericentriolar 
satellites are thought to sequester proteins in order to temporally prevent their centrosomal 
localization. To regulate Brca1’s mitotic function with respect to the particular cell cycle phase, 
Chk2-mediated phosphorylation of Brca1 might trigger Cep72-dependent delivery of potential 
Brca1 stimulating proteins to the centrosome.  
 
directed transport of pericentriolar satellite associated proteins (Figure 4.3. b). 
Consequently, it is conceivable that Cep72 is responsible for the conveyance of proteins 
that stimulate Brca1’s mitotic function. Interestingly, the finding that partial loss of CHK2 
impairs Brca1-Cep72 binding (Figure 3.1 c) might support this theory. Hence, Chk2 
would temporally regulate Brca1’s function by triggering Cep72-mediated delivery of 
Brca1 stimulating proteins to the centrosome. 






Figure 4.4 Overexpression as well as repression of CEP72 cause the disruption of 
pericentriolar satellites, which might interfere with proper and timely stimulation of 
Brca1 during mitosis. a) Overexpression of CEP72 leads to disruption of pericentriolar satellites 
and forms cytoplasmic aggregates that sequester particular satellite proteins like PCM1 or Cep290. 
The sequestration might include potential positive regulators of Brca1, thus, impairing Brca1 
stimulation during mitosis. b) Partial loss of CEP72 causes pericentriolar satellite fragmentation and  
 




the accumulation of associated proteins at centrosomes. Agglomeration of potential Brca1 
stimulating proteins might cause Brca1 hyperstimulation and thereby altered spindle microtubule 
polymerization. 
 
Importantly, both, the downregulation and the overexpression of CEP72 results in the 
disruption of pericentriolar satellites (Stowe et al. 2012). Whereas CEP72 repression 
causes satellites fragmentation and the accumulation of associated proteins at 
centrosomes, the overexpression of CEP72 leads to the formation of cytoplasmic 
aggregates that sequester particular satellite proteins like PCM1 or Cep290 (Stowe et al. 
2012). Consequently, partial loss of CEP72 would cause a centrosomal agglomeration of 
activating proteins, which might result in aberrant hyperstimulation of Brca1 (Figure 4.4). 
In contrast, lasting sequestration of a Brca1 activating protein within Cep72 aggregates 
would impair the stimulation of Brca1’s function to regulate mitotic spindle assembly. 
Thus, also the timely regulation of Brca1 by Cep72 localization in pericentriolar satellites 
might represent a possible mechanism. Another protein being crucial for the integrity of 
centriolar satellites is their scaffolding component PCM1. As in the case of CEP72, 
downregulation of PCM1 also results in the disruption of centriolar satellites and 
associated proteins are transported to the centrosome where they accumulate (Lopes et 
al. 2011; Stowe et al. 2012; Tollenaere et al. 2014; Bärenz et al. 2011). Interestingly, 
both, repression of PCM1 and the partial loss of dynein mediating the retrograde 
transport of pericentriolar satellites and thus, the delivery of associated proteins to the 
centrosome (Tollenaere et al. 2014; Dammermann & Merdes 2002), causes enhanced 
spindle microtubule growth rates as well (my unpublished data, Stolz et al. 2015). This 
might support the hypothesis that centriolar satellites are possibly involved in the 
regulation of mitotic spindle assembly probably by sequestration of activating or 
inhibitory proteins. 
Although the identification of Cep72 gives new insights into the regulation of Brca1 
during mitosis, the way Brca1 exerts its function to regulate spindle microtubule 
assembly remains elusive. However, evidence that Brca1 restrains the hyper-activation of 
Aurora A at mitotic centrosomes was already given by Ertych et al., 2014. Aurora A in 
turn might promote microtubule polymerization by phosphorylating TACC3, thus, 
triggering the recruitment of the microtubule polymerase ch-TOG to mitotic centrosomes 
and the mitotic spindle (Barr & Gergely 2008; LeRoy et al. 2007; Thakur et al. 2013; 
Brouhard et al. 2008; Widlund et al. 2011). A loss or deregulation of Brca1 would 
consequently result in an increased level of active Aurora A at mitotic centrosomes 
(Ertych et al. 2014), which than stimulates microtubule plus end assembly by the TACC3-
ch-TOG axis. Furthermore Aurora A was shown to regulate the microtubule depolymerase 
Kif2a during mitosis. The Aurora A mediated phosphorylation of Kif2a confines its 
localization to spindle microtubules as well as mitotic centrosomes and inhibits its 




depolymerase activity (Jang et al. 2009). Interestingly, the repression of Kif2a causes 
enhanced spindle microtubule polymerization rates (my unpublished data) and is 
associated with elongated spindles (Ganem & Compton 2004) as seen upon CEP72 
overexpression or repression of BRCA1 (3.2.3). Thus, elevated Aurora A activity might 
also stimulate microtubule assembly by inhibiting the microtubule depolymerase Kif2A. 
Moreover, it is conceivable that Brca1 directly regulates spindle microtubule dynamics. 
Brca1 contains a RING domain as well as two BRCT domains and the question, which 
domain mediates the tumour suppressive function of Brca1 is controversially discussed. 
While the BRCT domains represent phospho-protein specific binding motifs (Henderson 
2012; Yu 2003), which are crucial for the formation of Brca1 complexes mainly involved 
in DNA damage repair (Savage & Harkin 2014), the RING domain enables the interaction 
with its obligatory binding partner BARD1. Together, both proteins form a heterodimer 
and complement an E3-ubiquitin ligase being responsible for the ubiquitination of various 
substrates (Hashizume et al., 2001; Wu etal. 2008; Savage & Harkin, 2014). Also during 
mitosis the domain mediating Brca1’s function to ensure proper spindle assembly is 
unknown. Interestingly, the disruption of the E3-ubiquitin ligase function of Brca1 by 
repression of BARD1 or by using a Brca1 mutant lacking E3 ubiquitin-ligase activity leads 
to increased spindle microtubule plus end assembly as induced upon repression of BRCA1 
(Figure 3.5). These findings indicate that the ubiquitination activity of Brca1 might be 
crucial for its mitotic function to counteract microtubule polymerization. Consequently, 
Brca1 seems to promote the destabilization of spindle microtubules, which is possible in 
three different ways: 1) by impairing polymerization, 2) by promoting depolymerization 
or 3) by triggering catastrophe events (van der Vaart et al. 2009). Thus, Brca1 might 
trigger the activity of microtubule depolymerizing enzymes at mitotic centrosomes such 
as Kif2a and Kif2b (Manning et al. 2007). However, direct interactions or evidence for 
such a regulation have not been given, yet. Another interesting candidate is the 
microtubule associated protein 4 (MAP4), which, together with Cep72, was identified as 
new protein interacting with Brca1 during mitosis (Lüddecke et al. 2015). Associated with 
microtubules throughout the cell cycle MAP4 counteracts catastrophe induction and 
promotes rescue events (Ookata et al. 1995), hence triggering microtubule assembly in 
interphase and mitosis (Illenberger et al. 1996; Ebneth et al. 1999; Chang et al. 2001; 
Xiao et al. 2012; Zahnleiter et al. 2015). In order to prevent enhanced microtubule 
polymerization Brca1 might ubiquitinate and therefore restrain the function of MAP4 
during mitosis. Furthermore, Brca1 was shown to regulate microtubule nucleation activity 
by ubiquitination of γ-tubulin and subunits of the γ-TuRC complex, which results in 
disassembly from the centrosomes and a low microtubule nucleation potential during 
interphase (Sankaran et al., 2007, 2005). In mitosis the Aurora A mediated 
phosphorylation of Brca1 inhibits this post-translational modification and γ-TuRCs re-




assemble into the PCM leading to an increased microtubule nucleation activity in order to 
form the mitotic spindle (Sankaran et al., 2007). Interestingly, several mutations in γ-
TuRC subunits were shown to severely influence microtubule dynamicity per se. In fission 
yeast, mutations in homologues of GCP2 were shown to cause continuously growing 
microtubule plus-ends in interphase and mitosis (Zimmerman & Chang 2005). Moreover, 
mutations in the GCP2 homologue alp4 or the overexpression of its C-terminal fragment 
reduced catastrophe rates (Zimmerman & Chang 2005; Masuda et al. 2006; Raynaud-
Messina & Merdes 2007). Also in Drosophila γ-TuRCs localize along microtubules at least 
in interphase and promote their stabilization by reducing catastrophe events. During 
mitosis γ-TuRCs are further important for stabilization of astral microtubules in order to 
achieve a proper spindle anchorage. Depletion of the γ-TuRC component Dgrip75 results 
in spindle misorientation and elongated spindles due to enhanced microtubule 
dynamicity, which can be reversed by treatment with microtubule stabilizing drugs and 
downregulation of proteins that promote microtubule dynamics such as EB1 (Bouissou et 
al. 2014). In fact, also the depletion of human GCP4 leads to spindle orientation defects 
and the mislocalization of EB1. Upon GCP4 repression, EB1 localizes along whole 
microtubules rather than only at plus tips resulting in increased GTP-bound tubulin along 
the lattice and microtubules, which spent longer time in the growing state (Bouissou et 
al. 2014). Similarly, the deregulation of the Chk2-Cep72-Brca1 axis causes, beside 
elongated microtubules (Figure 3.13), spindles with orientation defects during 
prometaphase (Ertych et al. 2014), resembling the phenotype observed after depletion of 
different γ-TuRC components. Likewise, the defects are reversible by lowering spindle 
microtubule polymerization rates using low dose Taxol® (Figure 3.12)(Ertych et al. 2014) 
as observed by Bouissou et al., 2014. Thus, it might be possible that Brca1/BARD1 
mediated ubiquitination of γ-tubulin or other GCPs might be crucial for proper γ-TuRC 
function to regulate microtubule dynamics along spindle microtubules during mitosis. 
Moreover, other E3 ubiquitin ligases were shown to directly ubiquitinate subunits of the 
α/ß-tubulin heterodimer. While Parkin was shown to ubiquitinate α- and ß-tubulin in 
order to degrade misfolded tubulin subunits (Ren et al. 2003; Srivastava & Chakrabarti 
2014), the E3 ubiquitin-ligase Mohugonin ring-finger 1 (MGRN1) polyubiquitinates α-
tubulin and positively modulates microtubule polymerization. Accordingly, an inhibition of 
MGRN1 activity results in reduced spindle aster length and spindle orientation defects 
(Srivastava & Chakrabarti 2014). Interestingly, MGRN1 influences α-tubulin properties by 
Lys6-linked polyubiquitination (Srivastava & Chakrabarti 2014), an uncommon ubiquitin 
linkage, which is also mediated by Brca1/BARD1 (Morris & Solomon, 2004; Nishikawa et 
al., 2004; Wu-Baer et al. 2003). Moreover, Lotti et al. detected a co-localization of Brca1 
and α- as well as ß-tubulin to spindle microtubules and mitotic centrosomes. The 
interactions were further confirmed by coimmunoprecipitations (Lotti et al. 2002) and are 
also present in our own analyses of Brca1 interacting proteins during mitosis (Lüddecke 




et al. 2015). Therefore, it might be possible that the Brca1/BARD1 heterodimer, similar 
to MGRN1, directly modulates α- or ß-tubulin properties, thus promoting microtubule 
disassembly or catastrophe events. 
Enhanced spindle microtubule polymerization, which is caused by deregulation of the 
Chk2-Cep72-Brca1 pathway, or in particular, as induced upon downregulation of BRCA1 
or CEP72 overexpression, results in abnormal spindle formation (3.2.3). In contrast to 
ball-like spindle structures, cells with increased spindle microtubule growth exhibit curved 
or distorted spindles. The closer investigation of those spindles revealed significantly 
longer microtubules, which were accompanied by increased inter-centrosomal distance 
(Figure 3.13). This phenotype is presumably due to perpetual increased microtubule plus 
end assembly, while the depolymerization at the minus end remains constant or is even 
impaired. When the polymerization speed at the plus tip exceeds the depolymerization 
rate at the minus end, net growth is induced, providing an explanation for the elongation 
of microtubules upon enhanced microtubule polymerization. Since microtubules 
emanating from both spindle poles are antiparallel linked by Eg5 (Kapitein et al. 2005) or 
connected by particular binding to chromosomes at the equatorial plane of the spindle, 
enhanced microtubule growth generates forces, which pushes centrosomes apart. 
Additionally, the cell membrane limits the space for centrosome separation. When 
microtubules keep growing and thus, continue elongation, it is likely that they take a 
curved and distorted spindle structure. Furthermore, the deregulation of other 
mechanisms involved in balancing spindle length might contribute to increased inter-
centrosomal distance. Kinesins, which are attached to chromosome arms can exert an 
outward pushing force (Dumont & Mitchison 2009; Kwon et al. 2004), whereas dynein at 
the cell cortex was reported to provide a pulling force on astral microtubules (Tanenbaum 
&  Medema 2010).  
Nevertheless, a balanced regulation of inward and outward forces and thus, the 
maintenance of a proper spindle length is required for accurate microtubule-kinetochore 
attachment and chromosome segregation (van Heesbeen et al. 2014; Syrovatkina et al. 
2013). Consequently, cells with longer or shorter spindles show chromosome segregation 
defects, which is in line with the findings in this study (3.2.3). The enhanced microtubule 
plus end assembly caused by overexpression of CEP72 and a deregulation of the Chk2-
Brca1 axis during mitosis leads to the formation of elongated spindles with a curved and 
distorted morphology. This, in turn, is associated with spindle geometry defects that 
facilitate merotelic attachments, lagging chromosomes and CIN (Nam et al. 2014; 
Silkworth & Cimini 2012; Stolz et al. 2014). Since increased spindle microtubule 
polymerization does not affect the error correction machinery per se (Ertych et al. 2014; 
Stolz et al. 2014), it is likely that elevated formation of erroneous microtubule-
kinetochore attachments overwhelms the error-correction machinery.   




In summary, we identified Cep72 as a hitherto unknown interaction partner and inhibitor 
of the tumour suppressor Brca1. Like a loss of BRCA1, the overexpression of CEP72 is 
linked to aberrant mitotic cell division and the induction of chromosomal instability. 
Hence, CEP72 represents a putative onco- and bona fide CIN gene. While BRCA1 is 
famous for being mutated or lost in human breast cancer (Savage & Harkin 2014), CEP72 
expression is rarely affected in this tumour entity (3.2.1). However, in human colorectal 
cancer, which is highly associated with chromosomal instability, CEP72 is strikingly 
overexpressed (3.2.1). In addition, CEP72 localizes to the lung cancer susceptibility gene 
locus 5p15.33, and was shown to be frequently amplified in non-small cell lung cancer 
comprising lung adenocarcinoma and squamous cell carcinoma (Kang et al., 2008; 
cBioPortal for Cancer Genomics www.cbioportal.org). Remarkably, beside breast and 
colorectal cancer, non-small cell lung cancer represents another tumour entity, which is 
frequently linked to CIN and a poor patient outcome (McGranahan et al. 2012; Masuda & 
Takahashi 2002). Thus, CEP72 gene amplification, which comes along with 
overexpression of CEP72 (cBioPortal for Cancer Genomics www.cbioportal.org) might also 
contribute to chromosomal instability in tumour types other than colorectal cancer. 
Substantial similarities can be found to alterations in the CHK2 expression, which is 
frequently lost or repressed in colorectal (Stolz et al. 2010; Ertych et al. 2014) and lung 
cancer (P. Zhang et al. 2004; Stolz et al. 2010). Furthermore, CHK2 is often mutated in 
breast cancer entities, which are not affected by BRCA1 mutations (Meijers-Heijboer et 
al. 2002). Consequently, in addition to BRCA1 mutations, alterations of the Brca1 
stimulating proteins Cep72 and Chk2 might represent alternative genetic lesions which 
contribute to chromosomal instability and poor patient prognosis. 
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